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Abstract 
 
ABSTRACT 
ENGLISH:  
Cardiovascular disease (CVD) is one of the main causes of disability and death worldwide. 
Importantly, in a large extent, CVD are preventable.  
The Mediterranean Diet (MedDiet) is recognized as one of the healthier dietary patterns.  
To date, strong evidence exists supporting the benefits of the MedDiet for the prevention and 
management of CVD.  
This thesis has been conducted in the framework of the PREDIMED Study, a parallel-group, 
multicenter, randomized nutrition trial that evaluated the effects of a MedDiet, compared to a 
low-fat control diet, on the primary prevention of CVD.   
The main objective of the present thesis was to asses the associations between the key 
components and nutrients of the Mediterranean diet (nuts, olive oil and its varieties, and 
magnesium) and CVD, cause-specific and all-cause mortality on an elderly Mediterranean 
population at high cardiovascular risk. All of these foods are key components of the MedDiet 
pattern and are highly consumed in our population.  
The results of the present work demonstrate that after 4.8 years of follow-up, the frequency of 
nut consumption was inversely related to cardiovascular, cancer and total mortality. Olive oil 
consumption, specifically the extra-virgin variety, was associated with a reduced risk of 
cardiovascular disease and cardiovascular mortality. It was also observed that dietary 
magnesium intake was inversely associated with cardiovascular, cancer and total mortality.  
In conclusion, the findings of this work support the healthy benefits of the components of the 
MedDiet on the primary prevention of cardiovascular disease and mortality. 
 
CATALÀ:  
Les malalties cardiovasculars (CV) són una de les primeres causes de morbimortalitat mundial. 
Aquestes malalties, en gran mesura, es podrien prevenir. 
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Abstract 
 
La Dieta Mediterrània ha estat reconeguda com un dels patrons alimentaris més saludables.  
Fins el moment existeix l’evidència científica que demostra els beneficis de la dieta Mediterrània 
en la prevenció i el tractament de la malaltia cardiovascular. 
La tesi que es presenta s’ha realitzat en el context de l’estudi PREDIMED, un estudi clínic 
paral·lel, multicèntric i aleatoritzat que ha avaluat l’efecte de la dieta Mediterrània, en 
comparació a una dieta baixa en greix, en la prevenció primària de la malaltia cardiovascular.  
L’objectiu principal d’aquesta tesi ha estat determinar l’efecte dels components i nutrients de la 
dieta Mediterrània (fruits secs, oli d’oliva i les seves varietats, i magnesi) en la malaltia 
cardiovascular i la  mortalitat (per causa específica i per totes les causes) en una població 
Mediterrània amb alt risc cardiovascular. 
S’ha tingut en compte que tots els aliments que s’han avaluat són components claus del patró de 
dieta Mediterrània i són consumits en quantitats relativament altes per la nostra població. 
Els resultats del present treball, després de fer un seguiment als participants durant una mitjana 
de 4,8 anys, demostren que consumir fruits secs amb més freqüència està inversament 
relacionat amb la mortalitat cardiovascular, amb la mortalitat per càncer i amb la mortalitat 
total. El consum d’oli d’oliva, concretament la varietat extra verge, s’associa a una disminució del 
risc de malaltia cardiovascular i mortalitat cardiovascular. També s’ha observat que el magnesi 
dietètic s’associa inversament a la mort cardiovascular, per càncer i mortalitat total.  
Podem concloure que els resultats d’aquesta tesi corroboren els efectes beneficiosos dels 
components de la dieta Mediterrània en la prevenció de malaltia cardiovascular i en la 
mortalitat.   
 
CASTELLANO:  
Las enfermedades cardiovasculares (CV) son una de las primeras causas de morbimortalidad 
mundial. En gran medida, estas enfermedades se podrían prevenir. 
La Dieta Mediterránea ha sido reconocida como uno de los patrones alimentarios más 
saludables. Hasta el momento, existe evidencia científica que demuestra los beneficios de la 
dieta Mediterránea en la prevención y el tratamiento de la enfermedad cardiovascular.  
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Abstract 
 
Esta tesis ha sido realizada en el contexto del estudio PREDIMED, un estudio clínico paralelo, 
multicéntrico y aleatorizado que evalúa el efecto de la dieta mediterránea, en comparación a una 
dieta baja en grasa, en la prevención primaria de la enfermedad cardiovascular.  
El principal objetivo ha sido determinar el efecto de los componentes y nutrientes de la dieta 
Mediterránea (frutos secos, aceite de oliva y sus variedades, y magnesio) en la enfermedad 
cardiovascular y la mortalidad (por causa específica y por todas las causas) en una población 
Mediterránea con alto riesgo cardiovascular.  
Todos los alimentos evaluados son componentes claves del patrón de dieta Mediterránea y son 
consumidos en altas cantidades en nuestra población. 
Después de seguir a los participantes durante una media de 4.8 años, los resultados del presente 
trabajo demuestran que consumir frutos secos con más frecuencia está inversamente 
relacionado con la mortalidad cardiovascular, mortalidad por cáncer y mortalidad total. 
Observamos también que el aceite de oliva, concretamente la variedad extra virgen, se asocia a 
un riesgo reducido de enfermedad cardiovascular y mortalidad cardiovascular. Por otra parte, el 
magnesio dietético se asocia inversamente a la muerte cardiovascular, por cáncer y mortalidad 
total. 
En conclusión, los resultados corroboran los efectos beneficiosos de los componentes de la dieta 
Mediterránea en la prevención de enfermedad cardiovascular y muerte. 
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1. INTRODUCTION 
1.1. CARDIOVASCULAR DISEASE  
Cardiovascular disease (CVD) is one of the main causes of disability and death worldwide. It is 
considered as non-communicable, and by definition, is non-infectious and non-transmissible 
among people. It has been estimated that more than 17 million people died from CVD in 2008. 
Of them, 3 million died before the age of 601. The percentage of premature deaths from CVD 
ranges from 4%, in high-income countries, to 42%, in low-income countries1. The high 
prevalence of CVD across the world has become an important health and socioeconomic 
problem, thus increasing public health cost. Since evidence suggests that most of CVD and its 
related risk factors are largely preventable by primary prevention, the efforts should be focused 
on increasing the awareness of its importance. Global and national strategies based on the use of 
adequate medication to reduce hospitalisation and incremental costs of cardiovascular events 
and also behavioural risk factors, including changes in lifestyle and diet, could be effective for 
the primary prevention of CVD. 
 
1.1.1. Definition and physiopathology 
CVD, the most frequent cause of worldwide deaths, comprises the diseases of the arterial tree. 
CVD is often manifested by coronary heart disease, which includes myocardial infarction or 
angina secondary to ischemic coronary artery disease, cerebrovascular disease (i.e. stroke) and 
peripheral vascular disease. Other manifestations of CVD are aorta aneurysm or erectile 
dysfunction1, which affect other arteries. The physiopathology of atherosclerosis is a 
progressive process that includes accumulation of lipids, cholesterol, fibrous elements and 
immune components in the subendothelial layer of the larger arteries. These accumulations lead 
to a progressive occlusion of the vessel lumen of the arteries; and increasing permeability of the 
endothelium layer contributes to the accumulation of low-density lipoprotein (LDL) particles in 
the intima. In the next stage, monocytes can be observed adhering to the surface of the 
endothelium. Here monocytes proliferate, differentiate into macrophages and take up the 
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lipoproteins to form subendothelial accumulations of cholesterol-rich macrophages called ‘foam 
cells’2. When the foam cells die, they release their lipid-filled content to the necrotic core of the 
lesion. Some fatty streaks subsequently accumulate in the smooth muscle cells and occlusive 
fibrous plaques develop2. The resulting atheromatous plaques occlude the blood vessel and 
reduce the elasticity of the artery walls, impeding blood flow. A key challenge is to identify the 
vulnerable or non-stable plaques because their rupture releases lipid fragments and cellular 
debris into the vessel lumen, where they are exposed to thrombogenic agents on the endothelial 
surface, resulting in the formation of a thrombus3. The rupture of the atherosclerotic plaque and 
the formation of a thrombus have important clinical relevance because they are complex 
pathological processes that develop over many years, ultimately contributing to coronary heart 
disease (CHD) and cerebrovascular disease with serious consequences.  
 
1.1.2. Epidemiology  
According to the World Health Organisation (WHO)1, of the 57 million global deaths that 
occurred in 2008, 17.3 million (30%) were due to CVD. In recent years, deaths from CVD have 
declined in high-income countries, but have increased in low- and middle-income countries to 
account for over 80% of all cardiovascular deaths. It is estimated that in 2030, about 23 million 
people, 36% more than in 2008, will die from CVD1 (See Figure 1). In 2011, the leading cause of 
death was CVD (31%) and other non-communicable disease (33%) (See Figure 2). Both in men 
and women, the first cause of cardiovascular death is ischemic heart disease (46% in men and 
38% in women), followed by cerebrovascular disease (34% in men and 37% in women)1 (See 
Figure 3).  
Importantly, 29% of non-communicable disease deaths in low-income countries and 13% in 
high-income countries occur before the age of 60. According to the WHO, CVD was responsible 
for the largest proportion (39%) of non-communicable disease deaths in people less than 70 
years old1. CHD is a major contributor to disability-adjusted life-years (DALYs) loss, which is 
calculated as the time lost due to premature mortality and time lived with disability. In Europe, 
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16 million DALYs were lost due to CHD in 20024. In Spain alone, 125,000 deaths per year are 
attributed to atherosclerosis, 5 million people are hospitalised because of CVD and about 56,000 
patients per year are diagnosed with CVD5.  
The main risk factors of CVD are type 2 diabetes, hypertension, dyslipidaemia and abdominal 
obesity. Other contributors are unhealthy diet, tobacco smoking, physical inactivity and the 
harmful use of alcohol, which lead to a subsequent weight gain. These features, in combination 
with an aging population, are triggers that increase the prevalence of CVD, which could be 
considered the epidemic of the 21st century.  
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Figure 1. World map showing the global distribution of cardiovascular disease mortality rates (age 
standardised, per 100 000) (WHO Report 2011)1.  
 
 
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
Introduction 
 
 
7 
 
 
 
 
 
 
 
Figure 2. Distribution of major causes of death worldwide (WHO Report 2011)1. 
 
 
 
 
Men Women 
Figure 3. Distribution of cardiovascular disease deaths due to myocardial infarction, stroke and other 
types of cardiovascular disease (WHO Report 2011)1. 
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1.1.3. Cardiovascular risk factors  
Cardiovascular risk factors are those that contribute to a higher probability or risk of suffering 
from CVD, and are related to an increased risk of death from cardiovascular causes. A number of 
metabolic and behavioural risk factors have been associated with an increased prevalence of 
CVD and mortality. Non-modifiable risk factors (e.g.  age, sex, ethnicity and family history) and 
modifiable risk factors (e.g. physical activity, tobacco smoking and diet) often coexist and act 
synergistically to increase the total risk of developing CVD, which can be considered a 
multifactor disease. Some of the well-identified strong risk factors of CVD are: type 2 diabetes 
mellitus, hypertension, dyslipidaemia, abdominal obesity and metabolic syndrome. Lifestyle and 
diet play an important role in the prevention of these risk factors that lead to an increased risk 
of CVD, its related complications and mortality. It has been demonstrated that reducing diastolic 
blood pressure by 5 mmHg through pharmacological treatment reduces the risk of stroke by 
34% and ischemic heart disease by 21%6. A meta-analysis has also shown that reducing LDL 
cholesterol concentrations by 1 mmol/L was associated with a 26.6% lower risk of CVD, a 28% 
lower risk of cardiovascular mortality and a 15.6% lower risk of all-cause mortality7. In the 
diabetic population, treatment with lipid-lowering medication also reduces cardiovascular risk8. 
In addition, a systematic review and meta-analysis of 87 studies found that metabolic syndrome 
is associated with a 2-fold increase in the risk of stroke, CVD and cardiovascular mortality and 
1.5-fold increase in the risk of all-cause death9.   
Besides pharmacological treatment to reduce cardiovascular risk factors that lead to 
hospitalisation, and increased cardiovascular events and its associated costs, a great percentage 
of CVD and deaths could be prevented by reducing modifiable risk factors. According to the 
WHO, 9% of deaths are attributed to tobacco smoking, 6% to physical inactivity and 5% to 
overweight and obesity1 (See Figure 4). Large epidemiologic cohort studies have demonstrated 
that a healthy lifestyle results in a lower risk of developing CVD and other chronic diseases. In 
1986, Health Professionals’ Follow-up Study (HPFS), which included 42,847 men, showed that 
those who did not smoke, had a body mass index (BMI) < 25 kg/m2, worked out at least 30 
minutes per day, had a moderate alcohol intake (5-30 g/day) and had a healthy diet according to 
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the United States Department of Agriculture (USDA) healthy index, had an 87% lower relative 
risk of cardiovascular events after 16 years of follow-up. It has also been demonstrated that for 
those who adopted 2 of these 5 healthy behaviours, the risk of CVD was lowered by 27%10. 
These results were consistent with later results found in the Nurses’ Health Study (NHS), 
including more than 84,000 women, where similar percentages for reduction for CVD risk were 
observed in the women who had a healthy lifestyle11. Large European Studies, such as the 
European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort, have also 
demonstrated the beneficial effect of healthy lifestyles on the prevention of CVD. The EPIC-
Norfolk study followed 20,244 men and women from England over 11 years and evaluated the 
association of 4 lifestyle factors on mortality. Each of the health behaviours: smoking, being 
physically inactive, not having a moderate alcohol intake, and a low fruit and vegetable intake as 
indicated by plasma vitamin C level <50 mmol/l were associated with significantly higher risks 
of mortality from all causes. After adjusting for potential confounders, the relative risk (95% 
confidence interval (CI)) of all-cause mortality for those who had one, two, three or four 
unhealthy factors were 1.39 (1.21-1.60), 1.95 (1.70-2.25), 2.52 (2.13-3.00) and 4.04 (2.95-5.54), 
respectively (P for trend <0.001)12. Data from the Potsdam Study, which included 23,153 
participants followed for 8 years, showed that adherence to four healthy behaviours (no 
smoking, BMI < 30 kg/m2, physical activity greater or equal to 3.5 hours per week, and a high 
consumption of fruits and vegetables, whole grains and a low consumption of red meat) was 
associated with a 78% lower risk of any of the following chronic disease: diabetes, myocardial 
infarction, stroke and cancer. Having only one of the healthy behaviours was associated with a 
reduced risk of chronic disease by 50%13. 
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Figure 4. Ranking of 10 selected risk factors of cause of death (WHO Report 2011)1. 
 
 
1.1.3.1. Non modifiable risk factors 
a) Sex and ethnicity 
The risk of incident CVD is generally greater in men, albeit the risk in women increases after 
menopause. This gender difference is due to the protective antioxidant effect of the hormone 
oestrogen in women during fertile years. Most CVD risk factors, CVD events and CVD-related 
mortality appear to be significantly higher among blacks than whites.  
On the basis of data collected from large prospective studies, such as the Atherosclerosis Risk in 
Communities Study (ARIC), the Cardiovascular Health Study (CHS), and the Multi-Ethnic Study of 
Atherosclerosis (MESA), it was determined that CVD events affect blacks earlier in life than 
whites. However, this association disappeared when the data was adjusted for CVD risk factors. 
In the ARIC study, black men and women aged 45 to 64 at baseline were shown to be more likely 
than their white counterparts to experience CHD14.  
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Coronary artery calcification strongly correlates with the magnitude of coronary atherosclerotic 
plaque burden and with the development of subsequent coronary events. A family history of 
premature CHD is a known risk factor for CHD events and may indicate an increased 
susceptibility to atherosclerosis development and progression. The MESA study assessed the 
association between family history of premature CHD and coronary artery calcification. The 
MESA study results showed that a family history of premature CHD is strongly associated with 
coronary artery calcification not only in whites and blacks but also in Hispanics and Chinese. In 
fact, the association of a family history of premature CHD with coronary artery calcification 
appeared stronger among Chinese Americans than other ethnic groups. These relationships 
were independent of other risk factors15.  
 
b) Age 
One of the most prominent, but also non-modifiable, risk factor of cardiovascular disease is 
advancing age. The burden of CVD has been accelerated in recent years by an increase in the 
ageing population. The increase in life expectancy in developed countries is not always balanced 
with the quality of life in later years, with CVD becoming increasingly common during advancing 
age. As a person gets older, the heart undergoes subtle physiologic changes, even in the absence 
of disease. Years ago, the most widely used risk prediction model, the Framingham equation, 
estimated 10-year risk of CHD and included age as one of the main risk factors for CHD, among 
others, such as blood pressure and smoking16. Subsequently, age has been included in many 
newer prediction models as a principal risk factor to predict the incidence of CVD.  
More recently, a meta-analysis using data from 18 cohort studies and including more than 
250,000 black and white participants showed that the risk of CVD increases with age. However, 
among participants who were 55 years of age, those with optimal risk-factor profile (e.g. optimal 
cholesterol, optimal blood pressure concentrations, non-smokers and non-diabetic) have a  
substantially lower risk of dying from CVD through 80 years of age than participants with more 
major risk factors (4.7% vs. 29.6% among men and 6.4% vs. 20.5% among women)17. 
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c) Genetics and familiar history 
It is extensively known that CVD is a well-known multifactorial disease that involves both 
genetic and environmental factors. CVD could also be associated with a multigenetic 
predisposition; however, this is still not clearly established.  
Family history of premature CHD has been strongly related to a higher prevalence and 
magnitude of CHD in several studies. In a multiethnic US study with a cohort of 38% White, 28% 
Black, 22% Hispanic, and 12% Chinese participants, the results showed that family history of 
premature CHD was significantly associated with coronary artery calcification in all ethnic 
groups, and the relation was independent of other risk factors and the Framingham Risk Score15. 
The findings of this study were consistent with previous published studies that showed familial 
clustering of CHD. For example, in the Framingham Heart Study, the risk for an adverse 
cardiovascular event was increased for those individuals having a family history of premature 
heart disease (Odds Ratio (OR), 1.7 to 2.0)18. In addition, early twin studies determined that 
heritability for coronary artery disease is an established risk factor. Data from 21,004 Swedish 
twins followed for 26 years showed that at younger ages, death from CHD were higher for 
monozygotic twins than dizygotic twins in both men and women. This study also observed 
genetic effects to be greater in younger twins than in older twins19. 
Besides twin studies, linkage analysis, allele sharing methods, association studies, and analysis 
of large crosses in model organisms are other approaches to genetically dissect CVD and other 
complex diseases. More than 300 candidate genes for coronary artery disease have been 
identified by the candidate gene approach, which assesses the association of a particular allele 
or variant of a gene with a disease. This can be done for a wide range of metabolic pathways 
involved in lipid metabolism, blood coagulation, blood pressure, inflammation, cell cycle 
regulation, and others. A common problem with many published association studies is that a 
positive association observed in one study is often not reproduced in subsequent studies. 
However, certain genes such as Angiotensin I converting enzyme (ACE), Angiotensin II receptor 
type 1 (AGTR1), Angiotensinogen (AGT), Methylenetetrahydrofolate reductase (MTHFR), Nitric 
oxide synthase 3 (NOS3), Paraoxonase 1 (PON1), Serpin peptidase inhibitor, clade E, member 1 
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(SERPINE1) and Interleukin-6 (IL6) that were found to be associated with CHD have been widely 
replicated across multiple study populations20. Using the approach of Genome Wide Association 
Scan (GWAS) based on Single Nucleotide Polymorphism (SNPs), 13 novel genomic regions at 
which common genetic variants influence the predisposition for CVD have been identified in a 
meta-analysis conducted by the Coronary Artery Disease Genome-Wide Replication Meta-
Analysis (CARDIoGRAM) group and ten previously established loci were replicated21. The 
International Consortium for Coronary Artery Disease is another group involved in large-scale 
meta-analyses of GWAS and has identified three additional loci. So far, 32 novel loci have been 
established from both independent GWAS studies and meta-analyses for CHD phenotype22. 
A few years ago, nutrigenetics arose as a way to identify informative genetic variants 
responsible for gene-diet interactions that differ dramatically among individuals. This provides 
additional information about the mechanisms associated with the interindividual variability in 
dietary response that can be used to develop more personalised dietary recommendations23. 
For instance, findings from the PREDIMED Study (PREvención con DIEta MEDiterrránea Study) 
showed that cardioprotective effects of the Mediterranean Diet (MedDiet) may be magnified in 
those participants with a genetic predisposition for diabetes24.  Transcription factor 7-like 2 
(TCF7L2) gene is the strongest and most widely replicated locus associated with type 2 diabetes 
but few studies have examined the relation of this gene with CVD. In the PREDIMED Study, the 
TCF7L2-rs7903146 polymorphism was associated with type 2 diabetes and stroke (adjusted HR 
1.87 (1.62–2.17) and 2.91 (1.36–6.19), respectively, for TT allele compared with CC alelle). The 
study determined that for allele homozygosis (TT) participants with a higher risk for diabetes 
and stroke, a greater adherence to the MedDiet attenuated their genetic risk24, underscoring the 
idea that the genetic predisposition towards CVD could be reduced by dietary intervention such 
as the MedDiet. Other findings from the PREDIMED Study have suggested that a variant 
(rs3812316, C771G, and Gln241His) in the MLXIPL (Max-like protein X interacting protein-like) 
gene encoding the carbohydrate response element binding protein were associated with lower 
plasma triglyceride concentrations and could be enhanced by adherence to the MedDiet25.  
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1.1.3.2. Modifiable risk factors 
a) Physical activity 
The first evidence relating physical activity to CVD dates from the 1953. “The London Bus Study” 
showed that individuals who worked as ticket collectors on double-decker London buses had a 
lower risk of dying from CVD compared to the drivers, who did not engage in physical activity 
during work time26. Since then, many studies have related physical activity, during both leisure 
and work, to lower prevalence and incidence of CVD. Recent studies have demonstrated that low 
to moderate physical activity reduces the risk of cardiovascular events. Thus, physical activity is 
a staple lifestyle target for the primary and secondary prevention of CVD27,28. In the context of 
CVD prevention, regular physical activity has been observed to contribute to weight loss, 
glycaemic control, and improved blood pressure, lipid profile and insulin sensitivity28. The 
beneficial effects of physical activity on CVD may be, in part, mediated by these risk factors. In 
fact, the current scientific societies recommend at least 30 minutes of low to moderate physical 
activity most days of the week to reduce the risk of cardiovascular. 
In addition, physical activity has also been associated with reduced risk of death from CVD. The 
risk of all-cause mortality is increased by 20-30% in people who are insufficiently physically 
active compared with those who moderately or intensely exercise at least 30 minutes most days 
of the week. Data from the WHO has corroborated that approximately 3.2 million deaths each 
year are attributable to insufficient physical activity1.  
On the other hand, results from prospective observational studies suggest a strong positive 
relation between sedentary lifestyle,  CVD and mortality29.  A noteworthy finding was that 
sedentary women who became physically active between baseline and after 6 years of follow-up 
had 32% and 36% lower all-cause and cardiovascular mortality rates, respectively, compared 
with women who were sedentary at both visits29. In addition, the risk of all-cause mortality in 
physically unfit or sedentary diabetics is >2 times higher compared with physically fit men and 
women diabetics regardless of body weight29.  
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b) Tobacco smoking 
Tobacco smoking is one of the main causes of death worldwide. Even though more than 3,000 
people die every day from tobacco-smoking related complications, about 30% of the world’s 
population smokes1. Harmful risks to health from tobacco use result not only from direct 
consumption of tobacco but also from exposure to second-hand smoke30. Approximately six 
million people die every year from smoking and exposure to second hand smoke, accounting for 
6% of all female and 12% of all male deaths in the world. By 2030, deaths related to smoking 
will increase to more than 8 million deaths per year1. It is estimated that smoking causes 10% of 
CVD, and that people who smoke have doubled the probability of suffering from a major 
cardiovascular event compared with non-smokers1. 
INTERHEART study reported that smoking was associated with a 3-fold increased risk of 
suffering from non-fatal CHD. In addition, the risk relationship was suggested to be dose-
dependent, with the risk increasing by 4.6-fold when 20 or more cigarettes per day were 
smoked31. Moreover, data from the Evaluation of secondary prevention of Coronary Heart Disease 
Study (EUROASPIRE III), which included European patients younger than 70 years of age who 
had suffered from cardiovascular events, demonstrated that 30% of the participants were 
smokers when they suffered the coronary event. These data were consistent with previous 
results from EUROASPIRE I and EUROASPIRE II studies32. Scientific evidence has also suggested 
smoking cessation provides a number of benefits on CHD and mortality1. The risk of myocardial 
infarction decreases by half after one year of smoking cessation compared with current 
smokers. Furthermore, after 5 to 15 years of smoking cessation, the risk of stroke and CHD is the 
same as the risk of those who had never smoked, if no target organ injuries occurred before 
smoking cessation33. 
 
c) Diet 
Briefly, a considerable body of evidence shows the negative effects of an unhealthy diet on CVD 
and mortality. High dietary intake of saturated fat, trans fat, cholesterol, salt and low dietary 
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intake of fruits, vegetables and fish have been positively associated with cardiovascular risk1. 
Obesity is one of the main risk factors of CVD and is strongly related to an unhealthy diet and 
physical inactivity.  
About 1.7 million (2.8%) deaths worldwide are attributed to a low intake of fruits and 
vegetables4, and an adequate consumption of fruit and vegetables has been shown to reduce the 
risk of CVD4. Another important dietary factor is salt, which can be used as a determinant of 
blood pressure levels and cardiovascular risk34. In addition, frequent consumption of high-
energy foods, such as processed foods that are high in salt, fats and sugars, leads to increased 
obesity and consequently a higher cardiovascular risk compared with consumption of low-
energy foods1. A healthy diet can contribute to a healthy body weight, a desirable lipid profile 
and an optimal blood pressure, thus, reducing the risk of CVD and mortality. Actions promoting 
a healthy and balanced diet should be the cornerstone of CVD primary and secondary 
prevention. More detailed data about dietary patterns, foods, nutrients, the components of the 
MedDiet and its relation with CVD and mortality are presented below. 
 
 
1.2. DIET, CARDIOVASCULAR DISEASE AND MORTALITY 
1.2.1. Dietary patterns, cardiovascular disease and mortality 
A growing body of literature has shown that not only the effect of isolated nutrients or foods 
(e.g. vitamins, minerals, fruits, vegetables and meat) is important, but we should also consider 
the diet as a whole and evaluate the combination of all dietary components on health. Dietary 
patterns allow us to assess the synergy of all the nutrients in different foods and how they 
interact. Certain types of dietary patterns are considered beneficial for health such as 
“Mediterranean” and “prudent” patterns, but others are considered disruptive for health, such 
as “Western” patterns, and have been associated with higher risk for chronic diseases35. Besides 
these principal dietary patterns, dietary patterns, such as the DASH-Diet, the Nordic diet or the 
Vegetarian diet have also been identified. Dietary patterns can influence cardiovascular health 
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by modifying risk factors such as obesity, dyslipidaemia and hypertension, as well as factors 
involved in systemic inflammation, insulin sensitivity, oxidative stress, endothelial function and 
thrombosis. 
 
1.2.1.1. Western pattern 
Current scientific evidence has suggested that Western dietary patterns are associated with an 
increased risk of CVD and mortality. The Western pattern is characterised by a high intake of 
red and processed meat, refined grains, processed food, sweets, desserts, high-fat dairy 
products and fried foods.  
Epidemiological evidence from a prospective cohort study conducted in the population of the 
NHS I, which included about 69,017 women aged 38 to 63 years, found that a higher Western-
pattern score was associated with a 46% (Relative risk (RR): 1.46; 95% CI, 1.07-1.99) higher 
risk of total myocardial infarction after multivariate adjustment. Similar results were found for 
fatal CHD and nonfatal myocardial infarction36. In the same cohort of the NHS, it was also 
observed that a greater adherence to the Western pattern may increase the risk of 
cardiovascular and total mortality among initially healthy women37. These data are in 
agreement with the prospective cohort HPFS that included men aged 40 to 75 years, where 
greater adherence to the Western pattern was associated with a 43% (RR: 1.43; 95% CI, 1.01-
2.01) increased risk of CHD compared with individuals with the lowest adherence to the 
Western pattern38.  
Data from the MESA study has also reported a positive association between the a posteriori “Fats 
and Processed Meat” dietary pattern and the incidence of CVD39. Recently, the associations 
between Western pattern and the risk of CHD have been analysed in Spanish individuals 
participating in the EPIC-Spain cohort study. The results from this study did not find any 
significant associations between the “Westernised pattern” and the risk of CHD. However, a 
MedDiet pattern was inversely associated with the risk of CHD40. The authors of the paper 
postulated that the pattern described as the Westernised pattern is not as unhealthy as the 
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Western patterns of other regions of the world, namely the United States. The Western dietary 
pattern has also been associated with an increased risk of cardiovascular and total 
mortality37,41,42. 
 
1.2.1.2. Prudent or healthy patterns 
On the other hand, prudent or healthy patterns have been associated with beneficial effects on 
cardiovascular health and other chronic diseases. The prudent pattern is characterised by a high 
intake of vegetables, fruits, legumes, whole grains, low-fat dairy, fish and poultry. Both the 
HPFS38 and the NHS36 have reported that greater adherence to what they termed “Prudent 
pattern” was associated with about a 25% lower risk of CHD. Results of the MESA study also 
showed an inverse association between the Whole Grains and Fruit dietary pattern and the risk 
of CVD39. In addition, the prudent diet was associated with a 28% (RR: 0.72; 95% CI, 0.60–0.87) 
lower risk of cardiovascular mortality and a 17% (RR: 0.83; 95% CI, 0.76–0.90) lower risk of all-
cause mortality when the top quintile was compared with the lowest quintile of adherence in 
the NHS37. 
 
1.2.1.3. Mediterranean type diet 
The much appreciated MedDiet is characterised by high intake of fruits, vegetables, legumes, 
fish, whole grains, nuts and olive oil; moderate consumption of dairy products and wine, and 
low intake of red and processed meat and foods that contain high levels of added sugar43 (See 
Figure 5). The relatively high intake of nuts, olive oil and moderate intake of wine, particularly 
red wine during meals, makes the MedDiet unique and different from the other prudent diet 
patterns. The traditional MedDiet has been allied with a reduced risk of cardiovascular risk 
factors, CVD and mortality44.  
The first scientific evidence, of the health benefits of the MedDiet, probably came from a study in 
which patterns of food consumption in seven different countries were compared. The ecological 
study which was conducted several years ago45 in the Mediterranean regions, revealed that the 
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dietary habits and the type of fat consumed had healthy compounds that prevent mortality from 
cardiovascular diseases45. As per the MONICA study, in Southern European Countries, low rates 
of CHD and its risk factors were also attributed to the cardio-protective effects of the MedDiet46.  
 
 
Figure 5. Mediterranean diet pyramid. Fundación dieta Mediterránea 2010. 
 
Over the years, a number of significant prospective cohort studies and intervention trials have 
been conducted, which analysed the relation between MedDiet, CVD and mortality. The 
foremost finding of such prospective cohort studies suggests associations between MedDiet 
pattern and a reduced risk of CHD and mortality44. Table 1 shows the data from prospective 
cohort studies performed to analyse the associations between MedDiet, CVD risk and all-cause 
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mortality. Most of the studies found a consistent inverse association between MedDiet, CVD and 
all-cause death, in different populations.  
For instance, in the NHS, a greater adherence to the MedDiet, as reflected by a higher Alternate 
MedDiet Score, was found to be associated with 29% (RR: 0.71; 95% CI, 0.62-0.82) lower risk of 
CHD incidence and 27% (RR:0.87; 95% CI, 0.73-1.02) lower risk of stroke in women47. In the 
EPIC-Spain cohort study, MedDiet was associated with 27% (RR: 0.73; 95% CI, 0.57–0.94) lower 
risk of CHD40. EPIC also showed that a 2-point increase in a MedDiet score was related to 25% 
and 8% reduced risk of all-cause mortality in a Greek population43 and in elderly subjects48 
respectively. Moreover, a meta-analysis comprising seven prospective cohort studies and 
2,000,000 subjects, showed that 2-point increase in adherence to the MedDiet, caused 
significant reduction in overall mortality (by 8%) and CVD incidence and mortality (by 10%)44.  
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Table 1. Summary of the evidence from epidemiological cohort studies on the Mediterranean diet 
and cardiovascular and all-cause mortality. 
Reference 
(year) 
Population
/ Region 
Cases/Total Endpoint 
Follow-
up 
Measurement 
Results 
Multivariate 
HR 
(95% CI) 
Trichopoulou 
et al, 199549 
Elderly/ 
Greeks 
53/182 
All-cause 
death 
1-year 
1-unit increase 
in MedDiet 
score 
0.83 
(0.69-0.99) 
Kouris-Blazos 
et al, 199950 
Elderly/ 
Greek 
Australians 
and Anglo-
Celts 
38/330 
All-cause 
death 
1-year 
1-unit increase 
in MedDiet 
score 
0.83 
(0.67-1.02) 
De Lorgeril et 
al, 199951 
Adults/ 
Swiss 
3,935/17,861 
(1,385 CVD 
death) 
CVD 
death  
All-cause 
death 
32-
years 
1-unit increase 
in MedDiet 
score 
CVD death: 
0.98 
(0.92-1.04) 
All-cause 
death: 0.96 
(0.94-0.98) 
Lasheras et al, 
200052 
Elderly/ 
Spanish 
96/161 
All-cause 
death 
9.5-
years 
1-unit increase 
in MedDiet 
score (only at 
age <80 years) 
0.69 
(0.43-0.93) 
 
Knoops et al, 
200453 
Elderly/ 11 
European 
countries 
935/2,339 
(371 deaths 
from CVD) 
CVD 
death 
All-cause 
death 
10-
years 
At least 4/8 
score in 
MedDiet 
 
CVD death: 
0.71 
(0.58-0.88). 
All-cause 
death: 0.77 
(0.68-0.88) 
Trichopoulou 
et al, 200554 
Elderly/ 10 
European 
countries 
4,047/74,607 
All-cause 
death 
7.5-
years 
2-unit increase 
in MedDiet 
score 
0.83 
(0.75-0.93) 
Lagiou et al, 
200655 
Adult 
women/ 
Swedish 
572/42,237 
All-cause 
death 
12.01-
years 
2-unit increase 
in MedDiet 
score 
0.93 
(0.83-1.03) 
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Table 1. Continuation. 
Reference 
(year) 
Population 
/ Region 
Cases/Total Endpoint 
Follow-
up 
Measurement 
Results 
Multivariate 
HR 
(95% CI) 
Mitrou et al, 
200756 
Adults/ 
American 
27,779 
/380,296 
(3,451 deaths 
from CVD) 
CVD 
death 
All-cause 
death 
10-
years 
6-9 MedDiet 
score 
compared to  
0-3. 
 
CVD death in 
men: 
0.78 
(0.69-0.87) in 
women: 
0.81 
(0.68-0.95) 
All-cause 
death in men: 
0.91 
(0.88-0.94) in 
women: 
0.80 
(0.75-0.85) 
Brunner et al, 
200857 
Adults/ 
British 
33/1,311 
(Fatal CHD + 
nonfatal MI) 
51/1,318 
(all-cause 
death) 
Fatal CHD 
+ 
nonfatal 
MI 
All-cause 
death 
15-
years 
MedDiet 
pattern 
compared to 
unhealthy 
dietary pattern 
Fatal CHD + 
nonfatal MI: 
0.77 
(0.50-1.19) 
All-cause 
death: 0.81 
(0.57-1.15) 
Trichopoulou 
et al, 200958 
Adults/ 
Greek 
1,075/23,349 
All-cause 
death 
8.5-
years 
2-unit increase 
in MedDiet 
score 
0.86 
(0.80-0.93) 
Fung et al, 
200947 
Adult 
women/ 
American 
794/76,522 
CVD 
death 
20-
years 
Quintile 5 of 
MedDiet score 
compared to 
Quintile 1 
Fatal CHD: 
0.58 
(0.45-0.75) 
Fatal Stroke: 
0.69 
(0.44-1.07) 
Buckland et 
al, 200959 
Adults/ 
Spanish 
609/41,078 
Fatal and 
non-fatal 
CHD 
10.4-
years 
1-unit increase 
in MedDiet 
score 
Men: 
0.94 
(0.91-0.97) 
Women: 
0.93 
(0.87-0.99) 
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Table 1. Continuation. 
Reference 
(year) 
Population/ 
Region 
Cases/Total Endpoint 
Follow-
up 
Measurement 
Results 
Multivariate 
HR 
(95% CI) 
Martínez-
González et 
al, 201160 
Middle-aged  
adults/ 
Spanish 
100/13,609 
(incident 
CVD, 8 fatal) 
Fatal and 
non-fatal 
CVD and 
fatal and 
non-fatal 
CHD 
4.9-
years 
2-units 
increase in 
MedDiet score 
Incident 
CVD: 0.80 
(0.62-1.02) 
Incident 
CHD: 0.74 
(0.55-0.99) 
Buckland et 
al, 201161 
Adults/ 
Spanish 
1,855/40,622 
(399 from 
CVD) 
CVD death 
All-cause 
death 
13.4-
years 
2-units 
increase in 
MedDiet score 
CVD deaths: 
0.88 
(0.81-0.95) 
All-cause 
death: 0.94 
(0.90-0.97) 
Gardener et 
al, 201162 
Adults/ 
American 
518/2,568 
(incident 
CVD, 314 
CVD deaths) 
Incident 
CVD 
CVD death 
9-years 
1-unit 
increase in 
MedDiet score 
Ischemic 
stroke: 1.00 
(0.90-1.10) 
MI: 0.94 
(0.84-1.05) 
CVD death: 
0.91 
(0.85-0.98) 
McNaughton 
et al, 201263 
Elderly/ 
British 
654/972 
All-cause 
death 
14-
years 
Quartile 4 of 
MedDiet score 
vs quartile 
0.78 
(0.62-0.98) 
Zazpe et al, 
201464 
Middle-aged 
adults/ 
Spanish 
148/16,008 
All-cause 
death 
6.96-
years 
Tertile 3 of 
MedDiet score 
vs tertile 1 
0.53 
(0.34-0.84) 
Atkins et al, 
201465 
Elderly 
men/ British 
933/3,328 
(327 CVD 
deaths) 
CVD death 
All-cause 
death 
11.3-
years 
Quartile 4 of 
MedDiet score 
vs quartile 1 
CVD death: 
0.63 
(0.42-0.94) 
All-cause 
death: 0.75 
(0.60-0.94) 
 
Abbreviations: HR, hazard ratio; CI, confidence interval; MedDiet, Mediterranean diet; CVD, cardiovascular diseases; 
CHD, coronary heart disease; MI, myocardial infarction. 
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The intervention studies have also helped to confirm causality on the protective role of the 
MedDiet on cardiovascular health. The Lyon Diet Heart Study was a randomised controlled trial 
(RCT) of secondary prevention and evaluated the effect of the MedDiet on the risk of suffering 
from a second myocardial infarction after 46 months of follow-up66. It was observed that the 
individuals who were randomised to the MedDiet group, had 47% reduced risk of myocardial 
infarction and cardiovascular death, as compared to the control group66. In the GISSI-
Prevenzione secondary prevention trial, patients who had suffered from a myocardial infarction 
and who were advised to have high intake of fish, fruits, olive oil, raw and cooked vegetables, 
had 49% reduced risk of death in comparison to those who weren’t advised so67. 
Until now, there has been no evidence of the effect of MedDiet on primary prevention of CVD. 
The PREDIMED trial is the largest and unique intervention study which has been designed to 
evaluate the effect of the MedDiet on primary cardiovascular prevention as compared to a low-
fat control diet68. So far, the results have demonstrated that the MedDiet supplemented with 
extra-virgin olive oil (EVOO) or nuts is associated with lower blood pressure, improved lipid 
profile, reduced concentration of inflammatory markers (such as C-reactive protein), decreased 
insulin resistance and diminished risk of type 2 diabetes and metabolic syndrome69–72. The most 
important observations of the PREDIMED Study suggested that among the persons who are at 
high risk of cardiovascular disease, an energy-unrestricted MedDiet supplemented with EVOO 
led to reduced risk of the primary end-point (a composite of myocardial infarction, stroke and 
cardiovascular death) by 30% (RR: 0.70; 95% CI, 0.54-0.92) and by 28% when the MedDiet was 
supplemented with nuts (RR: 0.72; 95%, 0.54-0.96). The results were expressed in comparison 
to the control group, following a low-fat diet68 (See Figure 6).  
The epidemiological evidence relating the MedDiet to cancer mortality is still inconclusive. 
However, a meta-analysis including seven prospective cohort studies suggested that 2-point 
increase in MedDiet score was associated with 6% reduced risk of death due to cancer (HR: 
0.94; 95%, 0.92-0.96)44. 
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Figure 6. Incidence of composite of primary endpoint in the PREDIMED trial68. 
 
 
 
1.2.2. Components of the Mediterranean diet, cardiovascular disease and mortality 
The beneficial health effects of the MedDiet are primarily attributed to the diet pattern’s key 
foods and characteristic food groups, which contain a number of bioactive compounds, such as a 
favourable fatty acids, high dietary fibre, antioxidants and phytochemicals73. Mediterranean 
food has strongly contributed to the observable healthy benefits of the MedDiet on 
cardiovascular health74.  
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1.2.2.1. Olive oil 
Olive oil has been proposed as one of the key components of the MedDiet which makes it cardio-
protective75. Olive oil is the main source of vegetable fat and is used abundantly as a culinary fat 
and for dressing dishes. It is mainly comprised of  the mono-unsaturated (MUFA) oleic acid76,77. 
The best quality olive oil, which is rich in taste and colour, and also contains high amount of 
bioactive compounds, is EVOO variety. Virgin and EVOO varieties are one of the important 
sources of vitamin E, polyphenols (mainly flavonoids) and other minor bioactive 
phytochemicals and lipid molecules (such as squalene, tocopherols, etc.)76. In the Mediterranean 
diet pyramid, olive oil is included as an essential food in the main meals.  
Experimental studies and clinical trials have shown that olive oil, especially the virgin olive oil, 
due to its antioxidant capacity, is beneficial in the prevention of CHD and its risk factors75. A 
MedDiet supplemented with olive oil has been observed to improve the lipid profile, and  have 
favourable effects on endothelial dysfunction, hypertension, inflammation, insulin sensitivity 
and diabetes69–72,75.  
The observational studies have provided  promising evidence which suggests that olive oil 
intake is inversely associated with CVD, in both the Spanish general population77 and in a cohort 
of Italian women78. In the Spanish cohort of the EPIC study, the total olive oil intake was found to 
be associated with a decreased risk of CHD, cardiovascular mortality and all-cause mortality79,80. 
It is worth mentioning that the effect of virgin olive oil on CHD was greater than the refined 
olive oil79. A lower risk of mortality was associated with regular consumption of olive oil, in an 
Italian population after myocardial infarction67 and also in an elderly population81.  
A recent meta-analysis concluded that epidemiologic studies consistently found an inverse 
association between olive oil consumption and stroke, but there were inconsistencies between 
the studies which assessed CHD as the end-point82. Besides, although the evidence is weak, it 
has been reported that olive oil could be beneficial in the prevention of certain cancers83, such as 
breast cancer.  
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1.2.2.2. Nuts 
Nuts are one of the important components of the MedDiet and a good source of unsaturated 
fatty acids, rich in vegetable fat and fibre, minerals (potassium, calcium and magnesium), 
vitamins (folate, vitamin C and E) and other bioactive compounds (phytosterols and 
polyphenols)84,85. There is strong scientific evidence, which suggests that the intake of nuts is 
favourable for cardiovascular health, and such effect can be attributed to their unique 
nutritional composition86. The current Spanish guidelines encourage the population to consume 
3 to 7 servings/week of nuts (1 serving equals 28 g).  
A large body of literature have shown that frequent nut consumption is associated with a 
reduced load of cardiovascular risk factors, like dyslipidaemia, type 2 diabetes and metabolic 
syndrome72,87–89.  A pooled analysis of four large-scale observational studies showed that the 
subjects in the highest category of nut consumption had a 35% reduced risk of incident CHD88. 
The results have been confirmed with the large-scale PREDIMED trial which has found 29% 
reduction in the risk of a composite of cardiovascular events in those individuals who were 
randomised to a MedDiet supplemented with nuts68. 
The frequency of nut consumption was also found to be related to lower rates of sudden cardiac 
death in a large cohort of men90. Reports from the Iowa Women’s Health study91, a large Dutch 
cohort92, and the U.S. NHS and HPFS93, suggested that frequent nut consumption is inversely 
related to total and cause-specific mortality. The more recent meta-analysis which included 18 
prospective cohort studies indicates that the consumption of nuts is inversely associated with 
ischemic heart disease, CVD, and all-cause mortality but not significantly with diabetes and 
stroke. Such findings support the recommendations to include nuts as part of a healthy dietary 
pattern for the prevention of chronic diseases94.  
The evidence on cancer mortality is scarce95, however, the prospective studies suggest inverse 
associations between intake of nuts and colorectal or endometrial cancer96–98, especially in 
women, and also prostate cancer99. Moreover, a recent prospective epidemiological study on the 
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NHS and HPFS has shown an inverse association between consumption of nuts and death due to 
cancer93. 
 
1.2.2.3. Fruits and vegetables  
The MedDiet is characterised by high intake of fruits and vegetables, which provide high 
amounts of vitamins and minerals (beta-carotene, folate, vitamin C, potassium) and also 
phytosterols and polyphenols (mainly flavonoids). These protective constituents of fruits and 
vegetables act through a variety of mechanisms, such as reducing antioxidant stress, improving 
lipoprotein profile, lowering blood pressure, and increasing insulin sensitivity100. It is a common 
belief that higher consumption of fruits and vegetables is protective against CVD101. It is 
recommended the intake of five servings per day of fruits and vegetables.  
In general, observational epidemiological studies report a favourable relation between fruit and 
vegetable intake and CHD occurrence, although sometimes the findings are inconsistent. A meta-
analysis of cohort studies have reported that fruit intake decreased the risk of CHD by 4% and 
vegetable intake by 7%100. Consumption of fruits and vegetables have also been inversely 
associated with cardiovascular and all-cause death102,103.   
 
1.2.2.4. Legumes and whole grains 
The data regarding association of legumes with CHD is still scarce and most of the research has 
focused on soy products only. However, the results from the National Health and Examination 
Nutrition Survey (NHANES) showed that legume consumption four or more times per week was 
associated with 22% lower risk of CHD as compared to less than once a week intake of 
legumes104. In fact, the Spanish guidelines support that legumes should be consumed two to four 
times per week (1 serving equals 60-80 g of raw legumes). 
Several studies have found an inverse association between the consumption of whole-grains and 
risk of CVD101. Moreover, a review of the available literature concluded that a relationship 
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between whole-grain intake and CHD is seen with at least 20% and perhaps 40% reduction in 
risk for those who eat whole-grain food frequently as compared to those who eat them rarely105. 
Whole grains should be chosen in front of refined grains and the current recommendations 
suggest that 2 servings/d of whole grains should be consumed.  
It may be possible that legumes and whole-grains could be inversely related to mortality, owing 
to the antioxidant activity of phenolic compounds present in legumes and whole-grains105,  the 
benefits of fibre, vitamins and minerals, and also the low glycaemic index (GI)85. However, there 
is still a lack of evidence on these associations. 
 
1.2.2.5. Dairy products 
Dairy products are good sources of vitamins (retinol, riboflavin and vitamin D) and minerals 
(particularly calcium) but they also contain high amounts of fat, especially saturated fat. For this 
reason, there is conflicting evidence on the health benefits of dairy products106. However, it is 
recommended the intake of dairy products between two to four servings/d depending on the 
age and physiologic situation. Low-fat dairy are recommended, in particular, to the adult 
population.  
Based on the current observational studies, the consumption of milk and dairy products is 
inversely related to the incidence of CVD. A systematic review concluded that the dairy 
products, although they contribute to the saturated fat composition of the diet, are not 
associated with an increased risk of CHD107. It has been suggested that dairy products could 
ameliorate characteristics of the metabolic syndrome, a cluster of risk factors that increase the 
risk of diabetes and CVD108. Dairy products, such as cheese, do not exert the negative effects on 
blood lipids, as predicted solely due to the content of saturated fat. Calcium and other bioactive 
components may modify the effects on LDL cholesterol and triglycerides. Yogurt may also 
contribute to beneficial probiotic effects. The consumption of yogurt, and other dairy products, 
in observational studies, is associated with loss of body weight in the context of energy 
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restriction109, and reduced risk of CVD. The findings are, in part, supported by randomised 
trials108.  
The association between the dairy products and mortality remains unclear, due to inconsistent  
findings in the observational studies, which have reported positive, negative or no 
associations107. However, a meta-analysis of 17 cohort studies seems to suggest that the intake 
of milk is not related to cardiovascular and all-cause death110. Therefore, studies, which may 
involve large cohorts, where regular and comprehensive assessments of dairy food consumption 
can be made, are required to confirm such associations. 
 
1.2.2.6. Fish and seafood 
Fish and seafood are rich in protein of high biologic value and are a major source of poly-
unsaturated fatty acids (PUFA), omega-3 and omega-6 fatty acids. An optimal balance between 
omega-6 and omega-3 fatty acids, the anti-inflammatory effects, and other benefits associated to 
these fatty acids are believed to be important for preventing CHD risk factors111.  According to 
the Mediterranean diet pyramid, fish should be consumed at least two times per week.  
A few studies have reported associations between fish and lower risk of CHD112. A meta-analysis 
of observational studies has found that fish consumption versus little to no fish consumption 
was associated with a reduced relative risk of fatal and non-fatal CHD104.  
 
1.2.2.7. Wine     
One of the main characteristics of the traditional MedDiet is the moderate intake of wine mainly 
during meals. Wine, particularly the red one, contains high amounts of polyphenolic compounds, 
flavonoids (quercetin, tannins, and catechin) and other compounds which are thought to be 
beneficial for cardiovascular health. Wine is included in the Mediterranean diet pyramid and it 
could be consume in moderate amounts by adults. 
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The consistent epidemiological data suggest that a light to moderate alcohol consumption is 
associated with reduced risk of fatal and non-fatal CHD and CVD mortality, independently of the 
type of alcohol beverage113. However, red wine, not because of its alcohol content but mainly 
due to its abundant content of polyphenolic compounds, is thought to provide additional 
benefits on lowering CVD risk114. An updated meta-analysis on the relationship between wine 
and cardiovascular events has found that the evidence from 16 prospective and case-cohort 
studies, confirms a J-shaped association between wine intake and fatal or non-fatal 
cardiovascular events. The lowest risk was apparent at 21 g/d of alcohol intake (RR = 0.69; 95% 
CI 0.58-0.82)114. Similar results from this meta-analysis showed that wine was associated with 
less risk of cardiovascular mortality (the maximal protection was 34% at 24 g/d) and also 
provided protection against the risk of total mortality (25% was the lowest risk at 10 g/d intake 
of wine)114. 
Heavy or binge alcohol consumption, unquestionably, leads to increased morbidity and 
mortality. Nevertheless, moderate alcohol consumption, especially of alcoholic beverages rich in 
polyphenols such as wine, seems to confer cardiovascular protective effects both in patients 
with documented CVD and even in healthy subjects115. 
 
 
1.2.3. Nutrients, cardiovascular disease and mortality 
In order to establish dietary patterns and to know the foods that provide benefits to health, it is 
essential to explore which nutrients play important roles in the target pathologies, in this case 
CVD and also death. Until now, macronutrients (carbohydrates, proteins and fats) and 
micronutrients, namely vitamins (vitamin C, E, A, B, D and K) and minerals (magnesium, 
selenium, sodium, calcium and potassium) have been studied to evaluate their effect on CVD and 
mortality. A plant-based diet, rich in fruits and vegetables, nuts, whole-grain cereals and olive 
oil, provides a range of nutrients such as dietary fibre, folate, plant sterols, potassium, 
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antioxidant vitamins, flavonoids and oleic acid, which has been associated with a low risk of 
CHD and stroke101.  
 
1.2.3.1. Macronutrients 
Traditionally, the evaluation of the relationship between the intake of macronutrients 
(carbohydrates, protein and fat) and the risk of CVD has been focused on the total consumption 
rather than their quality. However, several studies conducted during recent years, have 
highlighted the relevance of the effect of different types of carbohydrates, proteins and fats, and 
the replacement of one macronutrient by another on cardiovascular health, along with the 
evaluation of the effect of total macronutrients116.  
 
Carbohydrates 
The scientific evidence, relating carbohydrates to CVD, is still a bit inconsistent. Even though 
some evidence suggests that low-carbohydrate diets are associated with improvement in certain 
risk factors (such as serum triglycerides, High-density lipoprotein (HDL)-levels, glycaemia and 
weight loss)117, data from two cohort prospective studies have reported that a low-carbohydrate 
diet based on animal sources was associated with 23% higher risk of all-cause mortality (RR = 
1.23; 95% CI 1.01-1.24, comparing extreme deciles) in both men and women. On the contrary, a 
vegetable-based low-carbohydrate diet was found to be associated with about 20% lower risk of 
all-cause and CVD mortality rates118. In Europe, a cohort study, comprising more than 40,000 
participants who were followed-up for 15 years, indicated that after adjusting for potential 
confounders, a 2-unit increase in the low carbohydrate-high protein score was significantly 
associated with 5% high incidence of CVD119. In addition, a recent meta-analysis of more than 
272,216 individuals revealed that the risk of all-cause mortality, among the individuals who had 
higher punctuation in a low-carbohydrate score, was significantly elevated: the pooled RR (95% 
CI) was 1.31 (1.07-1.59). The risks of CVD incidence and mortality were not statistically 
significant, but showed a tendency to be so120. Probably, the source and the type of 
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carbohydrates consumed and the amount of fibre they contain is more important than the total 
intake of carbohydrates. High intake of dietary fibre is known to be associated with low risk of 
CVD as depicted in a recent review and meta-analysis121. 
The other factors, that have been widely studied in relation to the carbohydrates of the diet, are 
the glycaemic index (GI) and the glycaemic load (GL). GI has been defined as the incremental 
area under the blood glucose response curve of a 50 g carbohydrate portion of a test food, and is 
expressed as percent of the response to the same amount of carbohydrate from a standard food 
taken by the same subject122.  A low-GI and energy-restricted diet containing moderate amounts 
of carbohydrates, may be more effective than a high-GI and a low-fat diet, in reducing body 
weight and controlling the metabolic risk factors123. There is evidence from epidemiological 
cohort studies which suggests that high dietary GI and GL increase the risk of CHD124. A report 
from the NHS found that after adjustment for potential confounders, dietary GL was directly 
associated with the risk of CHD (HR: 1.98, 95% CI, 1.41-2.77 for the highest quintile of GL 
compared to the reference quintile)125. The results from the ARIC study indicated that every 30-
units increase in GL was associated with 14% (HR: 1.14; 95% CI, 1.02-1.26) increased risk of 
incident CHD in white non-diabetic individuals126. Among the Dutch and the Italian women, who 
consumed modest GL diets, high dietary GL and GI increase the risk of CVD, particularly in 
overweight women127,128. On the contrary, in a large prospective cohort study (EPIC-MORGEN), it 
was observed that the high dietary GL and carbohydrate intake from high-GI foods, increases 
the overall risk of CVD in men but not in women129. The two recent meta-analyses concluded 
that the high dietary GL and GI significantly increase the risk of CHD in women but not in men, 
the unfavourable effects being more pronounced in overweight or obese participants124,130. 
Results from another meta-analysis support that there is a linear dose-response relationship 
between the GL and the CHD risk131. Despite the findings that the dietary GI is slightly associated 
with the risk of CHD, the results of the meta-analysis were insignificant for stroke and stroke-
related death131. 
 
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
Introduction 
 
 
34 
 
Protein 
Generally, it is believed that the vegetable proteins protect from CVD whereas animal proteins 
increase the risk132. The scientific data relating the  protein consumption and health outcomes 
was reviewed recently, in both healthy adults133 and elderly population134. The evidence was 
found to range from suggestive to inconclusive for protein intake and mortality and morbidity. 
In contrast, the intake of vegetable proteins was associated with decreased risk of CVD in 
several studies. The potential adverse effects of protein intake exceeding 20-23% of total 
energy, remain to be investigated133,134. The results from the recent PREDIMED Study, 
demonstrated a U-shape relationship between protein consumption and both body weight and 
mortality (Unpublished results). In particular, the total protein intake was found to be associated 
with significant increase in risk of all-cause mortality in a Mediterranean population which is at 
high cardiovascular risk. These data are in line with the earlier studies, which indicated that a 
high protein intake leads to increased risk of CVD and mortality118,135. However, the evidence is 
still indecisive because some of the studies have found no associations136,137 or suggested 
protection due to high protein intake119,138,139. Probably, the recommendations should focus on 
the type of proteins consumed, giving preference to the vegetal proteins and restricting the 
animal proteins118,132.   
 
Fats 
Dietary fatty acids play significant roles in the cause and prevention of CVD and mortality. 
Briefly, the type of fat, rather than the total, or the ratio or balance between the saturated and 
certain unsaturated fats, may be the determinant. CVD risk could be reduced by decreasing the 
saturated fatty acids and replacing them by a combination of PUFA and MUFA. Table 2 
summarises the data available on the effect of dietary fats and major fat food sources on CVD 
and mortality.  
The trans-fatty acids, from partially hydrogenated vegetable oils, are well-known for their 
adverse effects, and should be significantly decreased from the dietary patterns for humans. 
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Both the n-6 and n-3 PUFA are essential and are linked to the benefits against the CVD risk. The 
intake of MUFA has been related to beneficial health effects, however, its relation with CVD is 
still unclear140. Lately, attention has been given to the effects of saturated fatty acids on 
cardiovascular health. Substantial accruing evidence from meta-analyses of prospective cohort 
studies and RCTs indicates that the effects of consumption of saturated fatty acids on CVD risk 
vary depending upon the replaced nutrient. Therefore, the American Heart Association (AHA) 
recommends to limit the intake of saturated fatty acids140. Recently, the research in the field, has 
questioned if there are really positive significant associations between saturated fat intake and 
CVD, as traditionally speculated. Most of the meta-analyses failed to show associations between 
the intake of saturated fat and risk of CHD, stroke or mortality. However, the studies were 
unable to consider the effects of replacing nutrients alone and it may be a bias in self-reporting 
the intake of saturated fat in dietary questionnaires141–144. For the moment, the available data is 
insufficient to conclude that the dietary saturated fat is associated with an increased risk of CVD, 
stroke and mortality.  
On the other hand, PUFA in place of saturated fat, was found to be associated with reduced risk 
of CHD and death in a pooled analysis of 11 prospective cohort studies, however, no association 
was seen for replacement with MUFA145. Another recent pooled analysis, of 8 RCTs, concluded 
that the CHD risk is reduced by 10% for every 5% intake of energy  from PUFA replacing 
saturated fatty acid146. Regarding the intake of the trans-fatty acids, there is strong evidence 
from meta-analyses supporting a highly significant association between the trans-fat and CVD 
morbidity and mortality141,142,147. This may be explained, chiefly, by the adverse effects of the 
trans-fat on HDL and LDL cholesterol levels, particularly the industrial hydrogenated trans-
fat148,149. The AHA recommends limiting the use of trans-fat to maximum extent. Owing to the 
detrimental effects of the trans-fat, there is no convincing reason to continue their use in food.   
The long-chain PUFA, most often, includes n-6 PUFA (linolenic and arachidonic acid) and n-3 
PUFA (alpha-linolenic acid (ALA), eicosapentaenoic and docosahexanoic acid). It has been 
suggested that PUFA improves blood lipids, blood pressure, inflammation and vascular function. 
The AHA concluded that consumption of at least 5-10% energy intake from n-6 PUFA reduces 
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the risk of CHD as compared to its lower intake150. In addition, for every 5% energy substitution 
of mainly n-6 PUFA, in place of saturated fat, a reduction of 10% in the CHD risk was 
observed146. The n-6 PUFA has also been inversely associated with sudden cardiac death151. A 
meta-analysis of 20 RCTs suggested that the n-3 PUFA supplementation protected against the 
cardiovascular death, but had no significant effect on CVD and total mortality152. Another meta-
analysis among the individuals with high CVD risk from 21 clinical trials, reported a 10% 
decrease in risk of cardiac death and 9% reduction in risk of CVD events and a trend towards 
low total mortality153. Two RCTs have not found any significant association for major 
cardiovascular events, cardiovascular death and death from any cause154,155. Thus, the evidence 
on n-3 PUFA is still inconclusive, but it seems that the protective effect of fish on CVD could be 
attributed to its n-3 PUFA content140. Moreover, the ALA exposure was found to be associated 
with moderately low risk of CVD in healthy adults156 . Even though MUFA (oleic acid is the major 
dietary MUFA) is reported to have various benefits against the cardiovascular risk factors, e.g. 
high HDL-cholesterol, low blood pressure and improved inflammatory status, there is no clear 
evidence available which indicates reduction in the risk of CVD and mortality by MUFA 
consumption140. Nonetheless, due to lack of any reported detrimental effects of MUFA-rich diets 
and due to the beneficial effects of MUFA against other cardiovascular risk factors, future 
studies may show a reduction in the risk of CVD and mortality. 
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Table 2. Summary of the effects of dietary fat and major fat food sources on cardiovascular 
disease and mortality. 
Dietary factor Endpoints Effect Scientific evidence 
Dietary fat 
Saturated fat 
Incident CVD 
Possible increased risk but 
not demonstrated 
 
Meta-analysis of 
cohorts116,141,142 
Meta-analysis of RCTs157 
 
 
Total and CVD 
mortality 
 
Possible increased risk but 
not demonstrated 
Meta-analysis of cohorts116 
Meta-analysis of RCTs157 
Trans fat 
Incident CVD 
Convincing, significantly 
associated with increased 
risk 
 
Meta-analysis of 
cohorts142,147,149 and cohorts 
and RCTs141 
 
Total and CVD 
mortality 
 
Possible increased risk but 
not demonstrated for total 
mortality 
Convincing, significantly 
associated with increased 
risk of CVD death 
 
Meta-analysis of cohorts and 
RCTs141 and RCTs157 
 
PUFA in place of  
saturated fat 
Incident CVD 
 
Probable, significantly 
associated with reduced 
risk 
 
Pooled analysis of cohorts145 
and meta-analysis of cohorts 
and RCTs146,157 
Total and CVD 
mortality 
 
Possible decreased risk but 
not demonstrated for total 
mortality 
Probable, significantly 
associated with reduced 
risk of CVD death 
 
Pooled analysis of cohorts145 
and meta-analysis of RCTs157 
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Table 2. Continuation.  
Dietary factor Endpoints Effect Scientific evidence 
Dietary fat 
MUFA in place of 
saturated fat 
Incident CVD 
Possible decreased risk but 
not demonstrated 
 
Meta-analysis of cohorts and 
RCTs142,145,157 
 
Total and CVD 
mortality 
Possible decreased risk but 
not demonstrated 
 
Pooled analysis of cohorts145 
and meta-analysis of RCTs157 
 
Seafood omega-3 
Incident CVD 
 
Probable, significantly 
associated with reduced 
risk 
 
Meta-analysis of 
RCTs152,153,158,159 
Total and CVD 
mortality 
 
Possible decreased risk but 
not demonstrated for total 
mortality 
Probable for significantly 
reduced CVD death 
 
Meta-analysis of 
RCTs152,153,158,159 
Plant food omega-3 
Incident CVD 
 
Possible decreased risk but 
not demonstrated 
 
Meta-analysis of cohorts 156 
Total and CVD 
mortality 
 
Possible decreased risk but 
not demonstrated 
 
Meta-analysis of cohorts 156 
 
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
Introduction 
 
 
39 
 
Table 2. Continuation.  
Dietary factor Endpoints Effect Scientific evidence 
Major fat food sources 
Processed meat 
Incident CVD 
 
Probable, significantly 
associated with increased 
risk 
 
Meta-analysis of cohorts160 
and 3 cohorts 161,162 
Total and CVD 
mortality 
 
Probable, significantly 
associated with increased 
risk 
3 cohorts161,162 
Fish and seafood 
Incident CVD 
 
Possible decreased risk but 
not demonstrated 
 
Meta-analysis of cohorts and 
RCTs163 
Total and CVD 
mortality 
 
Possible decreased risk but 
not demonstrated 
 
Meta-analysis of cohort 
studies164,165 
Dairy products 
Incident CVD 
 
Possible decreased risk but 
not demonstrated 
 
Meta-analysis of cohort 
studies107 
Total and CVD 
mortality 
 
Possible decreased risk but 
not demonstrated 
 
Meta-analysis of cohort 
studies110 
Eggs 
Incident CVD Possibly no effect 
 
Meta-analysis of cohort 
studies166,167 
Total and CVD 
mortality 
 
Possibly no effect 
Meta-analysis of cohort 
studies166,167 
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Table 2. Continuation. 
Dietary factor Endpoints Effect Scientific evidence 
Major fat food sources 
Olive oil 
Incident CVD 
 
Probable, significantly 
associated with reduced 
risk 
 
Meta-analysis of cohort 
studies168 and 1 RCT68 
Total and CVD 
mortality 
Possible decreased risk but 
not demonstrated 
 
Meta-analysis of cohort 
studies168 and 3 
cohorts67,78,79 
 
Nuts 
Incident CVD 
 
Convincing, significantly 
associated with decreased 
risk 
 
Meta-analysis of cohort 
studies94,169 and 1 RCT68 
Total and CVD 
mortality 
 
Convincing, significantly 
associated with reduced 
risk 
 
Meta-analysis of cohort 
studies 94,169 and 3 cohorts93 
 
Adapted from Michas et al. 2014140. Abbreviations: CVD, cardiovascular diseases; RCTs, randomized controlled trials. PUFA, 
polyunsaturated fats, MUFA, monounsaturated fats. Summary of the evidence for convincing, probable, possible or 
insufficient effects of dietary fats and major fat food sources on cardiovascular disease, cardiovascular mortality and total 
mortality. Best available evidence for each diet-disease relationship was obtained from high-quality published meta-
analyses of prospective cohorts or randomized trials (RCTs), as well as individual RCTs or prospective cohorts. 
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1.2.3.2. Vitamins and antioxidants 
A few observational studies have suggested an inverse association between vitamins and CVD. 
However, several large intervention studies have found little or no effect. A meta-analysis on 
antioxidant supplementation has linked high dose use of vitamin to a modest increase in 
mortality170,171. Most studies have focused on vitamin supplementation rather than the intake of 
vitamins from foods.  
 
Vitamin C 
The data on vitamin C from meta-analysis of prospective cohort studies have indicated a relative 
lower risk of CVD incidence, in those reported having higher intake of vitamin C supplements172. 
The evidence suggest that ascorbic acid alone did not improve the risk for a composite of 
cardiovascular events or its components; but there was a decrease in ischemic stroke for the 
combination of vitamin C and E173. This is consistent with meta-analysis of clinical trials where 
vitamin C showed no effect on the occurrence of CVD173. It is likely that if vitamin C reduces CVD, 
it will be most beneficial for populations with very low dietary intake.  
 
Vitamin E 
Findings from epidemiological studies have reported that vitamin E, mainly for being a potent 
antioxidant, is associated with lower risk of developing CHD170. Data from trials are less 
supportive showing no benefits except for very specific populations. Results from an RCT have 
provided evidence that high-dose of vitamin E among participants at high cardiovascular risk 
does not lower the incidence of CVD174,175. On the other hand, evidence from the Women’s Health 
Study have shown that vitamin E intake was associated with 24% reduction in the risk of 
cardiovascular mortality (RR 0.76; 95% CI, 0.59-0.98); however, a non-significant reduction in 
major cardiovascular events was found176. The effects of vitamin E from observational and 
intervention studies are mixed. Data from subgroup analyses from large primary and secondary 
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prevention trials among women suggest that benefit may be achieved at moderate doses over a 
long period of time170. 
 
Vitamin A 
The large-scale primary and secondary prevention trials of beta-carotene and vitamin A have 
failed to show benefits in CVD170,177. It could be concluded that there remains insufficient 
evidence for vitamin A, C, or E, singly or in combination, preventing cardiovascular events in a 
general population at risk.  
 
B Vitamins  
Briefly, the benefits on CVD of greater folate intake (or other B vitamins) are inconclusive, if 
there are benefits, they are likely to be modest and will mainly be observable in patients without 
prior CVD170. For instance, in a recent meta-analysis of 12 homocysteine lowering trials, the 
authors concluded that in secondary prevention the strength of the benefit of homocysteine 
lowering the risk of CVD may not be as strong as previously believed178. Current evidence 
supports the association between elevated plasma homocysteine concentration and CVD, but it 
does not support supplementation with folate or vitamins B6 or B12 for reducing cardiovascular 
risk177.   
 
Vitamin D 
Evidence from observational studies has associated lower serum 25-hydroxyvitamin D with 
higher incidence of CVD. Contrary, clinical trials have not demonstrated a reduction in 
cardiovascular events with vitamin D supplementation177. A recent meta-analysis of 
observational and RCTs, comparing bottom versus top thirds of baseline circulating 25-
hydroxyvitamin D, has shown that those in the bottom had increased risk of death from CVD 
(pooled HR: 1.35, 95% CI 1.13-1.61), death from cancer (pooled HR: 1.30, 95% CI: 1.07-1.59) 
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and all-cause mortality (pooled HR: 1.35, 95% CI 1.22-1.49). So, the authors concluded that 
evidence suggests inverse associations of circulating 25-hydroxyvitamin D with risk of death 
and also that supplementation with vitamin D3 significantly reduces overall mortality179. 
Another recent review of systematic reviews and meta-analysis suggested that there may be an 
inverse associations between vitamin D deficiency and the risk of CVD180.   
 
Vitamin K 
Recent results from the PREDIMED Study have reported that dietary intake of vitamin K has 
been related to a reduced risk of cardiovascular and all-cause mortality in a Mediterranean 
population at high cardiovascular risk181. Previous evidence seems to suggest that vitamin K 
intake is protective against the incidence of CHD or all-cause mortality182–184, but further studies 
are required to corroborate these associations.  
  
 
1.2.3.3. Minerals (magnesium, selenium, sodium, calcium, potassium)  
Magnesium 
Some existing evidence has suggested that high dietary magnesium intake (major sources of 
magnesium are vegetables, fruits, legumes, nuts and whole grains) plays a protective role in 
cardiovascular risk factors and the incidence of CVD. Indeed, a number of meta-analyses on this 
issue have been conducted. A meta-analysis of 532,979 participants from 19 studies has shown 
that the pooled RR of total CVD was 15% and 33% lower in the highest category of dietary 
magnesium and serum magnesium, respectively, than in the reference category185. Similarly, in 
another meta-analysis of seven prospective studies with 241,378 participants, a protection 
against ischemic stroke was found186. The most recent meta-analysis has shown significant 
associations between circulating magnesium and CVD events. Dietary magnesium was 
associated with 22% lower risk of ischemic heart disease and showed an inverse significant 
association between dietary magnesium and fatal ischemic heart disease up to a threshold of 
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250 mg/d compared with higher intakes187. There is also some evidence suggesting an inverse 
relationship between magnesium intake and cardiovascular mortality188,189. Up to the date, 
prospective studies on cancer mortality have not found associations between dietary 
magnesium intake and mortality190,191, further studies are needed to confirm if there is a 
relation between dietary magnesium and cancer death.  
 
Selenium 
Results from a recent meta-analysis of clinical trials showed that there were no statistically 
significant effects of selenium supplementation on all-cause mortality, CVD mortality, non-fatal 
CVD events or all cardiovascular events. The authors concluded that the available evidence does 
not support the use of selenium supplements in the primary prevention of CVD192.  
 
Sodium 
Two recent meta-analyses of RCTs have concluded that higher sodium intake is associated with 
a higher risk of incident stroke and CVD by nearly 30%. This supports that most people will 
likely benefit from reducing sodium intake34,193. Findings from observational studies have 
shown a J-shaped relation between sodium intake and risk of CVD194,195. Recently, the Institute 
of Medicine (IOM) explicitly concluded that studies on health outcomes are inconsistent in 
quality and insufficient in quantity to determine that sodium intake below specific amounts may 
increase or decrease the risk of heart disease, stroke or all-cause mortality196. However, the 
results of PREDIMED Study indicated that, in the context of a MedDiet, reducing sodium intake 
was associated with a reduced risk of all-cause death, and increased sodium intake was 
positively associated with CVD and CVD mortality (Unpublished results).  
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Calcium  
Lately, calcium intake in relation with CVD received growing attention. The results of the several 
prospective studies that examined the association between dietary or supplemental calcium and 
CVD incidence and mortality in both middle-aged and older adults were found to be 
inconclusive197. The relation between blood concentrations of calcium and CVD has also been 
found to be inconsistent. Secondary analyses of clinical trials have suggested that 
supplementation with calcium has no established effect on CVD. Large-scale randomised trials 
on calcium intake as the primary endpoint would be helpful to draw consistent conclusions on 
this topic197. Moreover, supplementation of calcium with or without vitamin D may even 
modestly increase the risk of CVD, especially myocardial infarction as shown in a reanalysis of 
Women’s Health Initiative and its inclusion in a meta-analysis with eight other studies198.  
 
Potassium  
Current body of evidence suggests a moderate association between potassium intake and blood 
pressure reduction in adults, resulting in benefits in the prevention of the risk of stroke and 
CHD199. Dietary potassium has been inversely associated with the risk of non-fatal and fatal 
strokes200,201. A meta-analysis including 11 prospective studies of potassium intake showed a 
reduction of 21% with increasing potassium intake and also a trend towards a lower risk of 
CVD202.   
Even though few other studies regarding other minerals, such as zinc, chromium, or mineral 
supplementation, and its relation with cardiovascular health have been conducted, there is still 
a lack of consistent evidence. Further studies need to be conducted to evaluate and confirm 
these associations.    
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2. RATIONALE AND JUSTIFICATION 
CVD is one of the most common chronic diseases worldwide, affecting an extensively increasing 
number of people, both in developing and developed countries. The mortality rate from this 
disease remains the topmost cause of death in many countries. A sharp rise in its prevalence has 
been observed in recent years in parallel to the obesity epidemics. It is estimated that it will 
continue to increase overwhelmingly in the upcoming years. Moreover, it has become an 
important public health problem because it is one of the main causes of morbidity and death. 
Public health services are overstretched by increasing population, and by human and financial 
burden to deal with heart disease, stroke, diabetes and CVD.  
Importantly, in a large extent, CVD are preventable. An increasing body of literature in recent 
years have found that several modifiable risk factors play important roles in the occurrence of 
CVD. Thus, the reduction of adverse behavioural risk factors, such as tobacco smoking, physical 
inactivity and unhealthy diet, is the cornerstone for the prevention of CVD in combination with 
an adequate pharmacologic treatment to prevent hard cardiovascular events.  
Epidemiological and clinical trials have observed inverse associations between healthy diet and 
CVD, and related outcomes and death. Recently, dietary patterns rather than individual 
nutrients and food have been identified to be associated with several health outcomes. The 
MedDiet is recognised as one of the healthiest dietary patterns worldwide. To date, strong 
evidence exists supporting the benefits of the MedDiet for the prevention and management of 
CVD. A common characteristic that makes MedDiet unique is the use of olive oil for dressing and 
cooking and also the high intake of nuts. Among others, olive oil and nuts are key components of 
the MedDiet that provide high amounts of vegetal fat and many bioactive compounds to the diet.  
The intake of magnesium is relatively high in Mediterranean population since it is present in 
some of the characteristic food of the MedDiet, such as in fruits, vegetables, legumes and nuts. 
For promoting and recommending MedDiet, it is important to have solid and strong scientific 
evidence that could explain the benefits and their mechanisms. Even though there is accruing 
data on the beneficial effect of the MedDiet on many health outcomes, further investigation is 
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required to confirm the associations and to explore new research areas. Previous 
epidemiological studies have suggested benefits of the MedDiet for the prevention of CVD and 
death in healthy populations and also for secondary prevention of CVD. However, the effect of 
the key components of the MedDiet—olive oil and nuts—on the primary prevention of CVD and 
mortality remains to be elucidated. The primary prevention of CVD is essential to reduce future 
morbidity and mortality and to decrease the cost of the treatment. 
Therefore, this work has been conducted in the framework of the PREDIMED Study, a parallel-
group, multicentre randomised trial evaluating the efficacy of a MedDiet compared to a low-fat 
control diet on the primary prevention of CVD. It has been investigated in depth, as an 
observational cohort study, the effect of nuts, olive oil and magnesium on the risk of CVD, cause-
specific and all-cause mortality on an elderly Mediterranean population at high cardiovascular 
risk. All of these are key components of the MedDiet pattern and are highly consumed in our 
population. Moreover, our population is a target population for the primary prevention, since 
they usually attend Primary Care Clinics.    
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3. HYPOTHESIS 
We hypothesized that the key components and nutrients of the Mediterranean Diet, olive oil, 
nuts and magnesium, are associated with a decreased risk of cardiovascular disease, cause-
specific and overall mortality in Mediterranean individuals at high cardiovascular risk from the 
PREDIMED Study. 
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4. OBJECTIVES 
The main objective was to assess the associations between the key components and nutrients of 
the Mediterranean Diet and cardiovascular disease, cause-specific and overall mortality in 
Mediterranean individuals at high cardiovascular risk from the PREDIMED Study. 
 
In Mediterranean individuals at high cardiovascular risk from the PREDIMED Study, the specific 
objectives were: 
 
- To assess the associations between frequency of nut consumption, cause-specific and 
overall mortality in individuals from Spain, a Mediterranean country with relatively 
high nut intake. 
 
- To assess the associations between the intake of total olive oil, its varieties (extra virgin 
olive oil and common olive oil) and the risk of cardiovascular disease, cause-specific 
and overall mortality. 
 
- To assess the association between dietary magnesium intake and the risk of 
cardiovascular disease, cause-specific and overall mortality in Mediterranean 
individuals with a high average magnesium intake. 
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5. MATERIAL AND METHODS 
5.1. STUDY DESIGN 
The PREDIMED Study is a large, multicenter, parallel-group, randomized and controlled clinical 
trial for the primary prevention of CVD. The main aim of the trial was to evaluate the effect of 
two traditional MedDiets, one supplemented with EVOO and another supplemented with nuts, 
compared with a low-fat control diet, on primary cardiovascular prevention (a composite of 
myocardial infarction, stroke and cardiovascular mortality) in a population at high 
cardiovascular risk. Other secondary endpoints were also evaluated in the context of the 
PREDIMED Study: death of any cause, cancer death, incidence of heart failure, diabetes mellitus, 
metabolic syndrome, dementia or other neurodegenerative disorders and major cancers 
(colorectal, breast, lung, stomach and prostate). Intermediate outcomes including changes in 
blood pressure, weight gain, fasting blood glucose, blood lipids and markers of inflammation 
were also assessed.   
 
5.2. STUDY POPULATION 
The participants were recruited between October 2003 and July 2011 in several recruiting 
centres from Spain (Málaga, Sevilla, Islas Baleares, Barcelona, Reus-Tarragona, Pamplona, País 
Vasco, Valencia, Gran Canaria). The study included men (aged 55 to 80 years) and women (aged 
60 to 80 years) who were free of CVD at enrolment but at high cardiovascular risk. The inclusion 
criteria for the participants in the study were having either type 2 diabetes mellitus, or three or 
more of the following risk factors:  
- Family history of premature CVD 
- Overweight or obesity (BMI ≥ 25 kg/m2) 
- Current smoking (> 1 cig/day during the last month) 
- Hypertension (systolic blood pressure ≥ 140 mmHg or diastolic blood 
pressure ≥ 90 mmHg or antihypertensive medication) 
- LDL cholesterol ≥ 160 mg/dL or lipid- lowering therapy 
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- HDL cholesterol ≤ 40 mg/dL in men or ≤ 50 mg/dL in women  
On the other hand, the exclusion criteria considered were:   
- Documented history of previous CVD, including CHD (angina, myocardial infarction, 
coronary revascularization procedures or existence of abnormal Q waves in the 
electrocardiogram) stroke (either ischemic or hemorrhagic, including transient 
ischemic attacks), or clinical peripheral artery disease with symptoms of intermittent 
claudication 
- Severe medical condition that may impair the ability of the person to participate in a 
nutrition intervention study (e.g. digestive disease with fat intolerance, advanced 
malignancy, or major neurological, psychiatric or endocrine disease) 
- Any other medical condition thought to limit survival to less than 1 year 
- Immunodeficiency or HIV-positive status 
- Illegal drug use, chronic alcoholism or problematic use of alcohol or total daily alcohol 
intake >80 g/d 
- Body mass index > 40 kg/m2 
- Difficulties or major inconvenience to change dietary habits 
- Impossibility to follow a Mediterranean-type diet, for religious reasons or due to the 
presence of disorders of chewing or swallowing (e.g. difficulties to consume nuts) 
- A low predicted likelihood to change dietary habits according to the Prochaska and 
DiClemente stages of change model 
- History of food allergy with hypersensitivity to any of the components of olive oil or 
nuts 
- Participation in any drug trial or use of any investigational drug within the last year 
- Institutionalized patients for chronic care, those who lacked autonomy, were unable to 
walk, lacked a stable address, or were unable to attend visits in the Primary Care Health 
Centres every 3 months 
- Illiteracy 
- Patients with an acute infection or inflammation (e.g. pneumonia) were allowed to 
participate in the study 3 months after the resolution of their condition 
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The selection process started extracting names of potential participants from the clinical 
records. The records were reviewed by the medical doctors and the study investigators to 
assess the eligibility criteria of the candidates and exclude those participants with any of the 
exclusion criteria.  
Potential participants were contacted by a telephone call or during the routine clinical visits; if 
they were interested in participating, a face-to face interview was scheduled. In the first 
interview, the characteristics and objectives of the study were explained and informed consent 
was obtained. The duration of the first visit was about 30 minutes and allowed to verify if the 
candidates met all the inclusion criteria. In this screening visit, the inclusion questionnaire 
(Appendix I) and general questionnaire (Appendix II) were completed by the PREDIMED 
investigators. The general questionnaire included questions on medical conditions and risk 
factors for the study purposes; the last electrocardiogram in the clinical history were revised or 
a new one was performed if the last one was not available; a 137 item food frequency 
questionnaire (Appendix III) and the Minnesota Physical Activity questionnaire (Appendix IV) 
were provided to the participants to complete at home and bring it in the next visit. Participants 
were also informed that they should come in fasting conditions in the next visit and written 
information of the study was provided. They were also informed that they might receive free 
olive oil or nuts for the duration of the study. After participants had signed the informed 
consent, both for the study participation and biochemical analysis and for the DNA recollection, 
they were randomized to three equally sized intervention groups. Tables of random allocation 
were centrally elaborated. 
 
5.3. INTERVENTION 
The participants of the PREDIMED Study were randomly assigned, in a 1:1:1 ratio, to one of 
three interventions (See Figure 7):  
-  A Mediterranean type diet supplemented with extra virgin olive oil (MedDiet + EVOO) 
- A Mediterranean type diet supplemented with nuts (MedDiet + nuts) 
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- Advice to follow a low-fat diet (control group) 
 
 
Cribbage
Mediterranean Diet + Nuts
Mediterranean Diet + Extra Virgin Olive oil
Control group (low fat diet)
3 months 6 months 9 monthsBaseline
Randomization Intervention period
Group session
 
 
Figure 7. Design of the PREDIMED Study. 
 
The PREDIMED dietary intervention followed a behavioural strategy focused on promoting a 
Mediterranean diet in the two intervention groups without specific recommendations on energy 
restriction or physical activity in any intervention arm. The free provision of extra virgin olive 
oil or nuts in the intervention groups increased the compliance and the adherence to the 
intervention. Participants in the control group received free small non-food gifts (kitchenware, 
tableware, aprons or shopping bags). Registered dieticians were responsible for the dietary 
intervention and they received several training sessions before and during the trial with experts 
in nutrition education. At baseline and at follow-up visits, dieticians gave personalized 
recommendations on dietary changes to the participants in order to achieve the specific aims of 
each intervention.   
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Mediterranean diet groups 
The participants in the two intervention MedDiet groups, (MedDiet + EVOO) and (MedDiet + 
nuts) received an intensive intervention including the free provision of approximately 1 litre per 
week of EVOO or 30 g of mixed nuts (15 g of walnuts, 7.5 g of hazelnuts, and 7.5 g of almonds), 
respectively. Dieticians ran individual and group dietary-training sessions at baseline visit and 
quarterly thereafter encouraging the adherence to the MedDiet. Dieticians provided the 
following recommendations to increase the adherence to the MedDiet: 
a) Use olive oil as the main fat for cooking and dressing 
b) The consumption of ≥ 2 daily servings of vegetables (at least one of them as fresh 
vegetables) 
c) ≥ 2-3 daily servings of fresh fruits (including natural juices) 
d) ≥ 3 weekly servings of legumes 
e) ≥ 3 weekly servings of fish or seafood (at least one serving of fatty fish) 
f) ≥ 1 weekly serving of nuts or seeds 
g) Select white meats (poultry without skin or rabbit) instead of red meats or processed 
meats (burgers, sausages) 
h) Cook regularly and dress vegetables, pasta, rice and other dishes (at least twice a week) 
with tomato, garlic and onion adding or not other aromatic herbs (sofrito) 
On the contrary, dieticians discourage the consumption of cream, butter, margarine, cold meat, 
pate, duck, carbonated and/or sugared beverages, pastries, industrial bakery products (such as 
cakes, donuts, or cookies), industrial desserts (puddings, custard), French fries or potato chips, 
and out-of-home pre-cooked cakes and sweets. Total fat intake was ad libitum and a high fat 
intake was allowed, as long as most fat is derived from fatty fish and vegetable sources, 
particularly olive oil or nuts. A 14-item questionnaire was used by dieticians to give 
personalized advice on MedDiet during the study visits. The score obtained in the questionnaire 
was used to assess the adherence to the MedDiet of the participants and also to focus the 
intervention on the points that participants were not following (Table 3). The maximum score 
was 14 points.   
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
Material and methods  
 
66 
 
Table 3. Quantitative score of adherence to the Mediterranean Diet. 
Foods and frequency of consumption Criteria for 1 point* 
1. Do you use olive oil as main culinary fat? Yes 
2. How much olive oil do you consume in a given day (including oil used for 
frying, salads, out of house meals, etc.)? 
4 or more tablespoons 
3. How many vegetable servings do you consume per day? 
(1 serving = 200g - consider side dishes as 1/2 serving) 
2 or more (at least 1 
portion raw or as salad) 
4. How many fruit units (including natural fruit juices) do you consume per 
day? 
3 or more 
5. How many servings of red meat, hamburger, or meat products (ham, 
sausage, etc.) do you consume per day? (1 serving = 100-150 g) 
Less than 1 
6. How many servings of butter, margarine, or cream do you consume per 
day? (1 serving = 12 g) 
Less than 1 
7. How many sweet/carbonated beverages do you drink per day? Less than 1 
8. How much wine do you drink per week? 7 or more glasses 
9. How many servings of legumes do you consume per week? (1 serving = 
150 g) 
3 or more 
10. How many servings of fish or shellfish do you consume per week? (1 
serving: 100-150 g fish, or 4-5 units or 200 g shellfish) 
3 or more 
11. How many times per week do you consume commercial sweets or 
pastries (not homemade), such as cakes, cookies, biscuits, or custard? 
Less than 3 
12. How many servings of nuts (including peanuts) do you consume per 
week? (1 serving = 30 g) 
3 or more 
13. Do you preferentially consume chicken, turkey or rabbit meat instead 
of veal, pork, hamburger or sausage? 
Yes 
14. How many times per week do you consume vegetables, pasta, rice, or 
other dishes seasoned with sofrito (sauce made with tomato and onion, 
leek, or garlic, simmered with olive oil)? 
2 or more 
*0 points if these criteria are not met  
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Control group 
The intervention in the control group was based on giving the participants dietary 
recommendations on a low-fat diet according to Third Report of the National Cholesterol 
Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood 
Cholesterol in Adults (Adult Treatment Panel III) 203. The goal was to reduce the intake of all 
types of fat, both animal fat and vegetable fat. The dieticians encourage the consumption of low-
fat dairy products, lean meats, cereals, potatoes, pasta, rice, fruits and vegetables and discourage 
the intake of red meat and processed meats, fatty fish, sweets and pastry, and also olive oil and 
nuts, for being foods which high amounts of fat. The recommendations that the dieticians gave 
to the control group were as follows:  
a) Use the least possible amount of oil (no more than 2 table spoons per day) for 
cooking and dressing food 
b) Remove all visible fat from meat before cooking and cool soups and broth to remove 
fat layer on top before heating 
c) If you choose to eat red meat, eat meat cuts low in fat instead of high-fat ones such as 
beacon, beef and lamb 
d) Do not eat butter, margarine, lard or other fat spreads 
e) Do not consume fat-enriched dairy products, heavy cream, custard, ice cream and use 
instead low-fat dairy products 
f) Cook legumes, pasta, rice and potatoes with the least amount of oil and other fats, 
such as fatty-meats, cold cuts, beacon, sausages, cracklings, and do not use sofrito 
(tomato sauce simmered with olive oil, garlic and herbs)  
g) Eat only lean fish and avoid fatty-fish 
h) Avoid eating liver, kidney and offal in general, fried foods, commercial sauces, 
mayonnaise and cooked foods 
I)  Do not eat sweets and pastry, such as cookies, cakes, pies and muffins 
j) Do not eat vegetal fatty foods such as tree nuts (walnuts, hazelnuts, almonds…), 
peanuts, sunflower seeds, French fries and other salty snacks. The dieticians used a 9-
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item quantitative score of compliance with the low-fat control diet to assess and give 
personalized advice in order to enhance the adherence to the intervention (Table 4). 
 
Table 4. Quantitative score of compliance with the Control diet (Low-Fat). 
Foods and frequency of consumption Criteria for 1 point* 
1. How much olive oil do you consume in a given day (including oil used for 
frying, salads, out of house meals, etc.)? 
2 or less tablespoons 
(1 table spoon=10 ml) 
2. Do you remove visible fat (or the skin) of chicken, duck, pork, lamb or veal 
meats before cooking and the fat of soups, broths, and cooked meat dishes 
before consumption? 
Yes 
3. How many servings of fat-rich meats, hamburger, commercial ground meat, 
sausage, cold meat, cured ham, bacon, salami, or offal do you consume per 
week? meat serving: 100 g; salami or bacon: 30 g) 
1 or less 
4. How many servings of butter, margarine, lard, mayonnaise, milk cream, or 
milk-based ice cream do you consume per week? (spread fat: serving: 12 g; 
ice cream: 100 g) 
1 or less 
5. Do you exclusively consume low-fat dairy products? 
Yes 
(id. If no dairy 
consumption) 
6. How many times per week do you prepare rice, pasta, potato, or legume 
dishes by using “sofrito” sauce (based on olive oil), bacon, salami, or fatty 
meats such as pork or lamb ribs? 
2 or less 
7. How many times per week do you consume fatty fish or fish or seafood 
canned in oil? 
1 or less 
8. How many servings of commercial sweets or industrial bakery products 
(not homemade), such as cakes, cookies, biscuits, or custard do you consume 
per week? (cake serving: 80 g; 6 biscuits: 40 g) 
1 or less 
9. How many times per week do you consume nuts (including peanuts), 
potato chips, French fries, or commercial snacks? 
1 or less 
*0 points if these criteria are not met  
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Other strategies were used by the dieticians to increase the compliance of the intervention in 
the three arms of the study such as specific personalized objectives taking into account the 
medical conditions and preferences of each participants, using the accomplishments in the 
previous months as support to provide further empowerment and self-reward, and try to avoid 
contradictory dietary advices from other health professionals external to the PREDIMED Study.  
 
Group sessions 
During all the follow-up, participants attended quarterly group sessions separated by 
intervention group (MedDiet + EVOO, MedDiet + nuts and control group) and attended by up to 
20 participants per session. The sessions included: 
- A briefly recall of the key points that should be followed according to 14-item 
questionnaire (MedDiet groups) or 9-items questionnaire (Control group)  
- Informative talk and description of written material (descriptions of 4 to 5 foods 
typical of the dietary pattern per each study arm and year season; 1-week shopping list; 
weekly plan of meals and recipes) 
- Clarification of any doubts regarding the instructions provided 
- Free provision of extra virgin olive oil and nuts to the MedDiet intervention groups 
and non-food gifts to the control group 
 
5.4. DATA COLLECTION 
At baseline and yearly during the follow-up PREDIMED personnel completed the questionnaires 
and conducted anthropometric and biochemical evaluations (Appendix II and Appendix V).  
A general questionnaire about CV risk factors, history of illnesses, medication use, family history 
of disease, smoking and alcohol use, educational achievement, occupation and socio-economic 
status were administered to the participants (Appendix II). Dieticians also completed a 
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validated 14-item questionnaire of adherence to the Mediterranean diet and a quantitative score 
of compliance with the control (low-fat diet group), as detailed before. Trained dieticians 
completed a 137-item semi-quantitative food frequency questionnaire (FFQ) (Appendix III) in a 
face-to-face interview with the participant; this questionnaire has been validated before in 
elderly population at high cardiovascular risk from Spain204. Energy and nutrient intake were 
estimated using Spanish food composition tables205,206. Physical activity was assessed using the 
validated Spanish version of the Minnesota Leisure-Time Physical Activity questionnaire 207 
(Appendix IV). A tolerance and side effect questionnaire was completed in the follow-up visits 
(Appendix VI).  
Participants were considered to be diabetic, hypercholesterolemic or hypertensive if they had 
previously been diagnosed as such, and/or they were being treated with antidiabetic, 
cholesterol-lowering, or antihypertensive agents, respectively. Trained personnel took the 
anthropometric and blood pressure measurements. Weight (kg) and height (m) were measured 
with light clothing and no shoes with calibrated scales and a wall-mounted stadiometer, 
respectively, and BMI (kg/m2) was calculated; waist circumference (cm) was measured midway 
between the lowest rib and the iliac crest using an anthropometric tape; blood pressure was 
measured using a validated oscillometer [Omron HEM705CP, Hoofddorp, Netherlands] in 
triplicate with a 5 minute interval between each measurement, and the mean of these values 
was recorded. 
Blood and urine samples were collected at baseline and years 1, 3, 5 and 7 (or final visit). Tubes 
for EDTA plasma, citrate plasma, buffy coat and serum were collected and aliquots are kept 
frozen (-80ºC).  
 
5.5. ASCERTAINMENT OF CARDIOVASCULAR DISEASE AND MORTALITY 
The primary endpoint of the trial was a composite of myocardial infarction, stroke and death 
from cardiovascular causes. Secondary endpoints were cardiovascular, cancer and all-cause 
mortality, among others. Information on primary endpoint and mortality was updated once a 
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year by the end-point adjudication committee, whose members were blinded to treatment 
allocation. Different sources of information were used: 1) yearly questionnaires and 
examinations to all participants, 2) family physicians, 3) yearly review of medical records; and 
4) linkage to the National Death Index. Medical records of deceased participants were 
requested, and the end-point adjudication committee adjudicated the cause of the death and 
confirmed cardiovascular events.  
 
5.6. STATISTICAL ANALYSIS 
The studies presented in this work are observational prospective cohort analyses in the 
framework of the PREDIMED trial. All the analyses were performed using SPSS statistical 
software, version 19 (SPSS Inc, Chicago, Illinois) and STATA software, version 12.0. The level of 
significance for all statistical tests was P <0.05 for bilateral contrast.  
In general for all the analyses, 
1. We used standard methods (Kolmogorov-Smirnov) to test the normal distribution of 
the analyzed variables.  
2. To compare the differences between continuous variables of the study participants we 
used ANOVA (parametric test) or the Pearson chi-squared (parametric test) tests for 
categorical variables.  
3. Follow-up time was calculated as the interval between the date of cardiovascular event, 
death (cardiovascular, cancer or other death) or the end of follow-up (the date of the 
last visit or the last recorded clinical event of participants still alive) and the date of 
randomization. 
4. We used multivariate Cox regression models to assess the risk of the main outcomes 
(CVD, all-cause mortality, cardiovascular mortality and cancer mortality) according to 
categories of the exposures. The models were adjusted for potential confounders.  
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5. Linear trend tests were assessed assigning the median value to each category and using 
it as a continuous variable in the various models. 
6. Multivariable analyses with generalized estimating equation models were used to 
assess the associations between yearly repeated measurements of the exposure and 
CVD and mortality. 
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6. RESULTS 
Three published original articles are part of the results of this thesis. All of them are 
observational prospective cohort studies in the context of the PREDIMED Study. The 
participants were Mediterranean individuals at high cardiovascular risk from Spain. The specific 
objectives and corresponding publications are summarized in Table 5.  
 
 
Table 5. Thesis objectives and corresponding publications. 
Objectives Publications 
To assess the associations between frequency 
of nut consumption, cause-specific and overall 
mortality. 
Guasch-Ferré M, Bulló M, Martínez-González MA, et al. 
Frequency of nut consumption and mortality risk 
in the PREDIMED nutrition intervention trial.  
BMC Med. 2013 Jul 16;11:164. PMID: 23866098. 
 
Impact factor 2013: 7.276 
To assess the associations between the intake 
of total olive oil, its varieties (extra virgin olive 
oil and common olive oil) and the risk of 
cardiovascular disease, cause-specific and 
overall mortality. 
Guasch-Ferré M, Hu FB, Martínez-González MA, et al. 
Olive oil intake and risk of cardiovascular disease 
and mortality in the PREDIMED Study.  
BMC Med. 2014 May 13;12(1):78. PMID: 24886626. 
 
Impact factor 2013: 7.276 
To assess the association between dietary 
magnesium intake and the risk of 
cardiovascular disease, cause-specific and 
overall mortality. 
Guasch-Ferré M, Bulló M, Estruch R, et al. Dietary 
magnesium intake is inversely associated with 
mortality in adults at high cardiovascular disease 
risk.  
J Nutr. 2014 Jan;144(1):55-60. PMID: 24259558. 
 
Impact factor 2013: 4.227 
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6.1. FREQUENCY OF NUT CONSUMPTION AND MORTALITY RISK IN THE PREDIMED 
NUTRITION INTERVENTION TRIAL 
 
Guasch-Ferré M, Bulló M, Martínez-González MÁ, Ros E, Corella D, Estruch R, Fitó M, Arós F, 
Wärnberg J, Fiol M, Lapetra J, Vinyoles E, Lamuela-Raventós RM, Serra-Majem L, Pintó X, Ruiz-
Gutiérrez V, Basora J, Salas-Salvadó J; PREDIMED study group. 
 
BMC Med. 2013 Jul 16;11:164. PMID: 23866098; doi:10.1186/1741-7015-11-164. 
 
Study 1 overview. Novelty and significance.  
What is already known? 
- Prospective studies in non-Mediterranean populations have consistently related increasing nut 
consumption to lower coronary heart disease mortality. 
- A small protective effect on all-cause and cancer mortality has also been suggested. 
- If an inverse association between nut consumption and all-cause mortality exists, the beneficial 
effect might be more robust in Mediterranean regions, where nut consumption per person is 
relatively high compared to other countries. 
What this study adds? 
- Our study was the first to demonstrate that consuming nuts >3 serving/week was associated 
with 39% (HR: 0.61, 95% CI: 0.45-0.83) reduction in the risk of total mortality after 4.8 years 
of follow-up, compared to non-consumers, in elderly participants at high cardiovascular risk. 
- A similar protective effect against cardiovascular and cancer mortality was observed. 
Summary 
- This study provides further evidence of the inverse relationship between the frequency of nut 
consumption and the risk of mortality in a Mediterranean population at high cardiovascular 
risk with relatively high nut intake. 
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RESEARCH ARTICLE Open Access
Frequency of nut consumption and mortality risk
in the PREDIMED nutrition intervention trial
Marta Guasch-Ferré1,2, Mònica Bulló1,2, Miguel Ángel Martínez-González3, Emilio Ros2,4, Dolores Corella5,
Ramon Estruch2,6, Montserrat Fitó2,7, Fernando Arós2,8, Julia Wärnberg9, Miquel Fiol10, José Lapetra2,11,
Ernest Vinyoles12, Rosa Maria Lamuela-Raventós13, Lluís Serra-Majem14, Xavier Pintó15, Valentina Ruiz-Gutiérrez16,
Josep Basora1,2, Jordi Salas-Salvadó1,2*, on behalf of the PREDIMED study group
Abstract
Background: Prospective studies in non-Mediterranean populations have consistently related increasing nut
consumption to lower coronary heart disease mortality. A small protective effect on all-cause and cancer mortality
has also been suggested. To examine the association between frequency of nut consumption and mortality in
individuals at high cardiovascular risk from Spain, a Mediterranean country with a relatively high average nut intake
per person.
Methods: We evaluated 7,216 men and women aged 55 to 80 years randomized to 1 of 3 interventions
(Mediterranean diets supplemented with nuts or olive oil and control diet) in the PREDIMED (‘PREvención con DIeta
MEDiterránea’) study. Nut consumption was assessed at baseline and mortality was ascertained by medical records
and linkage to the National Death Index. Multivariable-adjusted Cox regression and multivariable analyses with
generalized estimating equation models were used to assess the association between yearly repeated
measurements of nut consumption and mortality.
Results: During a median follow-up of 4.8 years, 323 total deaths, 81 cardiovascular deaths and 130 cancer deaths
occurred. Nut consumption was associated with a significantly reduced risk of all-cause mortality (P for trend <0.05, all).
Compared to non-consumers, subjects consuming nuts >3 servings/week (32% of the cohort) had a 39% lower
mortality risk (hazard ratio (HR) 0.61; 95% CI 0.45 to 0.83). A similar protective effect against cardiovascular and
cancer mortality was observed. Participants allocated to the Mediterranean diet with nuts group who consumed
nuts >3 servings/week at baseline had the lowest total mortality risk (HR 0.37; 95% CI 0.22 to 0.66).
Conclusions: Increased frequency of nut consumption was associated with a significantly reduced risk of mortality
in a Mediterranean population at high cardiovascular risk.
Please see related commentary: http://www.biomedcentral.com/1741-7015/11/165.
Trial registration: Clinicaltrials.gov. International Standard Randomized Controlled Trial Number (ISRCTN): 35739639.
Registration date: 5 October 2005.
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Background
Nuts are an important component of the so-called
Mediterranean diet (MedDiet) and a good source of
unsaturated fatty acids, fiber, minerals (potassium, calcium
and magnesium), vitamins (folate and tocopherols) and
other bioactive compounds, such as phytosterols and
polyphenols [1–4].
There is consistent evidence to suggest that the con-
sumption of nuts has a beneficial effect on cardiovascular
health, and this effect is attributable to their unique nutri-
tional composition [5]. A pooled analysis of four large-scale
observational studies showed that subjects in the highest
nut consumption categories had an approximately 35%
reduced risk of incident coronary heart disease (CHD) [6].
The frequency of nut consumption was also related to
lower rates of sudden cardiac death in a large cohort of
men [7]. Furthermore, epidemiologic studies and clinical
trials have shown that frequent nut consumption is
associated with a reduced load of cardiovascular disease
risk factors, such as dyslipidemia, type 2 diabetes, and
metabolic syndrome [4,6,8,9]. In addition, reports from
the Iowa Women’s Health study [10], a large Dutch cohort
[11], and the US Nurses’ Health Study [12], which assessed
populations with relatively low overall nut intake, suggested
that frequent nut consumption related inversely to
total mortality, albeit the protective effect was weak,
with adjusted risk reductions ranging from 5% to 15%
[10–12]. If an inverse association between nut con-
sumption and all-cause mortality exists, the beneficial
effect might be more robust in Mediterranean regions,
where nut consumption per person is relatively high
compared to other countries [13].
The main aim of the PREDIMED study was to test the
efficacy of two Mediterranean diets (one supplemented
with extra-virgin olive oil and another with nuts), as
compared to a control diet (advice on a low-fat diet), on
primary cardiovascular prevention. In contrast, in this
current manuscript our aims were only to assess the
association between baseline consumption of nuts
(that is, the consumption of nuts previous to starting the
intervention) and total mortality (instead of cardiovascular
events). We have additionally included the repeated
measurements for the consumption of nuts during follow-
up as another exposure, regardless of the allocated arm of
the trial; this is in contrast with the original PREDIMED
study, which used an intention-to-treat analysis.
We hypothesized that level of nut consumption would
be strongly associated with mortality in the cohort of
the PREDIMED (‘PREvención con DIeta MEDiterránea’)
study, including older men and women at high cardio-
vascular risk [14]. To this end, in this cohort we longitu-
dinally examined the association between the frequency
of nut consumption at baseline and the risk of mortality
at the end of follow-up.
Methods
Study population
The present study was conducted within the framework of
the PREDIMED trial, the design of which has been
described in detail elsewhere [14]. Briefly, the PREDIMED
study is a large, multicenter, parallel-group, randomized
and controlled clinical trial for the primary prevention of
cardiovascular disease (CVD) (http://www.predimed.es and
http://www.predimed.org). The main results of the trial on
the primary endpoint have been recently published [15].
We assigned 7,447 older participants (men aged 55 to 80
years and women 60 to 80 years) to 1 of 3 interventions:
a MedDiet enriched with extra-virgin olive oil (EVOO),
a MedDiet supplemented with mixed nuts, or advice on a
low-fat diet (control diet). Participants had no CVD at
enrollment but they were at high cardiovascular risk
because of the presence of type 2 diabetes or at least
three of the following risk factors: current smoking,
hypertension, hypercholesterolemia, low high-density
lipoprotein (HDL)-cholesterol, overweight or obesity,
and family history of premature CVD. Exclusion criteria
were the presence of severe medical condition that may
impair the ability of the person to participate in a nutrition
intervention study (for example, digestive disease with
fat intolerance, advanced malignancy, or major neuro-
logical, psychiatric or endocrine disease), immunodeficiency
or HIV positive status, alcohol or drug abuse, body mass
index (BMI) ≥40 kg/m2, and allergy or intolerance to olive
oil or nuts [16].
The primary endpoint of the main trial is a combination
of several cardiovascular events (myocardial infarction,
stroke or cardiovascular death). The present study was
conducted as an observational cohort using baseline
consumption of nuts as the exposure. The outcomes
were: (1) total mortality, (2) only cardiovascular mortality,
and (3) only cancer mortality. All participants provided
written informed consent according to a protocol approved
by the institutional review boards of the recruiting centers
(Comité de Ética e Investigación Clínica (CEIC) Hospital
Universitari Sant Joan de Reus, CEIC Universidad de
Navarra, CEIC Hospital Clínic de Barcelona, Comité de
Ética Universidad de Valencia, CEIC-Parc de Salut Mar,
CEIC Hospital Universitario Araba, CEIS del distrito
Sanitario Atención Primária Sevilla, IDIAP Jordi Gol,
CEIC Complejo Hospitalario Materno-Insular, CEIC
Facultad Medicina Universidad de Málaga, CEIC Illes
Balears, and CEIC Hospital Universitari Bellvitge).
Dietary assessment
At baseline trained dietitians completed a 137-item
semiquantitative food frequency questionnaire in a face-
to-face interview with the participant; this questionnaire
has been validated before in an older population at high
cardiovascular risk from Spain [17]. Energy and nutrient
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intake were estimated using Spanish food composition
tables [18,19]. Information on self-reported nut intake
was derived from the food frequency questionnaire. The
questionnaire includes one item regarding the consumption
of almonds, peanuts, hazelnuts, pistachios and pine nuts
(macadamias, cashews and Brazil nuts are rarely consumed
in Spain), and another question specifically inquired about
the consumption of walnuts. The dietitians asked the
participants if they consumed this food item never, between
1 to 3 times per month, times per week (1, 2 to 4, 5 to 6;
three options) or times a day (1, 2 to 3, 4 to 6, >6; four
options). For the purpose of the present study, 28 g of nuts
was considered to be one serving. Peanuts, almonds,
hazelnuts, walnuts, pine nuts, pistachios, Brazil nuts,
macadamia and cashews were all considered nuts. In
addition, dietitians administered a validated 14-item
MedDiet screener designed to assess the degree of
adherence to the traditional MedDiet [20]. We used
the score of this brief screener to control for the over-
all dietary pattern, because a higher adherence to the
MedDiet among frequent consumers of nuts could
introduce confounding. For this purpose, the question
about nut consumption was omitted from the brief
screener; therefore, a 13-point score was used as a covariate
(minimum 0, maximum 13).
Ascertainment of mortality
Information on mortality was updated once a year by
the End-point Adjudication Committee, whose members
were blinded to treatment allocation. Different sources
of information were used: (1) yearly questionnaires and
examinations to all participants, (2) family physicians,
(3) yearly review of medical records, and (4) linkage to the
National Death Index. Medical records of deceased partic-
ipants were requested, and the End-point Adjudication
Committee adjudicated the cause of the death.
Assessment of other covariates
At baseline, questionnaires about lifestyle variables,
educational achievement, history of illnesses, and medica-
tion use were administered. Physical activity was assessed
using the validated Spanish version of the Minnesota
Leisure-Time Physical Activity questionnaire [21]. Partici-
pants were considered to be diabetic, hypercholesterolemic
or hypertensive if they had previously been diagnosed as
such, and/or they were being treated with antidiabetic,
cholesterol-lowering, or antihypertensive agents, respect-
ively. Trained personnel took the anthropometric and
blood pressure measurements. Weight and height were
measured with light clothing and no shoes with calibrated
scales and a wall-mounted stadiometer, respectively; waist
circumference was measured midway between the lowest
rib and the iliac crest using an anthropometric tape; blood
pressure was measured using a validated oscillometer
(Omron HEM705CP; Hoofddorp, The Netherlands) in
triplicate with a 5-minute interval between each meas-
urement, and the mean of these values was recorded.
Statistical analyses
Follow-up time was calculated as the difference between
the date of either death or end of follow-up (the date of the
last visit or the last recorded clinical event of participants
still alive) and the date of recruitment. Extremes of total en-
ergy intake (>4,000 or <800 kcal per day in men and >3,500
or <500 kcal per day in women) were excluded from
the analysis [22]. Three categories of frequency of nut
consumption were considered (never or almost never,
1 to 3 servings per week and >3 servings per week). We
used analysis of variance (ANOVA) or the Pearson χ2 tests
to compare the quantitative or categorical baseline charac-
teristics of the study participants, respectively, across
servings of nut consumption. Results were expressed as
means ± SD or percentages. Because no interaction was
observed between sex and the main outcome, analyses
were conducted for men and women together.
To assess the risk of total mortality by frequency of nut
consumption, multivariate relative risks were computed
using Cox proportional hazard models, and potential con-
founders were controlled for. All analyses were stratified
by the recruitment center. Results are expressed as hazard
ratios (HRs) with 95% confidence intervals (CIs). Given
the different nutritional composition of walnuts and other
nuts [1], we performed separate analyses for the frequency
of total nut consumption, walnut consumption, and con-
sumption of nuts excluding walnuts. After the unadjusted
model, another model was adjusted for age (continuous),
sex and intervention group. Then, a second model, was
additionally adjusted for BMI (continuous), current smok-
ing status (never, former, or current smoker), educational
level (illiterate/primary education, secondary education,
academic/graduate), physical activity (MET-min/day), total
energy intake (kcal/day), history of diabetes (yes/no), history
of hypercholesterolemia (yes/no), use of oral antidiabetic
medication (yes/no), antihypertensive drugs (yes/no), and
statins (yes/no). Finally, a third, fully-adjusted model, was
additionally adjusted for alcohol intake (continuous, adding
a quadratic term), quintiles of consumption of dietary
food groups (vegetables, fruits, red meat, eggs, and fish),
and adherence to the MedDiet (13-point score). The same
models were used to assess the risk of cardiovascular
mortality or cancer mortality, also using Cox proportional
hazard models. Linear trend tests were assessed assigning
the median value to each category of nut consumption and
using it as a continuous variable in the various models. We
evaluated the interaction between baseline nut consump-
tion (three categories, two dummy variables) and the
intervention group (three groups, two dummy variables)
by introducing an interaction term with four degrees
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of freedom in the model. We used Cox regression
models to assess the risk of total mortality, cardiovas-
cular mortality and cancer mortality according to the
joint categories of total nut consumption and interven-
tion group. Linear trends were also tested. We had
yearly updated information on nut consumption, so to
take advantage of this updated information we repeated
the analysis using generalized estimating equations to
assess the association between repeated measurements
of nut consumption and mortality. For each 1-year period
we used as exposure the average nut consumption of all
repeated measurements from baseline to the beginning of
that yearly period.
The level of significance for all statistical tests was
P <0.05 for bilateral contrast. Analyses were performed
using SPSS statistical software, version 19 (SPSS Inc,
Chicago, IL, USA) and STATA software, version 12.0
(Stata Corp., College Station, TX, USA).
Table 1 Baseline characteristics of study participants by frequency of nut consumption
Variable Baseline frequency of nut consumption
Never (n = 2,118) 1 to 3 servings/week
(n = 2,803)
>3 servings/week
(n = 2,295)
P value
Age, years 67 ± 6 66 ± 6 67 ± 6 <0.001
Men, % (n) 36 (773) 43 (1,219) 47 (1,079) <0.001
BMI, kg/m2 30.6 ± 4.0 29.9 ± 3.7 29.4 ± 3.7 <0.001
Weight, kg 77.2 ± 12.0 77.1 ± 12.1 75.8 ± 11.6 <0.001
Waist circumference, cm 101.5 ± 10.5 100.7 ± 10.4 99.2 ± 10.0 <0.001
Leisure-time energy expenditure in physical activity, MET-min/day 195 ± 220 231 ± 232 264 ± 257 <0.001
Smoking status, % (n) <0.001
Never 64 (1,367) 61 (1,708) 59 (1,364)
Current 14 (310) 14 (402) 12 (292)
Former 21 (441) 24 (693) 28 (639)
Educational level, % (n) <0.001
Illiterate/primary education 82 (1,740) 76 (2,131) 75 (1,733)
Secondary education 12 (266) 16 (451) 16 (379)
Academic/graduate 5 (112) 8 (221) 8 (183)
Diabetes, % (n) 53 (1,118) 47 (1,338) 46 (1,071) <0.001
Hypertension, % (n) 83 (1,763) 83 (2,320) 82 (1,887) 0.670
Hypercholesterolemia, % (n) 70 (1,479) 73 (2,044) 73 (1,689) 0.012
Medication use, % (n)
Oral antidiabetic drugs 36 (760) 31 (884) 29 (679) <0.001
Antihypertensive drugs 75 (1,587) 72 (2,037) 71 (1,624) 0.008
Statins 48 (1,022) 48 (1,364) 47 (1,093) 0.761
Modified MedDiet score (13-point score) 8.1 ± 1.7 8.2 ± 1.8 8.6 ± 1.7 <0.001
Total energy intake, g/day 2,060 ± 529 2,222 ± 514 2,416 ± 537 <0.001
Nuts, g/day 0 4.9 ± 2.3 25.7 ± 14.4 <0.001
Alcohol, g/day 6.6 ± 13.4 8.4 ± 13.8 9.7 ± 14.7 <0.001
Vegetables, g/day 317 ± 144 329 ± 145 355 ± 149 <0.001
Fruit, g/day 344 ± 200 354 ± 195 407 ± 204 <0.001
Red meat (beef, pork, lamb), g/day 70.4 ± 44.3 79.1 ± 46.1 78.6 ± 46.2 <0.001
White meat (chicken, rabbit, turkey), g/day 44.6 ± 28.5 45.1 ± 27.1 44.5 ± 27.6 0.720
Eggs, g/day 19.4 ± 10.9 20.4 ± 11.5 20.0 ± 10.6 0.010
Fish, g/day 91.8 ± 47.8 99.9 ± 48.9 105.2 ± 53.7 <0.001
Dairy products, g/day 387 ± 224 374 ± 216 381 ± 222 0.095
Data are expressed as mean ± SD or percentage (n). P value for comparisons across servings of nut consumption (Pearson χ2 test for categorical variables or
one-way analysis of variance for continuous variable) as appropriate.
BMI, body mass index.
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Results
After those subjects with extremes of total energy intake
(n = 153) and those with incomplete dietary data
(lack of food frequency questionnaire) at baseline (n = 78)
had been excluded, 7,216 individuals were available for the
present analysis. The mean age of the participants was 67
years and there were a total of 3,071 men and 4,145
women. Table 1 shows the baseline characteristics of study
participants by frequency of total nut consumption.
Subjects who ate nuts more frequently had lower BMI
and waist circumference, were less likely to smoke, and
were more physically active compared to those who
rarely or never consumed nuts. In the upper category
of nut consumption there were fewer individuals with
type 2 diabetes mellitus or who used antidiabetic and
antihypertensive medication. In addition, frequent nut
consumption was associated with a higher intake of energy,
vegetables, fruit, and fish.
Changes in total nut consumption were +15.95 ± 21.10
g/day (mean ± SD) in the MedDiet supplemented with
nuts, -0.80 ± 16.31 g/day in the MedDiet supplemented
with extra virgin olive oil and −3.12 ± 13.85 g/day in the
control group.
During a median follow-up of 4.8 years, 323 total
deaths, 81 cardiovascular deaths and 130 cancer deaths
occurred. Table 2 shows HRs for total mortality by
frequency of total nut consumption, walnut consumption,
and consumption of other nuts. After adjustments for age,
sex and intervention group (model 1), the subjects who ate
nuts more frequently had a lower risk of total mortality in
all the types of nuts analyzed (P for trend <0.001 for
total nut and walnut consumption, and P = 0.010 for
non-walnut nuts). In fully adjusted models, participants
who consumed total nuts, walnuts, or non-walnut nuts >3
servings per week had significant reductions in total
mortality risk of 39%, 45%, and 34%, respectively, compared
to those who rarely or never consumed nuts. The relation-
ship between nut consumption and total mortality was
linear for all the models (P for trend <0.05), except for the
crude model of nut consumption excluding walnuts.
Those participants who ate total nuts, walnuts or other
nuts (excluding walnuts) >3 servings per week had also
Table 2 Hazard ratios of total mortality according to the frequency of nut consumption (including and not including walnuts)
Total mortality Never 1 to 3 servings/week >3 servings/week P for trend
Frequency of total nut consumption: n = 2,118 n = 2,803 n = 2,295
All causes of death, % (n) 5.6 (119) 4.2 (117) 3.8 (87)
Person-years, n 8,724 12,168 10,185
Crude model 1 (Reference) 0.68 (0.52 to 0.88) 0.60 (0.45 to 0.79) 0.005
Multivariable model 1 1 (Reference) 0.68 (0.52 to 0.89) 0.55 (0.41 to 0.73) 0.001
Multivariable model 2 1 (Reference) 0.69 (0.53 to 0.91) 0.59 (0.43 to 0.79) 0.005
Multivariable model 3 1 (Reference) 0.71 (0.54 to 0.93) 0.61 (0.45 to 0.83) 0.012
Frequency of walnut consumption: n = 2,916 n = 2,547 n = 1,753
All causes of death, % (n) 5.6 (164) 3.9 (100) 3.4 (59)
Person-years, n 12,124 11,122 7,825
Crude model 1 (Reference) 0.64 (0.50 to 0.83) 0.54 (0.40 to 0.73) <0.001
Multivariable model 1 1 (Reference) 0.66 (0.51 to 0.85) 0.50 (0.37 to 0.68) <0.001
Multivariable model 2 1 (Reference) 0.65 (0.50 to 0.84) 0.53 (0.39 to 0.73) <0.001
Multivariable model 3 1 (Reference) 0.66 (0.51 to 0.86) 0.55 (0.40 to 0.76) <0.001
Frequency of consumption of other nuts (excluding walnuts): n = 3,308 n = 2,643 n = 1,265
All causes of death, % (n) 5.0 (166) 4.1 (109) 3.8 (48)
Person-years, n 13,936 11,573 5,566
Crude model 1 (Reference) 0.77 (0.60 to 0.98) 0.71 (0.52 to 0.98) 0.068
Multivariable model 1 1 (Reference) 0.75 (0.59 to 0.96) 0.62 (0.44 to 0.86) 0.010
Multivariable model 2 1 (Reference) 0.78 (0.61 to 1.00) 0.64 (0.45 to 0.90) 0.021
Multivariable model 3 1 (Reference) 0.80 (0.62 to 1.03) 0.66 (0.46 to 0.93) 0.031
One serving of nuts equals 28 g. Cox regression models were used to assess the risk of all-cause mortality by frequency of nut consumption. Multivariable model
1 was adjusted for age in years, sex, and intervention group. Model 2 was additionally adjusted for body mass index (BMI) in kg/m2, smoking status (never,
former, current smoker), educational level (illiterate/primary education, secondary education, academic/graduate), leisure time physical activity in MET-min/day,
history of diabetes (yes/no), history of hypercholesterolemia (yes/no), use of oral antidiabetic medication (yes/no), use of antihypertensive medication (yes/no), use
of statins (yes/no), and total energy intake (kcal/day). Model 3 was also adjusted for dietary variables in quintiles (vegetables, fruits, red meat, eggs, and fish),
alcohol intake (continuous, adding a quadratic term) and Mediterranean diet adherence (13-point score). All models were stratified by recruitment centre.
Extremes of total energy intake were excluded.
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lower risk of cardiovascular mortality than those in the
reference category (Table 3). The HR of cardiovascular
mortality in the fully-adjusted model of total nut con-
sumption was 0.45 (95% CI 0.25 to 0.81). Table 4 shows
the HRs for cancer death by frequency of total nut
consumption, walnut consumption and consumption of
other nuts. Subjects in the upper category of total nut
consumption had a significant 40% (95% CI −37% to −98%)
reduction in cancer death, although the P for trend was
non significant.
Figure 1 shows the multivariate adjusted HRs for total
mortality by frequency of total nut consumption and
intervention group. In the three arms of the trial, individ-
uals who consumed nuts >3 servings per week tended to
have a lower risk of mortality than those in the reference
category. Subjects in the upper category of nut con-
sumption at baseline allocated to the MedDiet with
nuts intervention had a significant reduction in total
mortality risk of 63% (95% CI −34% to −78%), while
those allocated to the MedDiet with EVOO and the
control diet had non-significant reductions of 34%
(95% CI −64% to 10%) and 16% (95% CI −52% to 44%),
respectively. The interaction between baseline total
nut consumption and intervention group was signifi-
cant, P = 0.019).
When we used generalized estimating equations to
assess the association between yearly updated measure-
ments of total nut consumption and all-cause mortality
we also found a significant inverse association. The fully-
adjusted relative risk (RR) was 0.68 (95% CI 0.50 to 0.93)
with a significant linear trend test. When we repeated the
analysis to evaluate the association between nut intake and
cardiovascular mortality and cancer mortality the fully-
adjusted relative risk (RR) were 0.76 (95% CI 0.42 to 1.36)
and 0.63 (95% CI 0.39 to 1.03), respectively; however the
linear trend tests were not significant (data not shown).
Discussion
In this longitudinal cohort study of individuals at high
cardiovascular risk with relatively high nut intake living in
Table 3 Hazard ratios of cardiovascular mortality according to the frequency of nut consumption (including and not
including walnuts)
Cardiovascular mortality Never 1 to 3 servings/week >3 servings/week P for trend
Frequency of total nut consumption: n = 2,118 n = 2,803 n = 2,295
Cardiovascular death, % (n) 1.7 (36) 0.8 (23) 1.0 (22)
Person-years, n 8,724 12,168 10,185
Crude model 1 (Reference) 0.44 (0.26 to 0.74) 0.50 (0.29 to 0.85) 0.101
Multivariable model 1 1 (Reference) 0.44 (0.26 to 0.76) 0.47 (0.27 to 0.82) 0.075
Multivariable model 2 1 (Reference) 0.41 (0.24 to 0.71) 0.41 (0.23 to 0.73) 0.042
Multivariable model 3 1 (Reference) 0.42 (0.24 to 0.74) 0.45 (0.25 to 0.81) 0.091
Frequency of walnut consumption: n = 2,916 n = 2,547 n = 1,753
Cardiovascular death, % (n) 1.6 (46) 0.7 (18) 1.0 (17)
Person-years, n 12,124 11,122 7,825
Crude model 1 (Reference) 0.41 (0.24 to 0.71) 0.55 (0.31 to 0.96) 0.037
Multivariable model 1 1 (Reference) 0.42 (0.24 to 0.74) 0.54 (0.30 to 0.95) 0.040
Multivariable model 2 1 (Reference) 0.39 (0.22 to 0.69) 0.49 (0.27 to 0.88) 0.022
Multivariable model 3 1 (Reference) 0.41 (0.23 to 0.73) 0.53 (0.29 to 0.98) 0.047
Frequency of consumption of other nuts (excluding walnuts): n = 3,308 n = 2,643 n = 1,265
Cardiovascular death, % (n) 1.3 (43) 1.1 (28) 0.8 (10)
Person-years, n 13,936 11,573 5,566
Crude model 1 (Reference) 0.76 (0.47 to 1.22) 0.57 (0.28 to 1.13) 0.129
Multivariable model 1 1 (Reference) 0.73 (0.45 to 1.20) 0.48 (0.23 to 0.97) 0.056
Multivariable model 2 1 (Reference) 0.70 (0.43 to 1.15) 0.40 (0.19 to 0.83) 0.021
Multivariable model 3 1 (Reference) 0.74 (0.45 to 1.23) 0.42 (0.20 to 0.89) 0.031
One serving of nuts equals 28 g. Cox regression models were used to assess the risk of cardiovascular mortality by frequency of nut consumption. Multivariable
model 1 was adjusted for age (years), sex, and intervention group. Model 2 was additionally adjusted for BMI (kg/m2), smoking status (never, former, current
smoker), educational level (illiterate/primary education, secondary education, academic/graduate), leisure time physical activity (MET-min/day), history of diabetes
(yes/no), history of hypercholesterolemia (yes/no), use of oral antidiabetic medication (yes/no), use of antihypertensive medication (yes/no), use of statins (yes/no),
and total energy intake (kcal/day). Model 3 was also adjusted for dietary variables in quintiles (vegetables, fruits, red meat, eggs, and fish), alcohol intake
(continuous, adding a quadratic term) and Mediterranean diet adherence (13-point score). All models were stratified by recruitment centre. Extremes of total
energy intake were excluded.
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a Mediterranean country, the frequency of nut consump-
tion was inversely related to total mortality after 4.8 years
of follow-up. Compared to non-consumers, subjects who
consumed >3 servings of nuts per week at baseline had a
significant 39% lower risk of all-cause mortality. Relative
risk reductions were similar for the upper baseline category
of non-walnut nuts (34%) or walnut consumption (45%),
and when we evaluated the repeated measurements of total
nut consumption over time (32%).
Moreover, those in the upper category of baseline nut
consumption had a 55% lower risk of cardiovascular
mortality and 40% lower risk of cancer mortality compared
to those who never consumed nuts. The study subjects
participated in the PREDIMED study, a long-term, ran-
domized nutrition intervention trial [14], and those con-
suming more nuts at baseline and allocated to intervention
with a MedDiet supplemented with nuts showed a signifi-
cantly reduced total mortality risk of 63%.
The inverse association between baseline nut consump-
tion and total mortality was of borderline significance in
participants in the upper category of baseline nut consump-
tion in a MedDiet supplemented with EVOO group, while
there was no significant association in those allocated to a
low-fat control diet, who were advised to reduce intake of
all fatty foods, including nuts. Thus, advice against eating
nuts throughout the study might have counterbalanced
the protective effect of a lifetime intake of these foods. We
assume that the baseline assessment can be considered as
a good correlate of lifetime habits in this population.
Our findings concur with those of epidemiological
studies showing inverse associations between nut consump-
tion and cardiovascular mortality. Four large prospective
studies have reported consistent inverse associations
between nut consumption and fatal CHD or sudden
cardiac death [23–26]. In the Adventist Health Study,
subjects who consumed nuts >5 times per week had a
48% reduced risk of fatal CHD [23]. The reduction in
death from CHD among women who consumed nuts 2 to
4 times/week in the Iowa Women’s Health Study were
57% [24]. However, a later report from the same study
Table 4 Hazard ratios of cancer mortality according to the frequency of nut consumption (including and not including
walnuts)
Cancer mortality Never 1 to 3 servings/week >3 servings/week P for trend
Frequency of total nut consumption: n = 2,118 n = 2,803 n = 2,295
Cancer death, % (n) 2.1 (44) 1.9 (52) 1.5 (34)
Person-years, n 8,724 12,168 10,185
Crude model 1 (Reference) 0.82 (0.55 to 1.23) 0.64 (0.41 to 1.00) 0.070
Multivariable model 1 1 (Reference) 0.77 (0.51 to 1.16) 0.54 (0.34 to 0.86) 0.015
Multivariable model 2 1 (Reference) 0.79 (0.52 to 1.20) 0.60 (0.37 to 0.96) 0.052
Multivariable model 3 1 (Reference) 0.79 (0.52 to 1.20) 0.60 (0.37 to 0.98) 0.064
Frequency of walnut consumption: n = 2,916 n = 2,547 n = 1,753
Cancer death, % (n) 2.1 (62) 1.9 (48) 1.1 (20)
Person-years, n 12,124 11,122 7,825
Crude model 1 (Reference) 0.82 (0.56 to 1.20) 0.48 (0.29 to 0.80) 0.005
Multivariable model 1 1 (Reference) 0.76 (0.52 to 1.12) 0.41 (0.25 to 0.69) 0.001
Multivariable model 2 1 (Reference) 0.77 (0.52 to 1.14) 0.46 (0.27 to 0.77) 0.003
Multivariable model 3 1 (Reference) 0.76 (0.51 to 1.12) 0.46 (0.27 to 0.79) 0.005
Frequency of consumption of other nuts (excluding walnuts): n = 3,308 n = 2,643 n = 1,265
Cancer death, % (n) 2.0 (66) 1.6 (43) 1.7 (21)
Person-years, n 13,936 11,573 5,566
Crude model 1 (Reference) 0.77 (0.52 to 1.13) 0.79 (0.48 to 1.29) 0.439
Multivariable model 1 1 (Reference) 0.74 (0.50 to 1.10) 0.68 (0.41 to 1.14) 0.213
Multivariable model 2 1 (Reference) 0.79 (0.53 to 1.18) 0.73 (0.43 to 1.23) 0.318
Multivariable model 3 1 (Reference) 0.79 (0.53 to 1.18) 0.75 (0.44 to 1.27) 0.369
One serving of nuts equals 28 g. Cox regression models were used to assess the risk of cancer mortality by frequency of nut consumption. Multivariable model 1
was adjusted for age (years), sex, and intervention group. Model 2 was additionally adjusted for BMI (kg/m2), smoking status (never, former, current smoker),
educational level (illiterate/primary education, secondary education, academic/graduate), leisure time physical activity (MET-min/day), history of diabetes (yes/no),
history of hypercholesterolemia (yes/no), use of oral antidiabetic medication (yes/no), use of antihypertensive medication (yes/no), use of statins (yes/no), and
total energy intake (kcal/day). Model 3 was also adjusted for dietary variables in quintiles (vegetables, fruits, red meat, eggs, and fish), alcohol intake (continuous,
adding a quadratic term) and Mediterranean diet adherence (13-point score). All models were stratified by recruitment centre. Extremes of total energy intake
were excluded.
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with longer follow-up failed to confirm that nut con-
sumption protected from CHD death [10]. In addition,
the Nurses’ Health Study observed that women who
consumed nuts ≥5 times/week had a 30% reduced risk
of fatal CHD [25]. Finally, the Physicians’ Health Study
reported a 47% lower risk of sudden cardiac death and
30% lower risk of total CHD death among men who
consumed nuts twice a week or more [7].
In our study, a reduced risk of cancer mortality has
been observed in individuals that frequently consumed
total nuts and walnuts. Few epidemiologic studies have
been conducted evaluating the association between nut
consumption and cancer. An ecological study showed
that prostate cancer mortality was inversely associated
with nuts and oilseed consumption [27]. Moreover, findings
from prospective studies suggest inverse associations
between nut consumption and colorectal or endometrial
cancer, especially in women [28–31]. Some studies showed
inverse associations of nut intake and prostate cancer [32],
however the relationship between nuts and cancer inci-
dence and mortality is insufficient and further research is
needed [33]. A possible explanation that may account for
the inverse relationship between walnuts and cancer mor-
tality but not with other nuts could be that walnuts were
richer in free and total polyphenols than all the other nuts
[34]. As walnuts are usually consumed raw, and roasting
can cause a decline in the efficacy in the antioxidant cap-
acity, it has been shown that raw walnuts, as consumed in
the PREDIMED study, had the highest antioxidant efficacy
among all the nuts [34]; this could play a beneficial role in
the prevention of cancer.
The present results also support those of prior observa-
tional studies suggesting that nut consumption protects
against mortality. In the Iowa Women’s Health Study,
subjects consuming nuts ≥2 times/week had a significant
12% lower mortality risk than those who ate nuts less than
once monthly after a 12-year follow-up [10]. A recent study
from a large Dutch cohort followed for 10 years reported
that men and women in the 75th percentile of nut intake
had 8% and 5% lower risks of all-cause mortality, respect-
ively, compared with subjects in the 25th percentile [11].
Additionally, data from the Nurses’ Health Study, where
participants were followed-up for nearly 18 years, showed
that consuming nuts ≥2 times/week was associated with
a 14% reduced risk of all-cause mortality [12]. It is
noteworthy that the protection against total mortality
afforded by nut consumption in our study was ≥3 orders
of magnitude higher than that observed in studies of
non-Mediterranean populations. A likely reason is that
PREDIMED participants had a rather high self-selected
nut intake before entering the study. Thus, 32% of
PREDIMED participants consumed nuts >3 times/week,
Figure 1 Adjusted hazard ratios of total mortality by frequency of nut consumption and intervention group. The Cox regression models
were adjusted for age in years, sex, BMI in kg/m2, smoking status (never, former, current smoker), educational level (illiterate/primary education,
secondary education, academic/graduate), leisure time physical activity in MET-min/day, history of diabetes (yes/no), history of hypercholesterolemia
(yes/no), use of oral antidiabetic medication (yes/no), use of antihypertensive medication (yes/no), use of statins (yes/no), total energy intake (kcal/d),
dietary variables in quintiles (vegetables, fruits, red meat, eggs and fish), alcohol intake (continuous, adding a quadratic term), and Mediterranean diet
adherence (13-point score). The model was stratified by recruitment centre. Extremes of total energy intake were excluded. Values for the two upper
categories of nut consumption are 0.38 (95% CI: 0.23 to 0.63) and 0.37 (95% CI: 0.22 to 0.66) in the Mediterranean diet supplemented with nuts
(MedDiet + NUTS) group; 0.79 (95% CI: 0.50 to 1.24) and 0.63 (95% CI: 0.36 to 1.1) in the Mediterranean diet supplemented with extra-virgin olive oil
(MedDiet + EVOO) group; and 1.04 (95% CI: 0.64 to 1.69) and 0.84 (95% CI: 0.48 to 1.44) in the low-fat control diet group. P for the interaction between
baseline nut consumption and intervention group= 0.019. P for trend: MedDiet + NUTS, p=0.01; MedDiet + EVOO, p=0.15; Control diet, p=0.42.
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compared with nearly 10% consuming nuts ≥2 times/
week in both the Iowa Women’s Health Study [10] and
the Nurses’ Health Study [12]. In the Dutch study, par-
ticipants in the 75th percentile of nut consumption had
rather low average daily intakes of 11.1 g for men and
6.2 g for women [11].
The healthy nutritional profile of nuts may account
for the inverse association observed between nuts and
mortality. Nuts are high in monounsaturated fatty
acids, fiber, minerals, vitamins and many bioactive
compounds; all these nutrients may partly explain the
beneficial effects on health that nuts have been shown
to exert [3,4]. The frequency of nut consumption has
been inversely related to several chronic prevalent con-
ditions, such as diabetes, hyperlipidemia, hypertension,
obesity, metabolic syndrome, cancer, and CHD, among
others [5,26]. These inverse associations can be influenced
by various mechanisms: nuts improve the blood lipid
profile [6] and appear to decrease insulin resistance [8],
and there is also evidence suggesting that they can modu-
late inflammation [35], oxidative stress [36], and endothe-
lial function [37]. As a large body of evidence supports the
beneficial effects of frequent nut consumption on many
health outcomes, it is plausible that nuts protect as well
against all-cause mortality.
Our study has limitations. First, given its observational
nature, it is not possible to firmly conclude that the
inverse relationship between nut consumption and total
mortality reflects cause and effect. Second, even though
data were adjusted for all possible confounders, there is
still the possibility of residual confounding. However, the
enhanced protective effect against all-cause mortality
observed in frequent nut consumers at baseline who
continued eating nuts during follow-up because they
were allocated to the nuts intervention arm supports a
causal relationship between increasing dietary exposure
to nuts and reduced mortality. However, as the study
was conducted in an older Mediterranean population at
high cardiovascular risk, the results cannot easily be
extrapolated to the general population. Nevertheless, it
is relevant to assess these associations in individuals at
high cardiovascular risk because this population is the
most frequently attended by primary care physicians and
the segment of population that can obtain higher bene-
fits with diet or lifestyle changes.
There are also strengths to our study, such as a large
sample size, relatively long duration of follow-up, and
objective and thorough ascertainment of mortality as
outcome in this prospective observational assessment.
Conclusions
In summary, this study provides further evidence of the
inverse relationship between the frequency of nut con-
sumption and the risk of mortality in a Mediterranean
population at high cardiovascular risk with relatively high
nut intake.
Appendix: other PREDIMED Investigators
Hospital Clinic, Institut d’Investigacions Biomediques
August Pi i Sunyer, Barcelona, Spain: M Serra-Mir, A
Pérez-Heras, C Viñas, R Casas, LS Romero, M Cofán, C
Valls-Pedret, A Sala-Vila and M Doménech.
University of Navarra, Primary Care Centres, Pamplona,
Spain: E Toledo, A Sánchez-Tainta, I Zazpe, M Marques,
E Goñi, B Sanjulian, A Marti, P Buil-Cosiales, M
Serrano-Martinez, J Diez-Espino, A Garcia-Arellano
and FJ Basterra-Gortari.
University Rovira i Virgili, Reus, Spain: R Gonzalez, C
Molina, F Marquez, N Babio, P Martinez, N Ibarrola-
Jurado, R Balanza, A Díaz-López, M Juanola-Falgarona,
M Sorlí, J Garcia Roselló, F Martin, R Tort, A Isach, B
Costa, JJ Cabré and J Fernandez-Ballart.
Institut de Recerca Hospital del Mar, Barcelona, Spain:
MI Covas, H Schröder, S Tello, R de la Torre, MA Muñoz
and J Vila.
University Hospital of Alava, Vitoria, Spain: I Salaverría,
S Castro, E Sanz, F Ricarte and J Rekondo.
University of Málaga, Málaga, Spain: R Benítez-Pont, M
Bianchi-Alba, J Fernández-Crehuet and E Gómez-Gracia.
Department of Family Medicine, Primary Care Division
of Sevilla, Sevilla, Spain: FJ García, M Ortega-Calvo,
P Román, JM Santos and Y Corchado.
University of Las Palmas de Gran Canaria, Las Palmas,
Spain: J Álvarez-Pérez, E Díez-Benítez, I Bautista-Casta
ño and A Sánchez-Villegas.
University of Valencia, Department of Preventive
Medicine, Spain: C Ortega-Azorin, EM Asensio-Márquez,
P Guillem-Saiz, JI Gonzalez and O Portoles.
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olive oil; MedDiet: Mediterranean diet.
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6.2. OLIVE OIL INTAKE AND RISK OF CARDIOVASCULAR DISEASE AND MORTALITY IN THE 
PREDIMED STUDY 
 
Guasch-Ferré M, Hu FB, Martínez-González MA, Fitó M, Bulló M, Estruch R, Ros E, Corella D, 
Recondo J, Gómez-Gracia E, Fiol M, Lapetra J, Serra-Majem L, Muñoz MA, Pintó X, Lamuela-
Raventós RM, Basora J, Buil-Cosiales P, Sorlí JV, Ruiz-Gutiérrez V, Martínez JA, Salas-Salvadó J. 
 
BMC Med. 2014 May 13;12(1):78. PMID: 24886626; doi: 10.1186/1741-7015-12-78. 
 
Study 2 overview. Novelty and significance.  
What is already known? 
 
- Olive oil intake is inversely associated with cardiovascular disease and all-cause mortality in 
healthy adults and elderly. 
- Extra virgin olive oil, that contains higher amounts of polyphenols, may have cardiovascular 
benefits beyond lipid profile. 
- Most previous studies made no distinction among the different varieties of olive oil, and the 
associations have not been explored in individuals at high cardiovascular risk from a 
Mediterranean country with higher consumption of olive oil.  
 
-  What this study adds? 
- For the first time a prospective study in elderly Mediterranean at high cardiovascular risk has 
found that total olive oil intake was associated with a 35% (HR: 0.65, 95% CI:0.47-0.89) 
reduction in the risk of cardiovascular disease. 
- This association was even stronger for extra-virgin olive oil variety, 39% (HR: 0.61, 95% CI: 
0.44-0.85) reduction in the risk of cardiovascular disease was observed in those individuals in 
the higher tertile of olive oil intake, compared to the reference.  
- Per each 10 g/d increase in extra virgin olive oil it was associated with 10% (HR: 0.90, 95% CI: 
0.85-0.95) lower risk of cardiovascular disease. 
Summary 
 
- Greater consumption of total olive oil, especially extra-virgin olive oil, was associated with 
reduced cardiovascular disease and mortality risk in an elderly Mediterranean population at 
high cardiovascular risk.  
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Abstract
Background: It is unknown whether individuals at high cardiovascular risk sustain a benefit in cardiovascular
disease from increased olive oil consumption. The aim was to assess the association between total olive oil intake,
its varieties (extra virgin and common olive oil) and the risk of cardiovascular disease and mortality in a
Mediterranean population at high cardiovascular risk.
Methods: We included 7,216 men and women at high cardiovascular risk, aged 55 to 80 years, from the
PREvención con DIeta MEDiterránea (PREDIMED) study, a multicenter, randomized, controlled, clinical trial.
Participants were randomized to one of three interventions: Mediterranean Diets supplemented with nuts or
extra-virgin olive oil, or a control low-fat diet. The present analysis was conducted as an observational prospective
cohort study. The median follow-up was 4.8 years. Cardiovascular disease (stroke, myocardial infarction and
cardiovascular death) and mortality were ascertained by medical records and National Death Index. Olive oil
consumption was evaluated with validated food frequency questionnaires. Multivariate Cox proportional hazards
and generalized estimating equations were used to assess the association between baseline and yearly repeated
measurements of olive oil intake, cardiovascular disease and mortality.
Results: During follow-up, 277 cardiovascular events and 323 deaths occurred. Participants in the highest
energy-adjusted tertile of baseline total olive oil and extra-virgin olive oil consumption had 35% (HR: 0.65; 95% CI: 0.47
to 0.89) and 39% (HR: 0.61; 95% CI: 0.44 to 0.85) cardiovascular disease risk reduction, respectively, compared to the
reference. Higher baseline total olive oil consumption was associated with 48% (HR: 0.52; 95% CI: 0.29 to 0.93) reduced
risk of cardiovascular mortality. For each 10 g/d increase in extra-virgin olive oil consumption, cardiovascular disease
and mortality risk decreased by 10% and 7%, respectively. No significant associations were found for cancer and
all-cause mortality. The associations between cardiovascular events and extra virgin olive oil intake were significant
in the Mediterranean diet intervention groups and not in the control group.
Conclusions: Olive oil consumption, specifically the extra-virgin variety, is associated with reduced risks of cardiovascular
disease and mortality in individuals at high cardiovascular risk.
Trial registration: This study was registered at controlled-trials.com (http://www.controlled-trials.com/ISRCTN35739639).
International Standard Randomized Controlled Trial Number (ISRCTN): 35739639. Registration date: 5 October 2005.
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Background
Olive oil is a key component of the Mediterranean
Diet (MedDiet), being the main source of vegetable fat,
especially monounsaturated fatty acids (MUFA) [1]. Virgin
olive oil, produced by mechanically pressing ripe ol-
ives, contains multiple bioactive and antioxidant com-
ponents such as polyphenols, phytosterols and vitamin
E [1], and has an acidity of <1.5%. Extra-virgin olive oil
(EVOO) is also produced by mechanically pressing the
olives but is the oil with the best quality, the most in-
tense taste and its acidity is <1%. In contrast, common
olive oil, obtained from a mixture of virgin and refined oil
(usually more than 80% is refined), has fewer antioxidant
and anti-inflammatory compounds. Since refined olive oil
during the refining process loses phytochemicals, this oil
is mixed with virgin olive oil to enhance the flavor, consti-
tuting the so-called common olive oil [2].
Evidence suggests that olive oil intake is inversely as-
sociated with cardiovascular disease (CVD) in the Spanish
general population [3] and in a cohort of Italian women
[4]. In the Spanish cohort of the European Prospective
Investigation into Cancer and Nutrition (EPIC) study, total
olive oil intake has been associated with a decreased risk of
coronary heart disease, and also all-cause and cardiovas-
cular mortality [5,6]. Similarly, a lower risk of mortality
was associated with regular consumption of olive oil in
an Italian population after myocardial infarction [7] and
also in an elderly population [8]. A recent meta-analysis
concluded that epidemiologic studies consistently found
an inverse association between olive oil consumption and
stroke, but there were inconsistencies between studies
assessing coronary heart disease (CHD) as the end-point
[9]. Of note, most of the previous studies made no dis-
tinction among the different varieties of olive oil [4,7,8].
Except for the EPIC-Spanish cohort that found a greater
beneficial effect in CHD for the virgin olive oil variety
than for the common variety [5] and similar effects for
both varieties on all-cause mortality [6]. This distinction is
important because EVOO contains much higher amounts
of polyphenols than common olive oil. These polyphenols
may have cardiovascular benefits beyond the lipid profile.
It has also been reported that olive oil intake could be
beneficial in the prevention of certain cancers, such as
breast cancer [10], but the evidence is weaker.
Recently, in the context of the PREvención con DIeta
MEDiterránea (PREDIMED) Study, it has been demon-
strated that a MedDiet enriched with EVOO improved
lipid profile, decreased blood pressure and reduced the
risk of major cardiovascular events [11,12]. In this ob-
servational analysis of the PREDIMED population, we
aimed to assess the associations between baseline olive
oil consumption and the risk of CVD, cause-specific
and overall mortality. We hypothesized that higher con-
sumption of olive oil, especially the EVOO variety, would
be associated with a decreased risk of CVD, cause-specific
and overall mortality in an elderly Mediterranean popu-
lation at high cardiovascular risk, independent of the
allocated arm of the trial.
Methods
Study population
The present study was conducted within the framework of
the PREDIMED trial, whose design has been described
in detail elsewhere [13]. Briefly, the PREDIMED study
is a large, multicenter, parallel-group, randomized and
controlled clinical trial for the primary prevention of CVD
(http://www.predimed.es). The main results of the trial on
the primary endpoint have been published elsewhere [12].
We assigned 7,447 participants (men aged 55 to 80 years
and women 60 to 80 years) to one of three interventions:
a MedDiet supplemented with EVOO, a MedDiet supple-
mented with mixed nuts, or advice on a low-fat diet
(control diet). Participants had no CVD at enrollment, but
they were at high cardiovascular risk because of the pres-
ence of type 2 diabetes or at least three of the following risk
factors: current smoking, hypertension, high low-density
lipoprotein (LDL)-cholesterol, low high-density lipopro-
tein (HDL)-cholesterol, overweight or obesity, and family
history of premature CVD. Exclusion criteria were the
presence of any severe chronic illness, alcohol or drug
abuse, body mass index (BMI) ≥40 kg/m2, and allergy or
intolerance to olive oil or nuts. The primary endpoint of
the main trial was a composite of cardiovascular events
(myocardial infarction, stroke or death from cardio-
vascular causes). The present analysis was conducted
as an observational prospective cohort study using
baseline consumption of olive oil as the exposure, and
taking baseline data from the date of the first visit, be-
fore the individuals were randomized to the intervention
group. The outcomes were: (a) composite of cardiovascular
events, (b) cardiovascular mortality, (c) cancer mortality
and (d) all-cause mortality. All participants provided writ-
ten informed consent according to a protocol approved by
the institutional review boards of all the recruiting centers
(Comité de Ética e Investigación Clínica [CEIC] Hospital
Universitari Sant Joan de Reus, CEIC Universidad de
Navarra, CEIC Hospital Clínic de Barcelona, Comité
de Ética Universidad de Valencia, CEIC-Parc de Salut
Mar, CEIC Hospital Universitario Araba, CEIS del distrito
Sanitario Atención Primaria Sevilla, IDIAP Jordi Gol, CEIC
Complejo Hospitalario Materno-Insular, CEIC Facultad
Medicina Universidad de Málaga, CEIC Illes Balears,
CEIC Hospital Universitari Bellvitge).
Assessment of olive oil consumption and other covariates
At baseline and yearly during the follow-up, trained
dieticians completed a 137-item semiquantitative food
frequency questionnaire (FFQ) in a face-to-face interview
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with the participants. This questionnaire has been validated
before in a population at high cardiovascular risk from
Spain. Reproducibility and validity of the FFQ for total
olive oil consumption, estimates by the Pearson correl-
ation coefficient (r) were 0.55 and 0.60, respectively, and
the intraclass correlation coefficients for reproducibility
and validity were 0.71 (P <0.001) [14]. Energy and nutrient
intake were estimated using updated Spanish food compos-
ition tables [15,16]. Information on consumption of differ-
ent types of olive oil intake was derived from the FFQ. The
questionnaire includes three different questions regarding
the consumption of olive oil: EVOO intake (produced by
mechanically pressing the olives, acidity <1%), refined olive
oil intake (refined olive oil, acidity <0.3%) and pomace olive
oil (obtained from the residue of pressing the olives and
mixed with other refined olive oils, acidity <0.3%). The die-
ticians asked the participants if they consumed one table-
spoon of olive oil (for each of the specific varieties): never,
between one to three times per month, times per week
(once, two to four, five to six, three options) or times a day
(once, two to three, four to six, more than six, four options).
These questions were transformed to continuous variables
in grams per day. The first question was used to assess
EVOO intake, the sum of the second and third questions
(refined olive oil and pomace olive oil) was considered
common olive oil intake. The sum of all the three questions
provides the total amount of olive oil consumed.
In addition, dieticians administered a validated 14-item
MedDiet screener designed to assess the degree of adher-
ence to the traditional MedDiet [17]. Two questions in the
screener are related to olive oil intake (use of olive oil as
the main fat for cooking (1 point if the answer is yes)
and using four or more tablespoons of olive oil (1 point
if the answer is yes), with 14 points the total score of the
questionnaire). To control for the overall dietary pattern,
we used this MedDiet screener removing the variables re-
lated to olive oil consumption; thus, a 12-point score was
used as a covariate in the models.
At baseline, a questionnaire about lifestyle variables,
educational achievement, history of illnesses and medica-
tion use was administered. Physical activity was assessed
using the validated Spanish version of the Minnesota
Leisure-Time Physical Activity questionnaire [18]. Partici-
pants were considered to be diabetic, hypercholesterolemic
or hypertensive if they had previously been diagnosed
as such, and/or they were being treated with antidia-
betic, cholesterol-lowering or antihypertensive agents,
respectively. Trained personnel took the anthropometric
and blood pressure measurements. Weight and height
were measured with light clothing and no shoes with
calibrated scales and a wall-mounted stadiometer, re-
spectively. Waist circumference was measured midway
between the lowest rib and the iliac crest using an an-
thropometric tape. Blood pressure was measured using
a validated oscillometer (Omron HEM705CP; Hoofddorp,
The Netherlands) in triplicate with a five-minute interval
between each measurement, and the mean of these values
was recorded.
Ascertainment of cardiovascular disease and mortality
Information on CVD and mortality was updated once a
year by the End-point Adjudication Committee, whose
members were blinded to treatment allocation and to
the dietary habits of participants. Different sources of
information were used: (a) yearly questionnaires and
examinations for all participants, (b) primary care physi-
cians, (c) yearly review of medical records, and (d) linkage
to the National Death Index. Medical records of deceased
participants were requested. The End-point Adjudication
Committee adjudicated the cause of the death and con-
firmed cardiovascular events.
Statistical analyses
Follow-up time was calculated as the interval between
the date of cardiovascular events, death (cardiovascular,
cancer or all-causes of death) or the end of follow-up
(the date of the last visit or the last recorded clinical event
of participants still alive) and the date of randomization.
Extremes of reported total energy intake (>4,000 or <800
kcal per day in men and >3,500 or <500 kcal per day in
women) were excluded from the present analysis [19].
Baseline characteristics of the studied population are pre-
sented according to energy-adjusted tertiles of total olive oil
consumption, as means (SD) for quantitative variables and
percentage (number) for categorical variables.
Multivariate Cox proportional hazard models were
used to assess the associations between baseline energy-
adjusted tertiles of olive oil intake and the risk of CVD,
cardiovascular mortality, cancer mortality and all-cause
mortality. Baseline total olive oil intake has also been
analyzed as a continuous variable. All analyses were
repeated using energy-adjusted tertiles of EVOO and
common olive oil consumption. We also tested the associa-
tions between baseline olive fruit consumption and CVD
and mortality (consumption of the whole olive fruit, not oil).
All analyses were stratified by the recruitment center.
Results are expressed as hazard ratios (HRs) with 95%
confidence intervals (CIs). Model 1 was adjusted for
age (continuous), sex and the intervention group. Model
2 was additionally adjusted for BMI (kg/m2), smoking
status (never, former, current smoker), alcohol intake
(continuous, adding a quadratic term), educational
level (illiterate/primary education, secondary educa-
tion, academic/graduate), leisure time physical activity
(Metabolic Equivalent of Task (MET)-minutes/d), preva-
lence of diabetes (yes/no), prevalence of hypertension
(yes/no), prevalence of hypercholesterolemia (yes/no),
use of antihypertensive medication (yes/no) and use of
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statins (yes/no). A third model was additionally adjusted for
baseline MedDiet adherence (12-point score). Additionally,
myocardial infarction and stroke were used as outcomes
of the analysis. Linear trend tests were assessed using the
median value to each category of total olive oil, EVOO
and common olive oil consumption and included as a
continuous variable in the various models. We used Cox
regression models to assess the association between total
olive oil and CVD, cardiovascular mortality, cancer mor-
tality and all-cause mortality separated by intervention
group. Linear trends were also tested. As a secondary
analysis and to take advantage of the updated informa-
tion of yearly intake of total olive oil, we repeated the
analysis using generalized estimating equations to assess
the association between yearly repeated measurements
of total olive oil consumption during follow-up and CVD
and mortality. For each one-year period we used as ex-
posure the average of total olive oil consumption of all
repeated measurements from baseline to the beginning
of that yearly period (between two and eight years).
Sensitivity analyses were conducted including only the
events observed in the two first years, between the second
and fourth years, and after four years of follow-up. Also,
sensitivity analyses were conducted excluding early cases
(less than one year) and late cases (more than four years).
The level of significance for all statistical tests was P<0.05
for bilateral contrast. Analyses were done using SPSS stat-
istical software, version 19 (SPSS Inc., Chicago, IL, USA).
Results
After excluding those individuals with extremes of reported
total energy intake (n = 153) and those with incomplete
baseline dietary data (n = 78), a total of 7,216 participants
were included in the present analysis. During a median of
4.8 y of follow-up we documented 277 incident cases of
major cardiovascular events, 81 cardiovascular deaths, 130
cancer deaths and 323 all-cause deaths. The mean age of
the participants was 67 y and 57.4% of them were women,
respectively. The baseline characteristics of the participants
according to energy-adjusted tertiles of total olive oil
consumption are described in Table 1. As compared
with participants in the lowest tertile of total olive oil
intake, those in the highest tertile were more likely to
have secondary education, lower total energy intake, lower
consumption of red meat and dairy products, and also to
drink less alcohol. The mean intake of total olive oil was
56.9 g/d in those participants allocated in the highest ter-
tile compared to 21.4 g/d in those of the lowest tertile.
Changes in total olive oil intake at the end of follow-up
were 3.85 ± 23.02 g/d (mean ± SD) for the combined par-
ticipants, 10.92 ± 22.91 g/d for those given MedDiet sup-
plemented with EVOO, 2.36 ± 21.81 g/d for those given
MedDiet supplemented with nuts and -3.03 ± 22.02 g/d in
the control group. The total olive oil consumption by year
during the follow-up for the total participants, and also by
the intervention group is shown in Additional file 1.
After adjusting for age, sex and intervention group,
there was a 34% (P for trend = 0.01) lower risk of major
cardiovascular events among individuals in the highest
tertile of baseline total olive oil intake as compared to those
in the reference (Table 2). The inverse association remained
statistically significant (P for trend = 0.01) after the ad-
justment for lifestyle variables and other potential con-
founders (36% lower risk (HR: 0.64; 95% CI: 0.46 to 0.87))
and even after further adjustment for MedDiet adherence
(35% lower risk (HR: 0.65; 95% CI: 0.47 to 0.89)). For each
10 g/d (one tablespoon) higher baseline total olive oil con-
sumption there was a 13% (HR: 0.87; 95% CI: 0.81 to 0.94)
decreased risk of major cardiovascular events. A 48% re-
duction in the risk of cardiovascular death (HR: 0.52; 95%
CI: 0.29 to 0.93) was found in the fully-adjusted model for
those individuals in the highest tertile of total baseline
olive oil consumption as compared to the reference. Also,
for each 10 g/d (one tablespoon) higher total baseline olive
oil consumption there was a 16% (HR: 0.84; 95% CI: 0.73
to 0.96) decreased risk of cardiovascular mortality. No
statistically significant associations were found for cancer
mortality and all-cause mortality.
The HR and 95% CIs for the association between
EVOO, CVD and also for mortality are presented in
Table 3. Baseline EVOO consumption was inversely as-
sociated with major events after adjusting for potential
confounders (39% lower risk (HR: 0.61; 95% CI: 0.44 to
0.85 (P for trend <0.01)). A non-significant inverse associ-
ation between baseline EVOO consumption and mortality
outcomes was found, specifically for overall mortality.
We observed non-significant associations between the
baseline intake of common olive oil and major events
and mortality (Table 4).
When we screened the risk of myocardial infarction and
stroke according to the different categories and varieties of
olive oil consumption it was observed that the inverse asso-
ciations were non-statistically significant (data not shown).
We have also analyzed the association between the
consumption of olive fruit (olives) and the risk of major
events. We found an association of 25% decrease in the
risk of major events in the top tertile of baseline olive
fruit consumption after adjusting for potential confounders
(HR: 0.75; 95% CI: 0.55 to 1.01, P for trend = 0.10).
The reduction in the risk of major cardiovascular events
according to tertiles of total baseline olive oil intake sepa-
rated by intervention group were 57% (HR: 0.43; 95% CI:
0.25 to 0.75, P for trend <0.01) and 55% (HR: 0.45; 95% CI:
0.25 to 0.82, P for trend <0.01) in the groups of MedDiet
supplemented with EVOO or nuts, respectively. In contrast,
the risk in the low fat control group was increased by
9% (HR: 1.09, 95% CI: 0.63 to 1.88, P for trend = 0.24)
(P-value of homogeneity test: 0.178). The association
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Table 1 Baseline characteristics of study participants according to energy-adjusted tertiles of total olive oil consumption
Baseline energy-adjusted tertiles of total olive oil consumption
Variable 1 (n = 2,405) 2 (n = 2,406) 3 (n = 2,405) P-value
Age (y) 67 ± 6 67 ± 6 67 ± 6 0.744
Men, % (n) 45.7 (1,099) 42.2 (1,016) 39.8 (956) <0.001
Intervention group, % (n) 0.476
MedDiet + EVOO 33.1 (796) 34.5 (830) 35.3 (848)
MedDiet + Nuts 32.6 (785) 32.9 (792) 32.6 (783)
Control low fat diet 34.3 (824) 32.6 (784) 32.2 (774)
BMI (kg/m2) 29.9 ± 3.73 29.9 ± 3.88 30.0 ± 3.93 0.427
Weight (kg) 77.0 ± 11.7 76.6 ± 12.0 76.6 ± 12.1 0.422
Leisure-time energy expenditure in physical activity (MET minutes/d) 243.1 ± 265.2 228.6 ± 225.5 221.3 ± 223.1 0.005
Smoking status, % (n) 0.262
Never 60.3 (1,450) 60.9 (1,466) 63.3 (1,523)
Current 14.4 (347) 14.2 (341) 13.1 (316)
Former 25.3 (608) 24.9 (599) 23.5 (566)
Educational level, % (n) 0.040
Illiterate/primary education 79.3 (1,907) 77.6 (1,866) 76.1 (1,831)
Secondary education 14.1 (338) 14.7 (354) 16.8 (404)
Academic/graduate 6.7 (160) 7.7 (186) 7.1 (170)
Prevalence of diabetes, % (n) 49.9 (1,200) 47.9 (1,153) 48.1 (1,156) 0.312
Prevalence of hypertension, % (n) 83.1 (1,998) 82.1 (1,976) 83.0 (1,995) 0.639
Prevalence of hypercholesterolemia, % (n) 73.6 (1,769) 71.7 (1,726) 71.4 (1,716) 0.190
Family history of coronary heart disease, % (n) 22.3 (536) 22.1 (531) 22.6 (544) 0.899
Medication use, % (n)
Oral antidiabetic drugs 33.6 (808) 31.4 (756) 31.6 (759) 0.195
Antihypertensive drugs 71.9 (1,728) 72.4 (1,743) 73.9 (1,777) 0.264
Statins 40.4 (972) 40.5 (974) 39.8 (958) 0.880
Modified MedDiet score (12-point score) 6.9 ± 1.7 7.0 ± 1.7 7.2 ± 1.7 <0.001
Total energy intake (kcal/d) 2,266 ± 479 2,242 ± 668 2,199 ± 457 <0.001
Total olive oil (g/d) 21.4 ± 8.00 38.8 ± 11.6 56.9 ± 10.8 <0.001
Extra virgin olive oil (g/d) 9.1 ± 11.2 19.5 ± 20.0 34.6 ± 27.4 <0.001
Common olive oil (g/d) 12.1 ± 11.7 18.6 ± 18.5 21.7 ± 25.9 <0.001
Alcohol (g/d) 8.51 ± 14.1 9.41 ± 15.5 7.06 ± 12.2 <0.001
Nuts (g/d) 11.3 ± 14.8 10.2 ± 14.2 8.7 ± 11.5 <0.001
Vegetables (g/d) 346 ± 156 328 ± 145 327 ± 137 <0.001
Fruit (g/d) 389 ± 219 363 ± 196 351 ± 184 <0.001
Red meat (beef, pork, lamb) (g/d) 79.6 ± 49.1 79.1 ± 46.1 70.4 ± 41.2 <0.001
White meat (chicken, rabbit, turkey) (g/d) 46.4 ± 28.2 45.9 ± 27.6 42.1 ± 27.1 <0.001
Eggs (g/d) 20.5 ± 10.2 20.1 ± 11.5 19.3 ± 11.5 <0.001
Fish (g/d) 95.7 ± 51.9 99.8 ± 52.0 102 ± 46.9 <0.001
Dairy (g/d) 407 ± 231 375 ± 220 357 ± 205 <0.001
Data are expressed as means ± SD or percentage (n). P-value for comparisons across tertiles of baseline energy-adjusted olive oil consumption (Pearson chi-square test
for categorical variables or 1-way analysis of variance for continuous variable) as appropriate. BMI, body mass index; EVOO, extra virgin olive oil; MedDiet, Mediterranean
diet; MET, Metabolic Equivalent of Task.
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between major events and EVOO intake showed rela-
tive risk reductions of 41% (HR: 0.59; 95% CI: 0.32 to
1.07, P for trend = 0.050), 63% (HR: 0.37; 95% CI: 0.20
to 0.71, P for trend <0.01) and 15% (HR: 0.85; 95% CI:
0.51 to 1.41, P for trend = 0.503) in the MedDiet supple-
mented with EVOO, nuts and control group, respectively
(P-value of homogeneity test: 0.364).
The inverse association between yearly updated measure-
ments of total olive oil consumption and CVD using gener-
alized estimating equations were also statistically significant
after adjusting for potential confounders. The fully adjusted
relative risk (RR) in the highest tertile of total olive oil con-
sumption, as compared to the reference, showed a relative
risk reduction of 34% (HR: 0.66; 95% CI: 0.48 to 0.91) with
a significant linear trend test (P for trend <0.01). When we
repeated the analysis to evaluate the associations between
total olive oil consumption and cardiovascular mortality
and cancer mortality, the fully adjusted relative risk (RR)
in the top tertile of total olive oil showed a relative risk
reduction of 44% (HR: 0.56; 95% CI: 0.31 to 1.02) and 24%
(HR: 0.76; 95% CI: 0.46 to 1.24), respectively. However,
the linear trend tests were non-significant. Finally, the
fully adjusted relative risk (RR) in the top tertile of total
olive oil consumption showed a relative risk reduction of
25% (HR: 0.75; 95% CI: 0.56 to 1.00, P for trend <0.01) for
all-cause mortality.
The results of several sensitivity analyses were consistent
with the findings of the primary analysis. When only the
events observed in the first two years (91 events included)
were considered, the risk of a major event in the top
tertile of total olive oil was: 0.87 (95% CI: 0.50 to 1.51).
When only events between the second and fourth years
Table 2 Risk of cardiovascular events and mortality according to baseline total olive oil intake
Energy-adjusted tertiles of total olive oil, g/day
1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend Energy-adjusted
total olive oil
intake (10 g/d)
Mean total olive oil intake 21.4 ± 8.00 38.8 ± 11.6 56.9 ± 10.8
Major event
Cardiovascular event, % (n) 4.5 (108) 3.6 (86) 3.5 (83) 3.8 (277)
Multivariable model 1 1 (Ref.) 0.76 (0.57, 1.02) 0.66 (0.48, 0.90) 0.01 0.87 (0.81, 0.94)
Multivariable model 2 1 (Ref.) 0.78 (0.58, 1.04) 0.64 (0.46, 0.87) 0.01 0.87 (0.81, 0.94)
Multivariable model 3 1 (Ref.) 0.78 (0.58, 1.04) 0.65 (0.47, 0.89) 0.01 0.87 (0.81, 0.94)
Cardiovascular mortality 1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend
Cardiovascular mortality, % (n) 1.4 (33) 1.0 (25) 1.0 (23) 1.1 (81)
Multivariable model 1 1 (Ref.) 0.68 (0.39, 1.16) 0.52 (0.29, 0.94) 0.04 0.83 (0.72, 0.96)
Multivariable model 2 1 (Ref.) 0.70 (0.41, 1.20) 0.51 (0.28, 0.92) 0.04 0.83 (0.72, 0.95)
Multivariable model 3 1 (Ref.) 0.69 (0.40, 1.18) 0.52 (0.29, 0.93) 0.04 0.84 (0.73, 0.96)
Cancer mortality 1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend
Cancer mortality, % (n) 1.8 (44) 2.0 (49) 1.5 (37) 1.8 (130)
Multivariable model 1 1 (Ref.) 1.13 (0.74, 1.72) 0.80 (0.49, 1.30) 0.96 0.93 (0.83, 1.05)
Multivariable model 2 1 (Ref.) 1.13 (0.74, 1.72) 0.84 (0.52, 1.36) 0.95 0.95 (0.84, 1.07)
Multivariable model 3 1 (Ref.) 1.13 (0.74, 1.72) 0.84 (0.52, 1.37) 0.94 0.95 (0.85, 1.07)
All-cause mortality 1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend
All causes of mortality, % (n) 4.8 (116) 4.4 (106) 4.2 (101) 4.5 (323)
Multivariable model 1 1 (Ref.) 0.90 (0.69, 1.19) 0.79 (0.59, 1.06) 0.21 0.93 (0.87, 1.00)
Multivariable model 2 1 (Ref.) 0.90 (0.69, 1.18) 0.77 (0.58, 1.04) 0.18 0.93 (0.87, 1.00)
Multivariable model 3 1 (Ref.) 0.90 (0.69, 1.18) 0.78 (0.58, 1.05) 0.18 0.94 (0.87, 1.00)
Cox regression models were used to assess the risk of cardiovascular events and mortality by baseline energy-adjusted tertiles of total olive oil (g/day) and as a
continuous variable (10 g/d). Results were presented as Hazard Ratios (95% CI). Multivariable model 1 was adjusted for age (years), sex and theintervention group.
Model 2 was also adjusted for body mass index (BMI) (kg/m2), smoking status (never, former, current smoker), alcohol intake (continuous, adding a quadratic
term), educational level (illiterate/primary education, secondary education, academic/graduate), leisure time physical activity (Metabolic Equivalent of Task
(MET)-minutes/d), prevalence of diabetes (yes/no), prevalence of hypertension (yes/no), prevalence of hypercholesterolemia (yes/no), use of antihypertensive
medication (yes/no) and use of statins (yes/no). Model 3 was also adjusted for Mediterranean diet adherence (Modified 12-point Mediterranean Diet score). All
models were stratified by recruitment center. Extremes of total energy intake were excluded. A major event was a composite of myocardial infarction, stroke and
death from cardiovascular causes.
Guasch-Ferré et al. BMC Medicine Page 6 of 112014, 12:78
http://www.biomedcentral.com/1741-7015/12/78
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
(99 events) were considered, the RR in the top tertile
of olive oil was: 0.55 (95% CI: 0.33 to 0.93), and only
including events occurred after four years the RR was:
0.56 (95% CI: 0.31 to 1.01). The RR for the top tertile
of olive oil excluding early cases occurred in the first year
(230 events included) was 0.60 (95% CI: 0.43 to 0.85), and
excluding late cases after four years (190 events included)
the RR was 0.68 (95% CI: 0.46 to 0.98).
Discussion
In this prospective study of Mediterranean individuals at
high cardiovascular risk, we found that baseline total
olive oil consumption, especially the extra-virgin variety,
was associated with a significant reduced risk of major
cardiovascular events and cardiovascular mortality in a
Mediterranean population at high cardiovascular risk.
Relative risk reductions in CVD and all-cause mortality
were similar for the upper baseline category of total
olive oil consumption when we evaluated the repeated
measurements of total olive oil consumption over time.
We also found a reduction in cardiovascular mortality
for an increased consumption of total olive oil. Each
increase of 10 g/d in EVOO intake was associated with
a 10% reduction in the risk of cardiovascular events.
To the contrary, consumption of common olive oil was
not significantly associated with cardiovascular morbidity
and mortality.
In both MedDiet groups of our study (supplemented
either with EVOO or nuts), participants in the top tertile
of total olive oil consumption at baseline showed a lower
risk of major events compared to those in the lowest ter-
tile, but no associations were found for those individuals
Table 3 Risk of cardiovascular events and mortality according to baseline extra-virgin olive oil intake
Energy-adjusted tertiles of extra-virgin olive oil, g/day
1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend Energy-adjusted
extra virgin olive
oil intake (10 g/d)
Mean extra-virgin olive oil intake 9.1 ± 11.23 19.5 ± 20.0 34.6 ± 27.4
Major event
Cardiovascular event, % (n) 4.6 (111) 4.2 (101) 2.7 (65) 3.8 (277)
Multivariable model 1 1 (Ref.) 1.01 (0.77, 1.33) 0.60 (0.43, 0.82) < 0.01 0.89 (0.84, 0.95)
Multivariable model 2 1 (Ref.) 1.00 (0.76, 1.32) 0.60 (0.44, 0.84) < 0.01 0.90 (0.85, 0.95)
Multivariable model 3 1 (Ref.) 0.99 (0.75, 1.31) 0.61 (0.44, 0.85) < 0.01 0.90 (0.85, 0.95)
Cardiovascular mortality 1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend
Cardiovascular mortality, % (n) 1.3 (32) 1.2 (28) 0.9 (21) 1.1 (81)
Multivariable model 1 1 (Ref.) 1.01 (0.60, 1.70) 0.64 (0.36, 1.15) 0.10 0.93 (0.84, 1.03)
Multivariable model 2 1 (Ref.) 0.99 (0.59, 1.67) 0.64 (0.36, 1.15) 0.10 0.93 (0.83, 1.03)
Multivariable model 3 1 (Ref.) 0.97 (0.58, 1.64) 0.65 (0.36, 1.17) 0.13 0.93 (0.84, 1.03)
Cancer mortality 1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend
Cancer mortality, % (n) 2.1 (50) 1.7 (41) 1.6 (39) 1.8 (130)
Multivariable model 1 1 (Ref.) 0.90 (0.59, 1.37) 0.87 (0.56, 1.37) 0.61 0.96 (0.88, 1.04)
Multivariable model 2 1 (Ref.) 0.88 (0.58, 1.35) 0.88 (0.56, 1.39) 0.68 0.96 (0.89, 1.05)
Multivariable model 3 1 (Ref.) 0.89 (0.58, 1.35) 0.90 (0.57, 1.41) 0.73 0.97 (0.89, 1.05)
All-cause mortality 1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend
All causes of mortality, % (n) 5.2 (125) 4.2 (100) 4.1 (98) 4.5 (323)
Multivariable model 1 1 (Ref.) 0.88 (0.67, 1.15) 0.81 (0.61, 1.07) 0.19 0.95 (0.91, 1.00)
Multivariable model 2 1 (Ref.) 0.84 (0.64, 1.10) 0.80 (0.60, 1.07) 0.20 0.95 (0.90, 1.00)
Multivariable model 3 1 (Ref.) 0.84 (0.64, 1.10) 0.82 (0.61, 1.09) 0.25 0.96 (0.91, 1.01)
Cox regression models were used to assess the risk of cardiovascular events and mortality by baseline energy-adjusted tertiles of extra virgin olive oil (g/day) and as a
continuous variable (10 g/d). Results were presented as Hazard Ratios (95% CI). Multivariable model 1 was adjusted for age (years), sex and the intervention group.
Model 2 was also adjusted for body mass index (BMI) (kg/m2), smoking status (never, former, current smoker), alcohol intake (continuous, adding a quadratic term),
educational level (illiterate/primary education, secondary education, academic/graduate), leisure time physical activity (Metabolic Equivalent of Task (MET)-minutes/d),
prevalence of diabetes (yes/no), prevalence of hypertension (yes/no), prevalence of hypercholesterolemia (yes/no), use of antihypertensive medication (yes/no) and use
of statins (yes/no). Model 3 was also adjusted for Mediterranean diet adherence (Modified 12-point Mediterranean Diet score). All models were stratified by recruitment
center. Extremes of total energy intake were excluded. A major event was a composite of myocardial infarction, stroke and death from cardiovascular causes.
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allocated to the control group. One explanation could be
that the advice against eating fat food such as olive oil in
the low fat control group throughout the study might
have counterbalanced the protective effect of a lifetime
intake of olive oil. However, we found inverse associa-
tions between olive oil consumption and CVD not only
in the group supplemented with EVOO but also in the
nuts group. Although it is difficult to isolate the effect
of a single food because a range of foods are consumed
in the whole diet, our study was able to distinguish the
effects attributed to olive oil, a food that it is clearly a key
component of the MedDiet. The positive association found
in the MedDiet groups seems to confirm these effects.
Recent findings of the PREDIMED Study have dem-
onstrated that adherence to the Mediterranean dietary
pattern, as a whole and enriched with EVOO or nuts,
reduce the incidence of major cardiovascular events by
30% within the context of primary prevention [12]. Our re-
sults further confirm the important role that olive oil con-
sumption may play, even though other key components of
the MedDiet, such as nuts, vegetables, fruits, legumes,
fish and wine could also contribute to the observed
beneficial effects. In agreement with our results, previ-
ous observational studies found an inverse association
between olive oil consumption and CVD. Thus, in the
EPICOR study conducted in 30,000 Italian women
followed for 7.8 years, a 44% reduction in the risk of
CHD was observed in those women in the top quartile of
total olive oil consumption compared to those in the lo-
west quartile [4]. Similarly, the hazard ratio of CHD in
Table 4 Risk of cardiovascular events and mortality according to baseline common olive oil intake
Energy-adjusted tertiles of common olive oil, g/day
1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend Energy-adjusted
common olive oil
intake (10 g/d)
Mean common olive oil intake 12.1 ± 11.7 18.6 ± 18.5 21.7 ± 25.9
Major event
Cardiovascular event, % (n) 3.5 (85) 3.6 (86) 4.4 (106) 3.8 (277)
Multivariable model 1 1 (Ref.) 1.06 (0.78, 1.45) 1.20 (0.88, 1.62) 0.23 1.04 (0.99, 1.10)
Multivariable model 2 1 (Ref.) 1.01 (0.74, 1.38) 1.13 (0.83, 1.54) 0.35 1.04 (0.98, 1.10)
Multivariable model 3 1 (Ref.) 0.99 (0.73, 1.36) 1.11 (0.82, 1.51) 0.40 1.03 (0.98, 1.09)
Cardiovascular mortality 1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend
Cardiovascular mortality, % (n) 1.3 (31) 1.0 (24) 1.1 (26) 1.1 (81)
Multivariable model 1 1 (Ref.) 0.87 (0.50, 1.51) 0.84 (0.48, 1.46) 0.60 0.98 (0.88, 1.09)
Multivariable model 2 1 (Ref.) 0.84 (0.48, 1.47) 0.84 (0.48, 1.48) 0.65 0.98 (0.88, 1.09)
Multivariable model 3 1 (Ref.) 0.83 (0.47, 1.46) 0.81 (0.46, 1.43) 0.56 0.98 (0.87, 1.09)
Cancer mortality 1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend
Cancer mortality, % (n) 1.7 (40) 1.7 (42) 2.0 (48) 1.8 (130)
Multivariable model 1 1 (Ref.) 1.07 (0.68, 1.68) 1.16 (0.74, 1.82) 0.51 1.01 (0.92, 1.10)
Multivariable model 2 1 (Ref.) 1.04 (0.66, 1.64) 1.16 (0.74, 1.82) 0.49 1.01 (0.93, 1.10)
Multivariable model 3 1 (Ref.) 1.03 (0.65, 1.62) 1.14 (0.73, 1.79) 0.52 1.01 (0.92, 1.10)
All-cause mortality 1 (low)
(n = 2,405)
2
(n = 2,406)
3 (high)
(n = 2,405)
P for trend
All causes of mortality, % (n) 4.2 (101) 4.4 (106) 4.8 (116) 4.5 (323)
Multivariable model 1 1 (Ref.) 1.14 (0.86, 1.51) 1.17 (0.88, 1.51) 0.34 1.01 (0.96, 1.07)
Multivariable model 2 1 (Ref.) 1.10 (0.83, 1.47) 1.16 (0.87, 1.54) 0.37 1.01 (0.96, 1.07)
Multivariable model 3 1 (Ref.) 1.09 (0.82, 1.45) 1.14 (0.85, 1.51) 0.44 1.01 (0.96, 1.07)
Cox regression models were used to assess the risk of cardiovascular events and mortality by baseline energy-adjusted tertiles of common olive oil (g/day) and as
a continuous variable (10 g/d). Results were presented as Hazard Ratios (95% CI). Multivariable model 1 was adjusted for age (years), sex and the intervention group.
Model 2 was also adjusted for body mass index (BMI) (kg/m2), smoking status (never, former, current smoker), alcohol intake (continuous, adding a quadratic term),
educational level (illiterate/primary education, secondary education, academic/graduate), leisure time physical activity (Metabolic Equivalent of Task (MET)-minutes/d),
prevalence of diabetes (yes/no), prevalence of hypertension (yes/no), prevalence of hypercholesterolemia (yes/no), use of antihypertensive medication (yes/no) and use
of statins (yes/no). Model 3 was also adjusted for Mediterranean diet adherence (Modified 12-point Mediterranean Diet score). All models were stratified by recruitment
center. Extremes of total energy intake were excluded. A major event was a composite of myocardial infarction, stroke and death from cardiovascular causes.
Guasch-Ferré et al. BMC Medicine Page 8 of 112014, 12:78
http://www.biomedcentral.com/1741-7015/12/78
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
participants in the top quartile of olive oil consumption in
the Spanish EPIC cohort was 0.78 (95% CI: 0.59 to 1.03)
compared to the reference, after a 10.4-year follow-up. In
this study, the reduction of CHD risk was greater for vir-
gin olive oil than for the common variety [5].
We found a strong relationship between total olive oil
consumption and the composite of cardiovascular major
events, but when we analyzed separately myocardial in-
farction and stroke, the associations were non-significant.
This could be explained by the lack of statistical power,
but, according to our results, two previous case-control
studies conducted in an Italian population also reported
no associations between olive oil intake and myocardial
infarction [20,21].
Our data suggest that total olive oil intake was in-
versely associated with cardiovascular mortality but not
with cancer mortality: each 10 g/d increase in total olive
oil consumption is associated with a 16% reduction in
cardiovascular mortality. These results are supported by
the findings of EPIC-Spain, where a 44% reduction in
CVD mortality was found in participants at the top quartile
of total olive oil consumption compared to those in the
bottom quartile [6] and they can contribute to solving
the inconsistencies reported by a recent meta-analysis [9].
In the same study of EPIC-Spain, total olive oil intake was
not associated with cancer mortality [6]. However, like our
study, this study did not examine specific types of cancer.
A recent review of epidemiological studies reported some
evidence suggesting that olive oil can decrease the risk of
upper digestive and respiratory tract neoplasms, breast
cancer and probably cancer in other sites [10]. Therefore,
future larger studies or meta-analyses may need to focus
on incidence and mortality of specific cancer sites.
The outcomes regarding olive oil consumption and
all-cause mortality have been inconsistent, as reported in
a recent meta-analysis including a large number of partici-
pants [9]. A previous study conducted in participants from
Italy, who have suffered a myocardial infarction, showed that
there was a 24% (HR: 0.76; 95% CI: 0.64 to 0.91) reduction
in the risk of overall mortality for those consuming olive
oil regularly compared to those who never consumed
olive oil [7]. The results from the EPIC-cohort indicated
a 26% (HR: 0.74; 95% CI: 0.64 to 0.87) reduction in the
risk of overall mortality for those in the highest quartile
of total olive oil intake compared to the lowest quartile
[6]. On the contrary, no associations were found between
total olive oil intake and all-cause mortality in a free-
living Greek population [22]. Our findings suggest a
non-significant possible inverse relation between each
10 g/d (one tablespoon of oil) increase in total olive oil
and EVOO consumption and all-cause mortality.
The inverse associations between olive oil consumption
and CVD could be explained by several mechanisms.
The beneficial effects of olive oil are mainly attributed
to its high content on MUFAs (that are less susceptible to
oxidation than other type of fatty acids) but also to other
minor components with important biological properties,
such as phenolic compounds, vitamin E and other lipid-
derivate molecules (squalene, tocopherols, triterpenic
alcohols and so on), especially occurring in EVOO [2,3].
Evidence suggests that olive oil has anti-inflammatory
and anti-atherogenic effects and it may also play a beneficial
role in reducing oxidative stress and improving endothelial
function [3,23,24]. Moreover, it has been observed that
EVOO, particularly in a context of a MedDiet, improved
lipid profile, insulin sensitivity, glycemic control, decreased
blood pressure [11,24-27] and also was inversely associated
with new-onset diabetes [28], all of them considered strong
risk factors for CVD.
The strengths of the present study are its prospective
design and a relatively long duration of follow-up. In
addition, previous studies made no distinctions among
different varieties of olive oil, but we analyzed the associa-
tions for EVOO and common olive oil separately. The
present study was conducted in a population where the
intake of total olive oil was relatively high, allowing a
better assessment of the association between olive oil
consumption and CVD or mortality.
Some limitations of our study deserve attention. First,
the generalizability of our results may be limited, as the
studied population was composed of Mediterranean elderly
individuals at high cardiovascular risk who increased their
intake of olive oil due to the intervention. However, the
findings from our study are broadly consistent with those
from other populations. Although the individuals changed
their oil consumption during the study and this could have
affected the observed beneficial effects of olive oil, it should
be noted that the baseline intake of olive oil was high
and the baseline assessment can be considered as a good
correlate of lifetime habits in this population. Second,
because of the observational nature of the study, residual
confounding remains a possibility even though our analyses
were extensively adjusted for a wide range of cardiovascu-
lar risk factors. Nonetheless, our observational findings
are consistent with the intervention effects observed in
the olive oil enriched arm in the PREDIMED trial. Finally,
although the FFQ used was validated, measurement errors
are inevitable, especially regarding self-reported different
varieties of olive oil.
Conclusions
In summary, we found that greater consumption of total
olive oil, especially EVOO, was associated with reduced
cardiovascular disease and mortality risk in an elderly
Mediterranean population at high cardiovascular risk.
Our findings underscore olive oil consumption as one
of the key components of the MedDiet for cardiovascu-
lar disease prevention.
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6.3. DIETARY MAGNESIUM INTAKE IS INVERSELY ASSOCIATED WITH MORTALITY IN 
ADULTS AT HIGH CARDIOVASCULAR DISEASE RISK 
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Raventós RM, Ruiz-Gutiérrez V, Salas-Salvadó J; PREDIMED Study Group. 
 
J Nutr. 2014 Jan;144(1):55-60. PMID: 24259558; doi: 10.3945/jn.113.183012. 
 
Study 3 overview. Novelty and significance.  
What is already known? 
- The relation between dietary magnesium intake and cardiovascular disease and mortality was 
evaluated in several prospective studies, but few of them have assessed the risk of all-cause 
mortality. 
- This has never been evaluated in Mediterranean individuals at high cardiovascular risk.  
 
What this study adds? 
- In our prospective study of Mediterranean individuals at high risk followed for a median of 4.8 
years, we found that dietary magnesium intake was associated with cardiovascular, cancer and 
all-cause mortality.  
- Compared with lower consumers, individuals in the highest tertile of magnesium intake had 
37% (HR: 0.63, 95% CI: 0.46-0.86) reduction in all-cause mortality risk. 
Summary 
- Our findings suggest an inverse association between dietary magnesium intake and 
cardiovascular, cancer, and all-cause mortality in participants at high cardiovascular risk. 
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Dietary Magnesium Intake Is Inversely Associated with
Mortality in Adults at High Cardiovascular Risk1–3
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Abstract
The relation between dietary magnesium intake and cardiovascular disease (CVD) or mortality was evaluated in
several prospective studies, but few of them have assessed the risk of all-cause mortality, which has never been
evaluated in Mediterranean adults at high cardiovascular risk. The aim of this study was to assess the association
between magnesium intake and CVD and mortality risk in a Mediterranean population at high cardiovascular risk with
high average magnesium intake. The present study included 7216 men and women aged 55–80 y from the PREDIMED
(Prevencio´n con Dieta Mediterra´nea) study, a randomized clinical trial. Participants were assigned to one of two
Mediterranean diets (supplemented with nuts or olive oil) or advice on a low-fat control diet. Mortality was ascertained
by linkage to the National Death Index and medical records. We fitted multivariable-adjusted Cox regressions to assess
associations between baseline energy-adjusted tertiles of magnesium intake and relative risk of CVD and mortality.
Multivariable analyses with generalized estimating equation models were used to assess the associations between yearly
repeated measurements of magnesium intake and mortality. After a median follow-up of 4.8 y, 323 total deaths, 81
cardiovascular deaths, 130 cancer deaths, and 277 cardiovascular events occurred. Energy-adjusted baseline magnesium
intake was inversely associated with cardiovascular, cancer, and all-cause mortality. Compared with lower consumers,
individuals in the highest tertile of magnesium intake had a 34% reduction in mortality risk (HR: 0.66; 95% CI: 0.45, 0.95;
P < 0.01). Dietary magnesium intake was inversely associated with mortality risk in Mediterranean individuals at high risk of
CVD. This trial was registered at controlled-trials.com as ISRCTN35739639. J. Nutr. doi: 10.3945/jn.113.183012.
Introduction
Magnesium is an essential mineral for the human body, acting as
a coenzyme in different ATP-dependent reactions and in the
production and transport of energy and proteins (1). The major
food sources of magnesium are vegetables, fruits, legumes, nuts,
soy products, and whole grains. Some evidence suggests that
high dietary magnesium intake plays a protective role not only
in cardiovascular risk factors, such as diabetes mellitus (2),
2 Author disclosures: M. Guasch-Ferre´, M. Bullo´, R. Estruch, D. Corella, M. A.
Mart´ınez-Gonza´lez, E. Ros, M. Covas, F. Aro´s, E. Go´mez-Gracia, M. Fiol, J. Lapetra,
M. A´. Mun˜oz, L. Serra-Majem, N. Babio, X. Pinto´, R. M. Lamuela-Ravento´s, V.
Ruiz-Gutie´rrez, and J. Salas-Salvado´, no conflicts of interest.
3 Supplemental Appendix is available from the "Online Supporting Material" link in the
online posting of the article and from the same link in the online table of contents at
http://jn.nutrition.org.
1 This study was funded in part by the Spanish Ministry of Health (Institute of Salud
Carlos III) grant PI1001407, Thematic Network grants G03/140 and RD06/0045, the
European Fund of Regional Development, and the Catalan Center for Nutrition of the
Institute of Catalan Studies. The Communal Olive Heritage Foundation and Hojiblanca
(Ma´laga, Spain), CaliforniaWalnut Commission (Sacramento, CA), Borges (Reus, Spain),
and Morella Nuts (Reus, Spain) donated the olive oil, walnuts, almonds, and hazelnuts,
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hypertension (3), and metabolic syndrome (4), but also in
cardiovascular disease (CVD)20 (5).
A meta-analysis evaluating the association between magne-
sium and the risk of cardiovascular events demonstrated that
both dietary and serum magnesium were inversely related with
the risk of total CVD events (6). Similarly, inverse associations
between dietary magnesium intake and risk of stroke or ischemic
heart disease were also demonstrated in two other recent meta-
analyses (7,8).
Prospective studies have also been made into the relation
between magnesium and cardiovascular and cancer mortality.
Some suggest inverse associations (9,10) between magnesium
intake and cardiovascular mortality, but others have found no
significant associations (4,11,12). Two prospective studies have
evaluated the association between dietary magnesium intake and
cancer death (11,12). Finally, an inverse association between
dietary or plasma magnesium concentrations and sudden
cardiac death was reported recently (13), and serum magnesium
has also been inversely associated with cardiovascular, cancer,
and all-cause mortality in middle-aged men (14).
Although some studies have shown that dietary magnesium
intake is inversely related to CVDs and mortality, very few
have evaluated the risk of all-cause mortality (11), and these
associations have not been evaluated previously in Mediterra-
nean individuals.
We hypothesized that dietary magnesium intake is inversely
associated with CVDs and mortality. Therefore, the main aim of
the present study was to assess the association between dietary
magnesium intake and the risk of CVD (a composite including
stroke, myocardial infarction, and cardiovascular death) and
cardiovascular, cancer, and all-cause mortality in Mediterranean
individuals at high risk of CVD and with a high average
magnesium intake.
Materials and Methods
Study population. The PREDIMED (Prevencio´n con Dieta Medi-
terra´nea) study is a multicenter, randomized, parallel-group clinical trial
conducted in Spain. Details of the cohort, design of the study, and
methods were described previously (15–18). The study was registered at
controlled-trials.com as ISRCTN35739639 (19). A complete list of the
PREDIMED investigators is listed in the Supplemental Appendix. The
study included men (aged 55–80 y) and women (aged 60–80 y) who were
free of CVD at enrollment but at high CVD risk. The inclusion criteria
for the participants in the trial were having type 2 diabetes mellitus or
three or more of the following cardiovascular risk factors: 1) family
history of premature CVD; 2) overweight or obesity; 3) current smoking;
4) hypertension; 5) hypercholesterolemia; and 6) low HDL-cholesterol.
The exclusion criteria included the following: 1) presence of BMI $ 40
kg/m2; 2) alcohol or drug abuse; 3) any severe chronic illness; and 4)
allergy or intolerance to olive oil or nuts. The study included 7447
participants who were randomized to one of two Mediterranean diets
(MedDiets) [supplemented with either extra-virgin olive oil (EVOO) or
mixed nuts] or to a control diet (advice on a low-fat diet). All
participants included in the study provided written informed consent
according to a protocol approved by the institutional review boards of
the recruiting centers. In the present study, we analyzed data as in an
observational prospective cohort.
Assessment of magnesium intake and other covariates. Dietary
magnesium intake was assessed by a validated baseline 137-item FFQ
completed by trained dieticians (20). We used Spanish food composition
tables to estimate energy and nutrient intake (21,22). Reproducibility and
validity of the FFQ for dietary magnesium intake estimated by the
Pearsons correlation coefficient (r) was 0.71, and the intraclass correlation
coefficients for reproducibility and validitywere 0.83 and 0.67, respectively
(P < 0.001). At baseline, we administered several questionnaires about
history of illnesses, medication use, lifestyle variables, and educational
achievement. The validated Spanish version of theMinnesota Leisure-Time
Physical Activity questionnaire was used to assess physical activity (23).
If participants were being treated with antidiabetic, cholesterol-lowering,
or antihypertensive agents, or if they had been diagnosed previously, they
were considered to be diabetic, hypercholesterolemic, or hypertensive,
respectively. Anthropometric and blood pressure measurements were taken
by trained personnel. We used calibrated scales and a wall-mounted
stadiometer to measure weight and height, respectively, with participants
in light clothing and no shoes. Waist circumference was measured midway
between the lowest rib and the iliac using an anthropometric tape.We used
a validated oscillometer (HEM705CP; Omron) to measure blood pressure
in triplicate with a 5-min interval between each measurement, and we
recorded the mean of these three values.
Ascertainment of CVD and mortality. For the present analysis, we
used the following endpoints: 1) a composite of cardiovascular events
(myocardial infarction, stroke, and death from cardiovascular causes);
and 2) cardiovascular, cancer, and all-cause mortality. The endpoint
adjudication committee, whose members were unaware of treatment
allocation, updated information on these endpoints once a year. The
committee used different sources of information: 1) yearly question-
naires and examinations for all participants; 2) family physicians; 3)
yearly review of medical records; and 4) linkage to the National Death
Index. Medical records of deceased participants were requested, and the
endpoint adjudication committee determined the cause of death.
Statistical analyses. ANOVA or the Pearsons x2 tests were used to
compare the quantitative or categorical baseline characteristics of the study
participants, respectively, across baseline energy-adjusted tertiles of mag-
nesium intake. The results were expressed as means 6 SEs or percentages.
Follow-up time was calculated as the difference between the date of
the cardiovascular event, death, or end of follow-up (the date of the last
visit or the last recorded clinical event of participants who were still
alive) and the date of recruitment.
Multivariate Cox regression models were fitted to estimate the
hazard ratios (HRs) and 95% CIs of the cardiovascular events and
cardiovascular, cancer, and all-cause mortality. We stratified all analyses
by the recruitment center. The first multivariate model was adjusted for
sex, age (years), and intervention group. The second model was also
adjusted for the following covariates: 1) BMI; 2) smoking status (never,
former, current smoker); 3) leisure time physical activity [metabolic
equivalent task (MET)-min/d, MET, 1 MET-min is approximately
equivalent to 1 kcal, METs-min/d); 4) educational level (illiterate/
primary education, secondary education, academic/graduate); 5) prev-
alence of hypertension (yes/no); 6) prevalence of diabetes (yes/no); 7)
prevalence of hypercholesterolemia (yes/no); 8) family history of
coronary heart disease (CHD) (no, yes before 55 y, yes after 55 y); 9)
use of aspirin (yes/no); 10) use of oral antidiabetic medication (yes/no);
11) use of antihypertensive medication (yes/no); 12) use of hypocholes-
terolemic medication (yes/no); and 13) alcohol intake (continuous,
adding a quadratic term). A third model was adjusted for the total of
dietary fiber and calcium intake. When myocardial infarction and stroke
were used as the outcomes of the analysis, the models were adjusted for
the same potential confounders used in model 2. We also separated the
analysis by intervention group. We assigned the median value to each
tertile of magnesium intake and used it as a continuous variable to assess
linear trend tests in various models. During the follow-up, we obtained
information on magnesium intake yearly. We repeated the analysis using
generalized estimating equations to evaluate the association between
repeated measurements of energy-adjusted magnesium intake and
mortality. For each 1-y period, the exposure indicator we used was the
average magnesium intake of all repeatedmeasurements from baseline to
the beginning of that yearly period.
The level of significance for all statistical tests was P < 0.05 for bilateral
contrast. Analyses were performed using SPSS statistical software (version
19; SPSS).
20 Abbreviations used: CVD, cardiovascular disease; EVOO, extra-virgin olive oil;
MedDiet, Mediterranean Diet; MET, metabolic equivalent task.
2 of 6 Guasch-Ferre´ et al.
 at H
AR
VAR
D
 UNIVERSITY on Novem
ber 22, 2013
jn.nutrition.org
D
ow
nloaded from
 
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
Results
For the present analysis, we excluded those participants with
high or low energy intake (<500 or >3500 kcal/d for women;
>800 or >4000 kcal/d for men) and those with incomplete
dietary data at baseline (n = 78). As a result, a total of 7216
participants were included. There were no significant interac-
tions between dietary magnesium intake and sex, alcohol intake,
smoking status, or the use of medication.
The baseline characteristics of study participants according
to baseline energy-adjusted tertiles of dietary magnesium are
shown in Table 1. The participants in the highest tertile of
dietary magnesium intake were mainly women, had lower body
weight, were more physically active, and were less likely to
smoke or drink alcohol. These participants also had intakes of
dietary fiber and calcium. The mean intake of magnesium in the
lowest and the highest energy-adjusted tertile, respectively, was
318 and 454 mg/d.
The median follow-up time of the study was 4.8 y; after this
period, 323 total deaths, 81 cardiovascular deaths, 130 cancer
deaths, and 277 cardiovascular events occurred (Table 2). Of the
total deaths, 145 were in the lower energy-adjusted tertile of
magnesium intake and 78 in the upper tertile.
Table 2 shows the HRs and 95% CIs for CVD and mortality
according to baseline energy-adjusted tertiles of magnesium
intake. After adjusting for potential confounders (model 2),
those participants with the highest magnesium intake had 37%
less risk of all-cause mortality (HR: 0.63; 95% CI: 0.46, 0.86;
P-trend < 0.01) than those participants in the lower tertile.
Magnesium intake was also inversely associated with cardio-
vascular and cancer mortality. The respective multivariable HRs
in model 2 for the highest energy-adjusted tertile of magnesium
intake were 0.53 (95% CI: 0.28, 0.99), P-trend = 0.06 and 0.55
(95% CI: 0.33, 0.91), P-trend = 0.04. Additional adjustment for
total intake of dietary fiber and calcium intake (model 3) did not
appreciably alter these results [HR for all-cause mortality for the
highest compared with the lowest tertile: 0.66 (95% CI: 0.45,
0.95); HR for cardiovascular mortality: 0.41 (95% CI: 0.19,
0.88); HR for cancer mortality: 0.63 (95% CI: 0.35, 1.15)]. To
exclude the potential bias effect of those individuals who took
TABLE 1 Baseline characteristics of study participants according to energy-adjusted tertiles of dietary magnesium intake1
Baseline energy-adjusted tertiles of magnesium intake
Variable 1 (n = 2405) 2 (n = 2406) 3 (n = 2405) P values2
Median magnesium intake, mg/d 312 341 442
Age, y 67 6 6 67 6 6 67 6 6 0.05
Men, % (n) 54.2 (1303) 38.7 (932) 34.8 (836) ,0.01
BMI, kg/m2 30.0 6 3.70 29.9 6 3.86 29.9 6 4.00 0.54
Weight, kg 78.2 6 11.9 76.2 6 12.1 75.8 6 11.7 ,0.01
Leisure-time energy expenditure in physical activity, MET-min/d 225 6 227 224 6 226 244 6 262 ,0.01
Smoking status, % (n) ,0.01
Never 53.6 (1290) 63.6 (1530) 67.3 (1619)
Current 18.9 (454) 12.4 (299) 10.4 (251)
Former 27.5 (661) 24.0 (577) 22.2 (535)
Educational level, % (n) 0.15
Illiterate/primary education 76.8 (1847) 78.3 (1885) 77.8 (1872)
Secondary education 16.5 (396) 14.8 (355) 14.3 (345)
Academic/graduate 6.7 (162) 6.9 (166) 7.8 (188)
Prevalence of diabetes, % (n) 46.2 (1111) 49.5 (1191) 50.9 (1225) ,0.01
Prevalence of hypertension, % (n) 83.1 (1998) 83.6 (2011) 81.5 (1961) 0.14
Prevalence of hypercholesterolemia, % (n) 68.8 (1654) 72.5 (1745) 75.4 (1813) ,0.01
Family history of myocardial infarction, % (n) 19.5 (468) 23.4 (563) 24.1 (580) ,0.01
Medication use, % (n)
Aspirin 21.3 (512) 21.9 (527) 23.9 (574) 0.08
Oral antidiabetic drugs 29.6 (712) 33.7 (812) 33.2 (799) ,0.01
Antihypertensive drugs 72.9 (1753) 74.1 (1784) 71.1 (1711) 0.06
Statins 37.2 (894) 40.4 (972) 43.2 (1038) ,0.01
Total energy intake, kcal/d 2340 6 565 2110 6 496 2260 6 542 ,0.01
Magnesium intake, mg/d 318 6 73.0 347 6 67.8 454 6 102 ,0.01
Alcohol intake, g/d 12.1 6 17.9 6.97 6 11.7 5.94 6 10.6 ,0.01
Total protein, g/d 86.9 6 20.9 88.1 6 19.4 98.9 6 21.6 ,0.01
Total carbohydrates, g/d 240 6 78.9 218 6 66.4 244 6 71.4 ,0.01
Total fat, g/d 105 6 28.0 92.8 6 26.0 93.9 6 29.0 ,0.01
Saturated fat, g/d 26.9 6 8.84 23.8 6 7.67 23.7 6 8.45 ,0.01
Monounsaturated fat, g/d 53.3 6 14.9 46.2 6 14.2 44.9 6 15.2 ,0.01
Polyunsaturated fat, g/d 15.8 6 6.4 14.6 6 5.90 16.2 6 7.26 ,0.01
Total fiber, g/d 20.4 6 5.55 23.0 6 5.57 32.3 6 9.19 ,0.01
Calcium intake, mg/d 890 6 306 1010 6 321 1190 6 375 ,0.01
1 Values are mean 6 SE or percentage (n). MET, metabolic equivalent task.
2 P values for comparisons across baseline energy-adjusted magnesium intake (Pearson x2 test for categorical variables or one-factor analysis of variance for continuous variable)
as appropriate.
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magnesium supplements and multivitamins, we conducted a
sensitivity analysis from which they were excluded (seven in-
dividuals from the total population, 0.09%), and the results did
not change.
After adjusting for all potential confounders included in the
previous model 2, the HRs for baseline dietary magnesium
intake and major cardiovascular event were 0.83 (95% CI: 0.6,
1.14; P-trend = 0.27) and 0.62 (95%CI: 0.36, 1.06;P-trend = 0.08)
when we analyzed only the risk of myocardial infarction. Neither
was any association found when we analyzed the risk of stroke
(HR: 1.10; 95% CI: 0.70, 1.74; P-trend = 0.64).
When we separated the analysis by intervention group, we
observed a significant reduction in the risk of all-cause mortality
in those individuals in the highest tertile of magnesium con-
sumption and assigned to the control low-fat diet (HR: 0.42;
95% CI: 0.22, 0.78; P-trend < 0.01). There were no associations
for those who were assigned to the MedDiet with nuts and
EVOO. Compared with the individuals in the lowest tertile of
magnesium intake, we observed a significant reduction in the
risk of cardiovascular mortality in the individuals in the highest
tertile of magnesium intake and assigned to the MedDiet
supplemented with nuts (HR: 0.27; 95% CI: 0.08, 0.87; P-trend
= 0.04). No associations were observed for the other intervention
groups and other outcomes (major event and cancer death).
When we used generalized estimating equations to assess the
association between yearly updated measurements of energy-
adjusted magnesium and all-cause mortality, we observed a
fully-adjusted RR of 0.70 (95% CI: 0.52, 0.95), but the linear
trend test was nonsignificant (P-trend = 0.32). The analysis to
assess the relation between magnesium intake and cardiovascu-
lar mortality and cancer mortality showed a fully-adjusted RR
of 0.77 (95% CI: 0.40, 1.48) and 0.50 (95% CI: 0.30, 0.83),
respectively. The linear trend tests were also nonsignificant
(P-trend = 0.91 and 0.12, respectively).
Discussion
In this prospective study of Mediterranean individuals at high
risk of CVD, an inverse association was found between dietary
magnesium intake and risk of mortality. No significant associ-
ations were observed between magnesium intake and major
cardiovascular events. When we evaluated the repeated mea-
surements of magnesium intake over time, we found a reduction
in the RR of all-cause and cancer mortality in those individuals
in the higher tertile of magnesium intake compared with those in
the lower tertile.
There were no associations between baseline magnesium
intake and mortality in participants in the highest tertile of
magnesium intake in either of the MedDiet groups (supple-
mented with EVOO or nuts). However, a significant association
was found in those randomized to a low-fat control diet; they
were advised to reduce the intake of all sources of fat. The lower
magnesium intake in this group, then, probably resulted in a
stronger inverse association between magnesium intake and
mortality. In fact, previous evidence has suggested an inverse
relation between marginal-to-moderate dietary magnesium de-
ficiency and several chronic diseases (24).
A meta-analysis of 532,979 participants from 19 studies has
shown that the pooled RR of total CVD events was 15% and
33% lower in the highest category of dietary magnesium and
TABLE 2 Hazard ratios and 95% CIs for cardiovascular event and mortality according to tertiles of magnesium intake1
Baseline energy-adjusted tertiles of dietary magnesium intake, HR (95% CI)
1 (low) (n = 2405) 2 (n = 2406) 3 (high) (n = 2405) P-trend
Major event2
Median magnesium intake, mg/d 312 341 442
Cardiovascular event, % (n) 4.6 (111) 3.8 (91) 3.1 (75)
Crude model 1 (Reference) 0.86 (0.65, 1.14) 0.73 (0.54, 0.98) 0.04
Multivariable model 13 1 (Reference) 0.96 (0.72, 1.28) 0.80 (0.59, 1.09) 0.15
Multivariable model 24 1 (Reference) 0.92 (0.68, 1.23) 0.83 (0.60, 1.14) 0.27
Cardiovascular mortality
Cardiovascular death, % (n) 1.7 (40) 1.0 (23) 0.7 (18)
Crude model 1 (Reference) 0.60 (0.36, 1.01) 0.49 (0.28, 0.85) 0.02
Multivariable model 1 1 (Reference) 0.70 (0.41, 1.18) 0.51 (0.28, 0.95) 0.04
Multivariable model 2 1 (Reference) 0.67 (0.39, 1.16) 0.53 (0.28, 0.99) 0.06
Cancer death
Cancer death, % (n) 2.6 (63) 1.5 (37) 1.2 (30)
Crude model 1 (Reference) 0.62 (0.42, 0.94) 0.52 (0.34, 0.81) 0.01
Multivariable model 1 1 (Reference) 0.67 (0.44, 1.02) 0.57 (0.35, 0.91) 0.04
Multivariable model 2 1 (Reference) 0.65 (0.42, 1.01) 0.55 (0.33, 0.91) 0.04
All-cause mortality
All causes of death, % (n) 6.0 (145) 4.2 (100) 3.2 (78)
Crude model 1 (Reference) 0.73 (0.57, 0.94) 0.59 (0.45, 0.78) ,0.01
Multivariable model 1 1 (Reference) 0.79 (0.61, 1.03) 0.64 (0.48, 0.86) ,0.01
Multivariable model 2 1 (Reference) 0.77 (0.59, 1.01) 0.63 (0.46, 0.86) ,0.01
1 Cox regression models were used to assess the risk of mortality by tertiles of dietary magnesium intake (mg/d).
2 Major event was a composite of myocardial infarction, stroke, and death from cardiovascular causes.
3 Multivariable model 1 was adjusted for age in years, sex, and intervention group.
4 Model 2 was also adjusted for body mass index (kg/m2), smoking status (never, former, current smoker), educational level (illiterate/primary education, secondary education,
academic/graduate), leisure time physical activity (metabolic equivalent task-min/d), prevalence of diabetes (yes/no), prevalence of hypertension (yes/no), prevalence of
hypercholesterolemia (yes/no), family history of coronary heart disease (no, yes before 55 y, yes after 55 y), use of aspirin (yes/no), use of antihypertensive medication (yes/no),
use of oral antidiabetic medication (yes/no), use of hypocholesterolemic medication (yes/no), alcohol intake (continuous, adding a quadratic term). All models were stratified by
recruitment center. Extremes of total energy intake were excluded.
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serum magnesium, respectively, than in the lowest (6). Results
were similar for ischemic stroke in another meta-analysis of
seven prospective studies with 241,378 participants (7). Signif-
icant associations between circulating magnesium and CVD
events were shown by the most recent meta-analysis, which also
associated dietary magnesium with 22% lower risk of ischemic
heart disease and showed an inverse significant association
between dietary magnesium and fatal ischemic heart disease up
to a threshold of ;250 mg/d compared with higher intakes (8).
The findings of these meta-analyses consistently showed inverse
associations between magnesium intake or status and cardio-
vascular events. However, in the present study of the PRE-
DIMED cohort, we have not demonstrated a significant
decreased risk in the composite of cardiovascular events.
To the best of our knowledge, five previous prospective
studies have directly assessed the associations between magne-
sium intake and the risk of cardiovascular death with diverging
results (4,9–11,13). In agreement with our results, a decreased
risk in mortality by CVD and sudden cardiac death was found in
the women of the Japan Collaborative Cohort and the Nurses
Health Study, respectively (10,13). Conversely, a nonsignificant
inverse association was found for fatal CHD in the men of the
Health Professional Follow-Up Study cohort (9), and a nonsig-
nificant effect was also found between dietary magnesium and
cardiovascular death in the Womens Health Study and the
Cohort of Swedish Men (4,11). The mean intake of magnesium
in the lowest categories in these studies was apparently adequate
for healthy individuals but probably not for individuals at high
cardiovascular risk, such as those in the PREDIMED study (24).
Only two prospective studies—the Cohort of Swedish Men
and the EPIC-Heidelberg Study—have assessed the association
between dietary magnesium intake and cancer mortality. Neither
of them showed any associations (11,12), so our study is the first to
find a significant inverse association between dietary magnesium
intake and cancer mortality in individuals at high cardiovascular
risk. However, middle-aged men with higher serum magnesium
concentrations had a 50% lower risk of cancer death than those in
the lower quartile of serum magnesium intake (14). Magnesium is
involved in several biochemical reactions modulating cell prolif-
eration, differentiation, and apoptosis (25). It was also shown to
play a key role in genetic stability and DNA synthesis (26), and
supplemental magnesium was shown to reduce the incidence of
cancer, possibly by means of inhibition of c-myc oncogene
expression in cancer cells (27,28). Intake of magnesium was also
reported to reduce insulin resistance and the risk of type 2 diabetes,
which is a potential risk factor for cancer (29).
Finally, only one prospective study has related dietary magne-
sium intake and all-cause mortality. The results of this study
concluded that there was no significant association between
magnesium intake and all-cause mortality in the men of the
Cohort of Swedish Men (11). However, in agreement with our
results, there was a 60% reduction in all-cause mortality in
individuals with a high concentration of serum magnesium
compared with those in the reference category (14). In our study,
we also found a significant reduction in the risk of all-cause
mortality. It should be mentioned that the enrollment conditions
of the present study—i.e., individuals at high cardiovascular risk,
most of whom are overweight or obese and who apparently
have increased requirements of dietary magnesium—have con-
tributed to the positive associations observed between magnesium
intake and disease or mortality. Moreover, magnesium deficiency,
through exacerbating chronic inflammatory stress, may play a role
in the onset of such chronic diseases as atherosclerosis, hyperten-
sion, osteoporosis, diabetes mellitus, and cancer (24).
There may be several explanations for these associations. In
particular, hypertension is a strong risk factor for CVD, and it is
known that magnesium can lower blood pressure (30). Also,
magnesium intake may inhibit platelet aggregation, modulate
inflammation, and improve endothelial function. All of these
mechanisms can have a beneficial effect on lowering the risk of
CVD and death (5,31).
We acknowledge that magnesium is an isolated nutrient, and it
is important to investigate the associations between the whole diet
and health. However, to establish appropriate dietary patterns, it is
essential to know which nutrients and food play an important role
in the target pathologies, in this case CVD and mortality.
Several potential limitations of our study deserve comment.
First, the present results may not be extrapolatable to the general
population because the study was conducted in participants with
a high risk of CVD. Second, there is the possibility of residual
confounding, especially of dietary fiber or other nutrients. To
prevent this from happening, we adjusted the analysis for
possible confounders. The FFQ may also lead to the misclassi-
fication of magnesium intake despite having been validated and
providing a reasonable reflection of dietary intake (20). Finally,
given the observational nature of the study, it is not possible to
firmly establish a cause-and-effect relation of the variables
studied. Conversely, the strengths of our study are that the
sample studied is large, the follow-up relatively long, and the
ascertainment of mortality accurate.
In conclusion, the findings from this prospective study
suggest an inverse association between dietary magnesium
intake and cardiovascular, cancer, and all-cause mortality.
Additional studies in different populations should confirm
these results.
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7. DISCUSSION 
The aim of the present study was to assess the effect of key components of the MedDiet on the 
risk of cardiovascular disease and mortality in a Mediterranean population at high 
cardiovascular risk. The focus is on three MedDiet components: total nuts, olive oil and its 
varieties, and dietary magnesium intake. Nuts and olive oil make MedDiet unique and different 
from other dietary patterns. These have been recognised, among others, as the key components 
that might explain the cardio-protective effect of MedDiet. On the other hand, magnesium is a 
nutrient which is found in high amounts in the MedDiet because it is present in most of the 
characteristic components of the MedDiet such as nuts, vegetables, fruits, legumes and whole 
grains.  
 
7.1. GENERAL DISCUSSION 
The research findings obtained in this project make an important contribution to the existing 
scientific evidence in the field of MedDiet and cardiovascular health. In particular, we have 
analysed, for the first time, the effect of MedDiet components on CVD and mortality in the 
context of the primary cardiovascular prevention. This is crucial because it could avoid further 
complications associated with CVD, reduce the financial and human burden and importantly 
decrease the risk of death from CVD.  
The PREDIMED Study has demonstrated that a MedDiet supplemented with extra-virgin olive oil 
or nuts reduced the incidence of major cardiovascular events68. The present work was carried 
out as a post-hoc analysis of the PREDIMED data treating the individuals as an observational 
cohort. The current prospective study was conducted on Mediterranean individuals at high 
cardiovascular risk from Spain, where the intake of nuts, olive oil and dietary magnesium is 
relatively high compared to other regions. We have observed that after a median of 4.8 years of 
follow-up, the frequency of nut consumption was inversely associated with cause-specific and 
all-cause mortality; the baseline total olive oil consumption, specifically the extra-virgin variety, 
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was inversely associated with cardiovascular events and cardiovascular mortality; and dietary 
magnesium was inversely associated with cause-specific and all-cause mortality.  
Our results expand the existing literature on the importance of consuming olive oil and nuts as 
part of a healthy dietary pattern. First of all, it is important to mention that there is still a 
popular belief that nuts and olive oil may increase body weight because they are an energy-
dense and high-fat food. However, the scientific evidence suggests that frequent nut 
consumption and olive oil intake does not lead to any appreciable weight gain208,209. Probably 
this could be explained by the fact that olive oil and nuts may increase satiety, diet-induced 
thermogenesis, daily energy expenditure and post-prandial fat oxidation that decrease energy 
intake from other sources208,210,211. Moreover, it has been shown that the quality of fat  is more 
important rather than the total fat of the diet140. In general, nuts and olive oil are vegetal fat rich 
in MUFA and some nuts (e.g. walnuts) in PUFA, which have been associated with several health 
benefits87,212. Besides not being associated with weight gain, nuts and olive oil have been 
consistently related to be beneficial in the prevention of cardiovascular and chronic 
diseases76,213.  
Even though there is an emerging body of evidence demonstrating the inverse associations 
between nuts and olive oil, CVD and mortality93,168,169; to date, none of the previous studies have 
analysed these associations in a Mediterranean population at high cardiovascular risk. In 
addition, most of the studies have made no distinction between different types of nuts (walnuts 
and non-walnuts) or different varieties of olive oil (extra-virgin olive oil and common olive oil). 
In contrast, our studies have differentiated between these varieties in the analyses.   
In agreement with our results showing an inverse association between nut consumption and all-
cause mortality, a recent meta-analysis including 11 prospective cohort studies has concluded 
that increasing intake of 1-serving of nuts was associated with 17% reduced risk of all-cause 
mortality (pooled RR was 0.83, and 95% CI: 0.76-0.91)94. Our research findings have also 
demonstrated an inverse relationship between the frequency of nut consumption and 
cardiovascular and cancer death. Large prospective studies have reported consistent inverse 
associations between nut consumption and fatal CHD or sudden cardiac death214–216. 
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Furthermore, a recent pooled analysis, using the cohorts of NHS and HPFS including 76,464 
women and 42,498 men, has observed that consuming nuts two or more times per week versus 
never consuming nuts was associated with 24% lower risk of dying from heart disease (pooled 
RR 0.76, 95% CI 0.67-0.85) and 17% lower risk of dying from cancer (pooled RR 0.83, 95% CI 
0.76-0.90)93. 
The findings of this thesis demonstrate an inverse association between olive oil intake and the 
risk of major cardiovascular diseases. These results are consistent with those from prior 
studies78,79. A 44% reduction in the risk of CHD was observed in Italian women in the top 
quartile of olive oil consumption78 and 22% reduction in the risk of CHD was also found in the 
Spanish EPIC cohort participants in the top quartile of olive oil intake79. A recent meta-analysis 
including studies which have investigated the association between olive oil consumption and 
CHD has found a non-significant reduction in the risk of CHD for 25 g increase in olive oil 
intake168. The main results of the PREDIMED trial have demonstrated that a MedDiet 
supplemented with EVOO reduced the risk of composite cardiovascular events by 30% (HR: 
0.70, 95% CI 0.54-0.92) as compared to the control group68. Our data suggested an inverse 
association between olive oil intake and all-cause mortality but the results were not significant. 
The results on this outcome are not well established; although some studies have found a 
reduction in the risk of all-cause mortality61,67 others have found no significant associations43. In 
line with a previous report of the Spanish EPIC-Study,61 we found an inverse relation between 
olive oil intake and cardiovascular mortality but not with cancer mortality. EVOO has been 
associated with even more reduced risk of CVD in our analyses, probably because it contains 
higher amounts of bioactive and antioxidant components than other varieties and it is 
considered as the best quality olive oil.  
Finally, we observed inverse associations between dietary magnesium intake and cause-specific 
and overall mortality. Few previous studies have assessed the association between dietary 
magnesium and all-cause mortality. No significant association was found in a cohort of Swedish 
men,190 but a 60% reduction was observed in individuals with a high concentration of serum 
magnesium intake217. Despite we found a 47% reduction in the risk of cardiovascular mortality 
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for the individuals in the higher tertile of magnesium intake, though the data on cardiovascular 
mortality seem to be inconsistent. Our results are in line with two prior prospective 
studies,189,218 but there are three others that found non-significant associations190,219,220. Since 
two previous studies failed to demonstrate inverse associations between cancer mortality and 
magnesium intake,190,191 our study is the first one that shows significant data on the inverse 
association between cancer death and magnesium intake. Even though meta-analyses of 
prospective cohorts found inverse associations between dietary and circulating magnesium 
intake,187,221,222 the results for the composite of cardiovascular events and dietary magnesium 
intake in the PREDIMED cohort  were not significant.  
The research findings of the present project further confirmed the important role that key 
components of MedDiet—nuts and olive oil, and also dietary magnesium—may play in the 
prevention of CVD and mortality. However, other components including vegetables, fruits, 
legumes, fish and wine could also contribute to the observed benefits suggesting that the 
adherence to a traditional MedDiet that includes all these foods might be the best option for the 
primary prevention of CVD.  
Several explanations can account for the observed inverse associations between nuts, olive oil, 
magnesium and CVD and mortality. The beneficial effects of nuts and olive oil are mainly 
attributed to its high contain of MUFA (in nuts, also PUFA), and minor components that have 
shown to have biological properties such as magnesium (in nuts), phytosterols, vitamin E, 
phenolic compounds and lipid molecules86,211,212. Evidence suggests that olive oil and nuts intake 
could improve blood lipid profile88,223 and insulin sensitivity, and modulate inflammation, 
oxidative stress and endothelial function70,74,89,224. Consequently, they reduce the risk of 
diabetes, hypertension, obesity, metabolic syndrome and CHD, among others75,76,87,216,225.  
Magnesium, which is found in high amounts in nuts, may exert similar effects on health. It is 
thought that it could lower blood pressure that reduces the risk of hypertension, which is a 
strong risk factor for CHD226. Magnesium also plays a role in improving inflammation status and 
endothelial function, thus decreasing the risk of CVD and death227,228.  
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7.2. STRENGTHS AND LIMITATIONS 
Several strengths and potential limitations of this study need to be addressed. First, one of the 
main limitations is the studied population. The population consisted of elderly individuals at 
high cardiovascular risk; because of this, it was probably easier to detect changes in metabolic 
parameters as compared to a healthier population. The extrapolation of our results to others 
may be limited. However, the results are broadly consistent with those from other studies. In 
addition, our participants were from a Mediterranean country, where the intake of the analysed 
food was relatively high. Further studies are needed to evaluate, if lower intakes of nuts, olive oil 
and magnesium are inversely associated with cardiovascular risk factors, cardiovascular disease 
and mortality. 
Second, given to the observational nature of our studies and the potential residual confounding, 
it is not possible to firmly conclude that the associations reflect cause and effect. Nevertheless, 
our observational findings are consistent with the intervention effects found in the PREDIMED 
trial.  
Third, although the FFQ was validated, its use to assess the intake of food could lead to a 
misclassification of the food and nutrient consumption and measurement errors, particularly, to 
the varieties of olive oil and magnesium intake.  
On the other hand, our study also has a number of strengths. The prospective design and the 
relatively long follow-up (a median of about 5 years) could be highlighted. Our sample is 
relatively large and individuals are well characterised, since they are frequently attended by 
primary care physicians for being at high cardiovascular risk; therefore, they can get higher 
benefits of diet and lifestyle changes. Finally, the ascertainment of cardiovascular disease and 
mortality was objective and accurate. An End-point Adjudication Committee, whose members 
were blinded to the treatment allocation, updated the information once a year.  
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7.3. GLOBAL PERSPECTIVE 
As a global perspective, CVD and death due to non-communicable diseases are among the 
important public health concerns worldwide. The results of this research are relevant because 
they emphasise the importance of nutrition for the primary prevention of CVD and mortality. Of 
note, the intakes of some key components of MedDiet seem to be beneficial for CVD prevention. 
These findings support and expand the existing scientific literature on the associations between 
MedDiet—nuts, olive oil and magnesium—and the risk of CVD and mortality, especially 
confirming these data in individuals at high cardiovascular risk. There is a need of preserving 
and promoting traditional MedDiet as a cultural heritage and a healthy dietary pattern.  
In the last years, globalisation, industrialisation, a rapid increase in fast-food restaurants and 
advances in food industry have transformed the MedDiet of most Mediterranean regions into a 
more global and “Western” dietary pattern229. The intake of fresh fruit and vegetables, nuts, 
legumes, whole-grain and non-processed meat and fish have been replaced by processed 
energy-dense food, rich in refined carbohydrates, sugar and fat230. The diet changes combined 
with a more sedentary lifestyle, both at work and in leisure time activities, are a possible 
explanation of the increase in obesity and CVD epidemic of the last decades. Therefore, scientific 
studies demonstrating and supporting the benefits of MedDiet and its components are essential 
to make the different populations aware about it. We have contributed to investigate these 
associations in a Mediterranean population at high cardiovascular risk. Public health policies 
and appropriate nutritional recommendations to promote MedDiet and a healthy lifestyle at 
different levels (schools, universities, primary care centres, hospitals, etc.) should be a 
cornerstone for prevention of chronic disease at a national and international level.  
Another point to address is the possibility that non-Mediterranean regions could adopt a 
Mediterranean dietary pattern, which would imply similar health benefits for others. Indeed, 
some of the studies suggesting inverse associations between MedDiet and also nuts with CVD 
and mortality have been conducted in non-Mediterranean populations47,53,55. In contrast, studies 
on olive oil have been conducted mainly in Mediterranean regions, so its extrapolation to other 
regions in the world remains to be elucidated. The food globalisation, the availability of most 
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foods out of season and in different regions from where they are produced, as well as an 
adaptation of the MedDiet to the habits and culture of the different populations could make it 
feasible to transfer the MedDiet to other regions231. Actually, some countries and regions, such 
as Australia, Chile or California, because of the similar weather and agricultural conditions of the 
Mediterranean regions, already consume and produce some of the characteristic components of 
the MedDiet, particularly wine, olive oil and nuts.  
 
7.4. FUTURE PERSPECTIVES 
From the findings of the present work, we could consider several future hypotheses that will 
help complete and understand the current knowledge on olive oil, nuts, magnesium and 
Mediterranean diet on the risk of CVD, its related risk factors and mortality. In addition, a better 
understanding of the mechanisms that could explain the associations reported in the current 
thesis will be an important point to investigate.  
Further epidemiological studies to extrapolate our results to other populations (healthy adults 
or individuals with overweight or obesity) will be of great interest to corroborate the 
associations in people without cardiovascular risk factors to evaluate if it is effective in 
conveying a message to these populations. Analyses of the transferability of the Mediterranean 
diet and its components, olive oil and nuts in non-Mediterranean individuals, where the 
consumption of these foods are lower, will be also an interesting line of research to explore. 
Regarding magnesium intake, it would be interesting to analyse the associations in healthy and 
non-Mediterranean populations with different levels of magnesium intake. Besides the 
magnesium intake, it would also be important to analyse the effect that serum magnesium has 
on CVD and death to avoid the possible interactions of magnesium with other components of the 
diet.  
Further clinical trials similar to the PREDIMED Study but with longer follow-up, larger number 
of participants and in different populations will be very helpful to expand knowledge in the area 
of Mediterranean diet and cardiovascular health.   
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Moreover, the results of this work suggest inverse associations between olive oil, nuts and 
magnesium and CVD and mortality, but the mechanisms involved in these associations have not 
been clearly demonstrated. An innovative and appropriate approach to understand the possible 
mechanisms could be conducting of metabolomics analyses in the context of the PREDIMED 
Study. Using metabolomics we can identify biomarkers, in an earlier stage, that are associated 
with an increased risk of suffering from diabetes, cardiovascular disease and other chronic 
disease. It would be interesting to evaluate if the dietary intervention conducted in the 
PREDIMED modifies the association between baseline metabolite profiles and diabetes and 
cardiovascular risk, and if an improvement in the metabolite profile resulting from the dietary 
intervention mediates the benefits of the Mediterranean diet on cardiovascular risk. Also, to 
identify the roles that olive oil and nuts may play in these associations. Investigating the 
metabolites that could influence in these associations through metabolomic techniques will 
allow us to provide effective public health messages for the primary prevention and 
management of cardiovascular disease.  
Furthermore, and because of the importance that genetics and the interaction between genetics 
and dietary habits have gained in the recent years, it would be compelling to apply other 
techniques such as nutrigenomics. This will provide a new insight to assess if the main 
components of the MedDiet, like olive oil or nuts, play a role in modulating genetic expression 
and consequently, if this association affects health and cardiovascular risk factors. To date, some 
genetic variants and single nucleotide polymorphisms have been related to cardiovascular and 
mortality. Therefore, it is essential to identify if some of these genetic loci are also associated 
with cardiovascular disease and mortality in a population at high cardiovascular risk; and, to 
evaluate the interactions between MedDiet and its components and these genetic variants. The 
techniques, such as lipidomics, proteomics, metabolomics, nutrigenomics, etc., will provide new 
tools that can lead to a more personalised nutrition.  
Finally, the findings of the present thesis combined with the near-future research on this topic 
will help provide strong scientific evidence to develop and promote public health actions based 
on diet, lifestyle and behavioural changes. 
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8. CONCLUSIONS 
From the results of this prospective cohort study of Mediterranean elderly individuals at high 
cardiovascular risk, following conclusions can be made:  
 
 
1. EFFECTS OF NUT INTAKE ON MORTALITY 
The frequency of nut consumption was inversely related to cardiovascular, cancer and total 
mortality after 4.8 years of follow-up. 
 
2. EFFECTS OF OLIVE OIL INTAKE ON CARDIOVASCULAR DISEASE MORTALITY 
Olive oil consumption, specifically the extra-virgin variety, was associated with reduced risk of 
cardiovascular disease and cardiovascular mortality after 4.8 years of follow-up. 
 
3. EFFECTS OF MAGNESIUM INTAKE ON CARDIOVASCULAR DISEASE AND MORTALITY 
Dietary magnesium intake was inversely associated with cardiovascular, cancer and total 
mortality risk after 4.8 years of follow-up.  
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Final comments 
The results of this work support the healthy benefits of the components of MedDiet on the 
primary prevention of cardiovascular disease and mortality. The key components of MedDiet 
play important roles in these associations. The observed benefits of MedDiet are probably 
explained by the sum of all the effects of its individual components. This work has contributed 
to add knowledge on the effect of specific foods of MedDiet —nuts, olive oil, magnesium and 
other nutrients—on cardiovascular disease and mortality. It has public health relevance due to 
the benefits that could be gained, both for financial and human burden, if more attention is paid 
on the primary prevention of cardiovascular disease.  
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PREDIMED Study.  
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
 
 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
 
 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
 
 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
 
 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
COMPONENTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR DISEASE AND MORTALITY IN A POPULATION AT 
HIGH CARDIOVASCULAR RISK. 
Marta Guasch Ferré 
Dipòsit Legal: T 1834-2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX V.  
Follow-up general questionnaire.  
PREDIMED Study. 
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Tolerance questionnaire. PREDIMED Study.  
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